id	sid	tid	token	lemma	pos
cord-305956-l02xdq87	1	1	key	key	JJ
cord-305956-l02xdq87	2	1	:	:	:
cord-305956-l02xdq87	2	2	cord-305956-l02xdq87	cord-305956-l02xdq87	CD
cord-305956-l02xdq87	2	3	authors	author	NNS
cord-305956-l02xdq87	2	4	:	:	:
cord-305956-l02xdq87	2	5	Alqahtani	Alqahtani	NNP
cord-305956-l02xdq87	2	6	,	,	,
cord-305956-l02xdq87	2	7	Saleh	Saleh	NNP
cord-305956-l02xdq87	2	8	A	A	NNP
cord-305956-l02xdq87	2	9	;	;	:
cord-305956-l02xdq87	2	10	Schattenberg	Schattenberg	NNP
cord-305956-l02xdq87	2	11	,	,	,
cord-305956-l02xdq87	2	12	Jörn	Jörn	NNP
cord-305956-l02xdq87	2	13	M	M	NNP
cord-305956-l02xdq87	2	14	title	title	NN
cord-305956-l02xdq87	2	15	:	:	:
cord-305956-l02xdq87	2	16	Liver	liver	NN
cord-305956-l02xdq87	2	17	injury	injury	NN
cord-305956-l02xdq87	2	18	in	in	IN
cord-305956-l02xdq87	2	19	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	2	20	:	:	:
cord-305956-l02xdq87	2	21	The	the	DT
cord-305956-l02xdq87	2	22	current	current	JJ
cord-305956-l02xdq87	2	23	evidence	evidence	NN
cord-305956-l02xdq87	2	24	date	date	NN
cord-305956-l02xdq87	2	25	:	:	:
cord-305956-l02xdq87	2	26	2020	2020	CD
cord-305956-l02xdq87	2	27	-	-	HYPH
cord-305956-l02xdq87	2	28	05	05	CD
cord-305956-l02xdq87	2	29	-	-	SYM
cord-305956-l02xdq87	2	30	26	26	CD
cord-305956-l02xdq87	2	31	journal	journal	NN
cord-305956-l02xdq87	2	32	:	:	:
cord-305956-l02xdq87	2	33	United	United	NNP
cord-305956-l02xdq87	2	34	European	European	NNP
cord-305956-l02xdq87	2	35	Gastroenterol	Gastroenterol	NNP
cord-305956-l02xdq87	2	36	J	J	NNP
cord-305956-l02xdq87	2	37	DOI	DOI	NNP
cord-305956-l02xdq87	2	38	:	:	:
cord-305956-l02xdq87	2	39	10.1177/2050640620924157	10.1177/2050640620924157	CD
cord-305956-l02xdq87	2	40	sha	sha	NNP
cord-305956-l02xdq87	2	41	:	:	:
cord-305956-l02xdq87	3	1	ad87636808fcce62fd2fe5f50c968b604dc21197	ad87636808fcce62fd2fe5f50c968b604dc21197	NNP
cord-305956-l02xdq87	3	2	doc_id	doc_id	CD
cord-305956-l02xdq87	3	3	:	:	:
cord-305956-l02xdq87	4	1	305956	305956	CD
cord-305956-l02xdq87	4	2	cord_uid	cord_uid	NNS
cord-305956-l02xdq87	4	3	:	:	:
cord-305956-l02xdq87	5	1	l02xdq87	l02xdq87	NNP
cord-305956-l02xdq87	5	2	Patients	Patients	NNP
cord-305956-l02xdq87	5	3	with	with	IN
cord-305956-l02xdq87	5	4	novel	novel	JJ
cord-305956-l02xdq87	5	5	coronavirus	coronavirus	NN
cord-305956-l02xdq87	5	6	disease	disease	NN
cord-305956-l02xdq87	5	7	2019	2019	CD
cord-305956-l02xdq87	5	8	(	(	-LRB-
cord-305956-l02xdq87	5	9	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	5	10	)	)	-RRB-
cord-305956-l02xdq87	5	11	experience	experience	VB
cord-305956-l02xdq87	5	12	various	various	JJ
cord-305956-l02xdq87	5	13	degrees	degree	NNS
cord-305956-l02xdq87	5	14	of	of	IN
cord-305956-l02xdq87	5	15	liver	liver	NN
cord-305956-l02xdq87	5	16	function	function	NN
cord-305956-l02xdq87	5	17	abnormalities	abnormality	NNS
cord-305956-l02xdq87	5	18	.	.	.
cord-305956-l02xdq87	6	1	Liver	liver	NN
cord-305956-l02xdq87	6	2	injury	injury	NN
cord-305956-l02xdq87	6	3	requires	require	VBZ
cord-305956-l02xdq87	6	4	extensive	extensive	JJ
cord-305956-l02xdq87	6	5	work	work	NN
cord-305956-l02xdq87	6	6	-	-	HYPH
cord-305956-l02xdq87	6	7	up	up	NN
cord-305956-l02xdq87	6	8	and	and	CC
cord-305956-l02xdq87	6	9	continuous	continuous	JJ
cord-305956-l02xdq87	6	10	surveillance	surveillance	NN
cord-305956-l02xdq87	6	11	and	and	CC
cord-305956-l02xdq87	6	12	can	can	MD
cord-305956-l02xdq87	6	13	be	be	VB
cord-305956-l02xdq87	6	14	multifactorial	multifactorial	JJ
cord-305956-l02xdq87	6	15	and	and	CC
cord-305956-l02xdq87	6	16	heterogeneous	heterogeneous	JJ
cord-305956-l02xdq87	6	17	in	in	IN
cord-305956-l02xdq87	6	18	nature	nature	NN
cord-305956-l02xdq87	6	19	.	.	.
cord-305956-l02xdq87	7	1	In	in	IN
cord-305956-l02xdq87	7	2	the	the	DT
cord-305956-l02xdq87	7	3	context	context	NN
cord-305956-l02xdq87	7	4	of	of	IN
cord-305956-l02xdq87	7	5	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	7	6	,	,	,
cord-305956-l02xdq87	7	7	clinicians	clinician	NNS
cord-305956-l02xdq87	7	8	will	will	MD
cord-305956-l02xdq87	7	9	have	have	VB
cord-305956-l02xdq87	7	10	to	to	TO
cord-305956-l02xdq87	7	11	determine	determine	VB
cord-305956-l02xdq87	7	12	whether	whether	IN
cord-305956-l02xdq87	7	13	liver	liver	NN
cord-305956-l02xdq87	7	14	injury	injury	NN
cord-305956-l02xdq87	7	15	is	be	VBZ
cord-305956-l02xdq87	7	16	related	relate	VBN
cord-305956-l02xdq87	7	17	to	to	IN
cord-305956-l02xdq87	7	18	an	an	DT
cord-305956-l02xdq87	7	19	underlying	underlying	JJ
cord-305956-l02xdq87	7	20	liver	liver	NN
cord-305956-l02xdq87	7	21	disease	disease	NN
cord-305956-l02xdq87	7	22	,	,	,
cord-305956-l02xdq87	7	23	drugs	drug	NNS
cord-305956-l02xdq87	7	24	used	use	VBN
cord-305956-l02xdq87	7	25	for	for	IN
cord-305956-l02xdq87	7	26	the	the	DT
cord-305956-l02xdq87	7	27	treatment	treatment	NN
cord-305956-l02xdq87	7	28	of	of	IN
cord-305956-l02xdq87	7	29	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	7	30	,	,	,
cord-305956-l02xdq87	7	31	direct	direct	JJ
cord-305956-l02xdq87	7	32	effect	effect	NN
cord-305956-l02xdq87	7	33	of	of	IN
cord-305956-l02xdq87	7	34	the	the	DT
cord-305956-l02xdq87	7	35	virus	virus	NN
cord-305956-l02xdq87	7	36	,	,	,
cord-305956-l02xdq87	7	37	or	or	CC
cord-305956-l02xdq87	7	38	a	a	DT
cord-305956-l02xdq87	7	39	complicated	complicated	JJ
cord-305956-l02xdq87	7	40	disease	disease	NN
cord-305956-l02xdq87	7	41	course	course	NN
cord-305956-l02xdq87	7	42	.	.	.
cord-305956-l02xdq87	8	1	Recent	recent	JJ
cord-305956-l02xdq87	8	2	studies	study	NNS
cord-305956-l02xdq87	8	3	proposed	propose	VBD
cord-305956-l02xdq87	8	4	several	several	JJ
cord-305956-l02xdq87	8	5	theories	theory	NNS
cord-305956-l02xdq87	8	6	on	on	IN
cord-305956-l02xdq87	8	7	potential	potential	JJ
cord-305956-l02xdq87	8	8	mechanisms	mechanism	NNS
cord-305956-l02xdq87	8	9	of	of	IN
cord-305956-l02xdq87	8	10	liver	liver	NN
cord-305956-l02xdq87	8	11	injury	injury	NN
cord-305956-l02xdq87	8	12	in	in	IN
cord-305956-l02xdq87	8	13	these	these	DT
cord-305956-l02xdq87	8	14	patients	patient	NNS
cord-305956-l02xdq87	8	15	.	.	.
cord-305956-l02xdq87	9	1	This	this	DT
cord-305956-l02xdq87	9	2	review	review	NN
cord-305956-l02xdq87	9	3	summarizes	summarize	VBZ
cord-305956-l02xdq87	9	4	current	current	JJ
cord-305956-l02xdq87	9	5	evidence	evidence	NN
cord-305956-l02xdq87	9	6	related	relate	VBN
cord-305956-l02xdq87	9	7	to	to	IN
cord-305956-l02xdq87	9	8	hepatobiliary	hepatobiliary	JJ
cord-305956-l02xdq87	9	9	complications	complication	NNS
cord-305956-l02xdq87	9	10	in	in	IN
cord-305956-l02xdq87	9	11	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	9	12	,	,	,
cord-305956-l02xdq87	9	13	provides	provide	VBZ
cord-305956-l02xdq87	9	14	an	an	DT
cord-305956-l02xdq87	9	15	overview	overview	NN
cord-305956-l02xdq87	9	16	of	of	IN
cord-305956-l02xdq87	9	17	the	the	DT
cord-305956-l02xdq87	9	18	available	available	JJ
cord-305956-l02xdq87	9	19	case	case	NN
cord-305956-l02xdq87	9	20	series	series	NN
cord-305956-l02xdq87	9	21	and	and	CC
cord-305956-l02xdq87	9	22	critically	critically	RB
cord-305956-l02xdq87	9	23	elucidates	elucidate	VBZ
cord-305956-l02xdq87	9	24	the	the	DT
cord-305956-l02xdq87	9	25	proposed	propose	VBN
cord-305956-l02xdq87	9	26	mechanisms	mechanism	NNS
cord-305956-l02xdq87	9	27	and	and	CC
cord-305956-l02xdq87	9	28	provides	provide	VBZ
cord-305956-l02xdq87	9	29	recommendations	recommendation	NNS
cord-305956-l02xdq87	9	30	for	for	IN
cord-305956-l02xdq87	9	31	clinicians	clinician	NNS
cord-305956-l02xdq87	9	32	.	.	.
cord-305956-l02xdq87	10	1	In	in	IN
cord-305956-l02xdq87	10	2	the	the	DT
cord-305956-l02xdq87	10	3	current	current	JJ
cord-305956-l02xdq87	10	4	pandemic	pandemic	NN
cord-305956-l02xdq87	10	5	coronavirus	coronavirus	NN
cord-305956-l02xdq87	10	6	disease	disease	NN
cord-305956-l02xdq87	10	7	(	(	-LRB-
cord-305956-l02xdq87	10	8	COVID-	covid-	NN
cord-305956-l02xdq87	10	9	19	19	CD
cord-305956-l02xdq87	10	10	)	)	-RRB-
cord-305956-l02xdq87	10	11	,	,	,
cord-305956-l02xdq87	10	12	almost	almost	RB
cord-305956-l02xdq87	10	13	every	every	DT
cord-305956-l02xdq87	10	14	country	country	NN
cord-305956-l02xdq87	10	15	in	in	IN
cord-305956-l02xdq87	10	16	the	the	DT
cord-305956-l02xdq87	10	17	world	world	NN
cord-305956-l02xdq87	10	18	has	have	VBZ
cord-305956-l02xdq87	10	19	now	now	RB
cord-305956-l02xdq87	10	20	registered	register	VBN
cord-305956-l02xdq87	10	21	COVID-19	covid-19	JJ
cord-305956-l02xdq87	10	22	cases	case	NNS
cord-305956-l02xdq87	10	23	,	,	,
cord-305956-l02xdq87	10	24	and	and	CC
cord-305956-l02xdq87	10	25	the	the	DT
cord-305956-l02xdq87	10	26	confirmed	confirm	VBN
cord-305956-l02xdq87	10	27	cases	case	NNS
cord-305956-l02xdq87	10	28	have	have	VBP
cord-305956-l02xdq87	10	29	exceeded	exceed	VBN
cord-305956-l02xdq87	10	30	one	one	CD
cord-305956-l02xdq87	10	31	million	million	CD
cord-305956-l02xdq87	10	32	to	to	IN
cord-305956-l02xdq87	10	33	date	date	NN
cord-305956-l02xdq87	10	34	.	.	.
cord-305956-l02xdq87	11	1	While	while	IN
cord-305956-l02xdq87	11	2	initial	initial	JJ
cord-305956-l02xdq87	11	3	clinical	clinical	JJ
cord-305956-l02xdq87	11	4	studies	study	NNS
cord-305956-l02xdq87	11	5	,	,	,
cord-305956-l02xdq87	11	6	especially	especially	RB
cord-305956-l02xdq87	11	7	from	from	IN
cord-305956-l02xdq87	11	8	China	China	NNP
cord-305956-l02xdq87	11	9	,	,	,
cord-305956-l02xdq87	11	10	the	the	DT
cord-305956-l02xdq87	11	11	USA	USA	NNP
cord-305956-l02xdq87	11	12	and	and	CC
cord-305956-l02xdq87	11	13	Italy	Italy	NNP
cord-305956-l02xdq87	11	14	,	,	,
cord-305956-l02xdq87	11	15	have	have	VBP
cord-305956-l02xdq87	11	16	highlighted	highlight	VBN
cord-305956-l02xdq87	11	17	the	the	DT
cord-305956-l02xdq87	11	18	dominant	dominant	JJ
cord-305956-l02xdq87	11	19	clinical	clinical	JJ
cord-305956-l02xdq87	11	20	symptoms	symptom	NNS
cord-305956-l02xdq87	11	21	including	include	VBG
cord-305956-l02xdq87	11	22	fever	fever	NN
cord-305956-l02xdq87	11	23	,	,	,
cord-305956-l02xdq87	11	24	cough	cough	NN
cord-305956-l02xdq87	11	25	,	,	,
cord-305956-l02xdq87	11	26	fatigue	fatigue	NN
cord-305956-l02xdq87	11	27	and	and	CC
cord-305956-l02xdq87	11	28	shortness	shortness	NN
cord-305956-l02xdq87	11	29	of	of	IN
cord-305956-l02xdq87	11	30	breath	breath	NN
cord-305956-l02xdq87	11	31	,	,	,
cord-305956-l02xdq87	11	32	the	the	DT
cord-305956-l02xdq87	11	33	later	later	JJ
cord-305956-l02xdq87	11	34	research	research	NN
cord-305956-l02xdq87	11	35	unveiled	unveil	VBD
cord-305956-l02xdq87	11	36	shreds	shred	NNS
cord-305956-l02xdq87	11	37	of	of	IN
cord-305956-l02xdq87	11	38	evidence	evidence	NN
cord-305956-l02xdq87	11	39	on	on	IN
cord-305956-l02xdq87	11	40	the	the	DT
cord-305956-l02xdq87	11	41	extrapulmonary	extrapulmonary	JJ
cord-305956-l02xdq87	11	42	manifestations	manifestation	NNS
cord-305956-l02xdq87	11	43	of	of	IN
cord-305956-l02xdq87	11	44	the	the	DT
cord-305956-l02xdq87	11	45	disease	disease	NN
cord-305956-l02xdq87	11	46	.	.	.
cord-305956-l02xdq87	12	1	These	these	DT
cord-305956-l02xdq87	12	2	reports	report	NNS
cord-305956-l02xdq87	12	3	highlighted	highlight	VBD
cord-305956-l02xdq87	12	4	that	that	IN
cord-305956-l02xdq87	12	5	beyond	beyond	IN
cord-305956-l02xdq87	12	6	severe	severe	JJ
cord-305956-l02xdq87	12	7	acute	acute	JJ
cord-305956-l02xdq87	12	8	respiratory	respiratory	JJ
cord-305956-l02xdq87	12	9	syndrome	syndrome	NN
cord-305956-l02xdq87	12	10	coronavirus	coronavirus	NN
cord-305956-l02xdq87	12	11	2	2	CD
cord-305956-l02xdq87	12	12	(	(	-LRB-
cord-305956-l02xdq87	12	13	SARS	SARS	NNP
cord-305956-l02xdq87	12	14	-	-	HYPH
cord-305956-l02xdq87	12	15	CoV-2	CoV-2	NNP
cord-305956-l02xdq87	12	16	)	)	-RRB-
cord-305956-l02xdq87	12	17	,	,	,
cord-305956-l02xdq87	12	18	a	a	DT
cord-305956-l02xdq87	12	19	complicated	complicated	JJ
cord-305956-l02xdq87	12	20	course	course	NN
cord-305956-l02xdq87	12	21	of	of	IN
cord-305956-l02xdq87	12	22	the	the	DT
cord-305956-l02xdq87	12	23	disease	disease	NN
cord-305956-l02xdq87	12	24	or	or	CC
cord-305956-l02xdq87	12	25	even	even	RB
cord-305956-l02xdq87	12	26	viral	viral	JJ
cord-305956-l02xdq87	12	27	infection	infection	NN
cord-305956-l02xdq87	12	28	itself	-PRON-	PRP
cord-305956-l02xdq87	12	29	can	can	MD
cord-305956-l02xdq87	12	30	lead	lead	VB
cord-305956-l02xdq87	12	31	to	to	IN
cord-305956-l02xdq87	12	32	involvement	involvement	NN
cord-305956-l02xdq87	12	33	of	of	IN
cord-305956-l02xdq87	12	34	other	other	JJ
cord-305956-l02xdq87	12	35	organs	organ	NNS
cord-305956-l02xdq87	12	36	and	and	CC
cord-305956-l02xdq87	12	37	multiorgan	multiorgan	NN
cord-305956-l02xdq87	12	38	failure	failure	NN
cord-305956-l02xdq87	12	39	.	.	.
cord-305956-l02xdq87	13	1	The	the	DT
cord-305956-l02xdq87	13	2	liver	liver	NN
cord-305956-l02xdq87	13	3	is	be	VBZ
cord-305956-l02xdq87	13	4	the	the	DT
cord-305956-l02xdq87	13	5	primary	primary	JJ
cord-305956-l02xdq87	13	6	organ	organ	NN
cord-305956-l02xdq87	13	7	for	for	IN
cord-305956-l02xdq87	13	8	detoxification	detoxification	NN
cord-305956-l02xdq87	13	9	and	and	CC
cord-305956-l02xdq87	13	10	metabolism	metabolism	NN
cord-305956-l02xdq87	13	11	,	,	,
cord-305956-l02xdq87	13	12	and	and	CC
cord-305956-l02xdq87	13	13	maintaining	maintain	VBG
cord-305956-l02xdq87	13	14	an	an	DT
cord-305956-l02xdq87	13	15	optimal	optimal	JJ
cord-305956-l02xdq87	13	16	function	function	NN
cord-305956-l02xdq87	13	17	is	be	VBZ
cord-305956-l02xdq87	13	18	imperative	imperative	JJ
cord-305956-l02xdq87	13	19	to	to	TO
cord-305956-l02xdq87	13	20	engage	engage	VB
cord-305956-l02xdq87	13	21	all	all	DT
cord-305956-l02xdq87	13	22	available	available	JJ
cord-305956-l02xdq87	13	23	therapeutic	therapeutic	JJ
cord-305956-l02xdq87	13	24	modalities	modality	NNS
cord-305956-l02xdq87	13	25	in	in	IN
cord-305956-l02xdq87	13	26	the	the	DT
cord-305956-l02xdq87	13	27	treatment	treatment	NN
cord-305956-l02xdq87	13	28	of	of	IN
cord-305956-l02xdq87	13	29	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	13	30	.	.	.
cord-305956-l02xdq87	14	1	Abnormal	abnormal	JJ
cord-305956-l02xdq87	14	2	liver	liver	NN
cord-305956-l02xdq87	14	3	function	function	NN
cord-305956-l02xdq87	14	4	requires	require	VBZ
cord-305956-l02xdq87	14	5	clinical	clinical	JJ
cord-305956-l02xdq87	14	6	evaluation	evaluation	NN
cord-305956-l02xdq87	14	7	,	,	,
cord-305956-l02xdq87	14	8	continuous	continuous	JJ
cord-305956-l02xdq87	14	9	surveillance	surveillance	NN
cord-305956-l02xdq87	14	10	and	and	CC
cord-305956-l02xdq87	14	11	,	,	,
cord-305956-l02xdq87	14	12	potentially	potentially	RB
cord-305956-l02xdq87	14	13	,	,	,
cord-305956-l02xdq87	14	14	specific	specific	JJ
cord-305956-l02xdq87	14	15	therapy	therapy	NN
cord-305956-l02xdq87	14	16	.	.	.
cord-305956-l02xdq87	15	1	To	to	TO
cord-305956-l02xdq87	15	2	support	support	VB
cord-305956-l02xdq87	15	3	clinical	clinical	JJ
cord-305956-l02xdq87	15	4	decision	decision	NN
cord-305956-l02xdq87	15	5	making	making	NN
cord-305956-l02xdq87	15	6	and	and	CC
cord-305956-l02xdq87	15	7	optimize	optimize	VB
cord-305956-l02xdq87	15	8	the	the	DT
cord-305956-l02xdq87	15	9	outcome	outcome	NN
cord-305956-l02xdq87	15	10	in	in	IN
cord-305956-l02xdq87	15	11	the	the	DT
cord-305956-l02xdq87	15	12	treatment	treatment	NN
cord-305956-l02xdq87	15	13	of	of	IN
cord-305956-l02xdq87	15	14	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	15	15	,	,	,
cord-305956-l02xdq87	15	16	it	-PRON-	PRP
cord-305956-l02xdq87	15	17	will	will	MD
cord-305956-l02xdq87	15	18	be	be	VB
cord-305956-l02xdq87	15	19	crucial	crucial	JJ
cord-305956-l02xdq87	15	20	to	to	TO
cord-305956-l02xdq87	15	21	clearly	clearly	RB
cord-305956-l02xdq87	15	22	understand	understand	VB
cord-305956-l02xdq87	15	23	the	the	DT
cord-305956-l02xdq87	15	24	possible	possible	JJ
cord-305956-l02xdq87	15	25	mechanisms	mechanism	NNS
cord-305956-l02xdq87	15	26	involved	involve	VBN
cord-305956-l02xdq87	15	27	in	in	IN
cord-305956-l02xdq87	15	28	liver	liver	NN
cord-305956-l02xdq87	15	29	injury	injury	NN
cord-305956-l02xdq87	15	30	.	.	.
cord-305956-l02xdq87	16	1	The	the	DT
cord-305956-l02xdq87	16	2	current	current	JJ
cord-305956-l02xdq87	16	3	review	review	NN
cord-305956-l02xdq87	16	4	summarizes	summarize	VBZ
cord-305956-l02xdq87	16	5	the	the	DT
cord-305956-l02xdq87	16	6	pathophysiology	pathophysiology	NN
cord-305956-l02xdq87	16	7	and	and	CC
cord-305956-l02xdq87	16	8	potentially	potentially	RB
cord-305956-l02xdq87	16	9	specific	specific	JJ
cord-305956-l02xdq87	16	10	role	role	NN
cord-305956-l02xdq87	16	11	of	of	IN
cord-305956-l02xdq87	16	12	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	16	13	in	in	IN
cord-305956-l02xdq87	16	14	liver	liver	NN
cord-305956-l02xdq87	16	15	disease	disease	NN
cord-305956-l02xdq87	16	16	based	base	VBN
cord-305956-l02xdq87	16	17	on	on	IN
cord-305956-l02xdq87	16	18	the	the	DT
cord-305956-l02xdq87	16	19	available	available	JJ
cord-305956-l02xdq87	16	20	data	datum	NNS
cord-305956-l02xdq87	16	21	and	and	CC
cord-305956-l02xdq87	16	22	case	case	NN
cord-305956-l02xdq87	16	23	series	series	NN
cord-305956-l02xdq87	16	24	published	publish	VBN
cord-305956-l02xdq87	16	25	,	,	,
cord-305956-l02xdq87	16	26	ahead	ahead	RB
cord-305956-l02xdq87	16	27	of	of	IN
cord-305956-l02xdq87	16	28	print	print	NN
cord-305956-l02xdq87	16	29	and	and	CC
cord-305956-l02xdq87	16	30	non	non	JJ
cord-305956-l02xdq87	16	31	-	-	JJ
cord-305956-l02xdq87	16	32	peer	peer	NN
cord-305956-l02xdq87	16	33	-	-	HYPH
cord-305956-l02xdq87	16	34	reviewed	review	VBN
cord-305956-l02xdq87	16	35	preprints	preprint	NNS
cord-305956-l02xdq87	16	36	as	as	IN
cord-305956-l02xdq87	16	37	of	of	IN
cord-305956-l02xdq87	16	38	2	2	CD
cord-305956-l02xdq87	16	39	April	April	NNP
cord-305956-l02xdq87	16	40	.	.	.
cord-305956-l02xdq87	17	1	The	the	DT
cord-305956-l02xdq87	17	2	search	search	NN
cord-305956-l02xdq87	17	3	strategy	strategy	NN
cord-305956-l02xdq87	17	4	is	be	VBZ
cord-305956-l02xdq87	17	5	detailed	detail	VBN
cord-305956-l02xdq87	17	6	in	in	IN
cord-305956-l02xdq87	17	7	the	the	DT
cord-305956-l02xdq87	17	8	Supplementary	Supplementary	NNP
cord-305956-l02xdq87	17	9	Material	Material	NNP
cord-305956-l02xdq87	17	10	online	online	RB
cord-305956-l02xdq87	17	11	.	.	.
cord-305956-l02xdq87	18	1	Emerging	emerge	VBG
cord-305956-l02xdq87	18	2	data	datum	NNS
cord-305956-l02xdq87	18	3	from	from	IN
cord-305956-l02xdq87	18	4	small	small	JJ
cord-305956-l02xdq87	18	5	clinical	clinical	JJ
cord-305956-l02xdq87	18	6	case	case	NN
cord-305956-l02xdq87	18	7	studies	study	NNS
cord-305956-l02xdq87	18	8	have	have	VBP
cord-305956-l02xdq87	18	9	proposed	propose	VBN
cord-305956-l02xdq87	18	10	that	that	IN
cord-305956-l02xdq87	18	11	liver	liver	NN
cord-305956-l02xdq87	18	12	injury	injury	NN
cord-305956-l02xdq87	18	13	in	in	IN
cord-305956-l02xdq87	18	14	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	18	15	is	be	VBZ
cord-305956-l02xdq87	18	16	frequently	frequently	RB
cord-305956-l02xdq87	18	17	seen	see	VBN
cord-305956-l02xdq87	18	18	,	,	,
cord-305956-l02xdq87	18	19	but	but	CC
cord-305956-l02xdq87	18	20	the	the	DT
cord-305956-l02xdq87	18	21	extent	extent	NN
cord-305956-l02xdq87	18	22	and	and	CC
cord-305956-l02xdq87	18	23	underlying	underlying	JJ
cord-305956-l02xdq87	18	24	mechanisms	mechanism	NNS
cord-305956-l02xdq87	18	25	remain	remain	VBP
cord-305956-l02xdq87	18	26	undetermined	undetermined	JJ
cord-305956-l02xdq87	18	27	.	.	.
cord-305956-l02xdq87	19	1	Figure	figure	NN
cord-305956-l02xdq87	19	2	1	1	CD
cord-305956-l02xdq87	19	3	summarizes	summarize	VBZ
cord-305956-l02xdq87	19	4	the	the	DT
cord-305956-l02xdq87	19	5	pathophysiological	pathophysiological	JJ
cord-305956-l02xdq87	19	6	findings	finding	NNS
cord-305956-l02xdq87	19	7	,	,	,
cord-305956-l02xdq87	19	8	which	which	WDT
cord-305956-l02xdq87	19	9	are	be	VBP
cord-305956-l02xdq87	19	10	discussed	discuss	VBN
cord-305956-l02xdq87	19	11	below	below	RB
cord-305956-l02xdq87	19	12	.	.	.
cord-305956-l02xdq87	20	1	The	the	DT
cord-305956-l02xdq87	20	2	liver	liver	NN
cord-305956-l02xdq87	20	3	exerts	exert	VBZ
cord-305956-l02xdq87	20	4	a	a	DT
cord-305956-l02xdq87	20	5	crucial	crucial	JJ
cord-305956-l02xdq87	20	6	function	function	NN
cord-305956-l02xdq87	20	7	in	in	IN
cord-305956-l02xdq87	20	8	host	host	NN
cord-305956-l02xdq87	20	9	defense	defense	NN
cord-305956-l02xdq87	20	10	against	against	IN
cord-305956-l02xdq87	20	11	microbes	microbe	NNS
cord-305956-l02xdq87	20	12	and	and	CC
cord-305956-l02xdq87	20	13	is	be	VBZ
cord-305956-l02xdq87	20	14	involved	involve	VBN
cord-305956-l02xdq87	20	15	in	in	IN
cord-305956-l02xdq87	20	16	most	most	JJS
cord-305956-l02xdq87	20	17	systemic	systemic	JJ
cord-305956-l02xdq87	20	18	infections	infection	NNS
cord-305956-l02xdq87	20	19	as	as	IN
cord-305956-l02xdq87	20	20	it	-PRON-	PRP
cord-305956-l02xdq87	20	21	receives	receive	VBZ
cord-305956-l02xdq87	20	22	both	both	CC
cord-305956-l02xdq87	20	23	the	the	DT
cord-305956-l02xdq87	20	24	portal	portal	JJ
cord-305956-l02xdq87	20	25	and	and	CC
cord-305956-l02xdq87	20	26	systemic	systemic	JJ
cord-305956-l02xdq87	20	27	circulation	circulation	NN
cord-305956-l02xdq87	20	28	.	.	.
cord-305956-l02xdq87	21	1	Certain	certain	JJ
cord-305956-l02xdq87	21	2	viruses	virus	NNS
cord-305956-l02xdq87	21	3	exert	exert	VBP
cord-305956-l02xdq87	21	4	a	a	DT
cord-305956-l02xdq87	21	5	direct	direct	JJ
cord-305956-l02xdq87	21	6	cytopathic	cytopathic	JJ
cord-305956-l02xdq87	21	7	effect	effect	NN
cord-305956-l02xdq87	21	8	on	on	IN
cord-305956-l02xdq87	21	9	hepatocytes	hepatocyte	NNS
cord-305956-l02xdq87	21	10	and	and	CC
cord-305956-l02xdq87	21	11	cholangiocytes	cholangiocyte	NNS
cord-305956-l02xdq87	21	12	although	although	IN
cord-305956-l02xdq87	21	13	,	,	,
cord-305956-l02xdq87	21	14	in	in	IN
cord-305956-l02xdq87	21	15	most	most	JJS
cord-305956-l02xdq87	21	16	cases	case	NNS
cord-305956-l02xdq87	21	17	,	,	,
cord-305956-l02xdq87	21	18	the	the	DT
cord-305956-l02xdq87	21	19	pathogenesis	pathogenesis	NN
cord-305956-l02xdq87	21	20	seems	seem	VBZ
cord-305956-l02xdq87	21	21	multifactorial	multifactorial	JJ
cord-305956-l02xdq87	21	22	.	.	.
cord-305956-l02xdq87	22	1	Yang	Yang	NNP
cord-305956-l02xdq87	22	2	et	et	NNP
cord-305956-l02xdq87	22	3	al	al	NNP
cord-305956-l02xdq87	22	4	.	.	NNP
cord-305956-l02xdq87	22	5	reported	report	VBD
cord-305956-l02xdq87	22	6	that	that	IN
cord-305956-l02xdq87	22	7	SARS	SARS	NNP
cord-305956-l02xdq87	22	8	-	-	HYPH
cord-305956-l02xdq87	22	9	CoV	CoV	NNP
cord-305956-l02xdq87	22	10	could	could	MD
cord-305956-l02xdq87	22	11	cause	cause	VB
cord-305956-l02xdq87	22	12	direct	direct	JJ
cord-305956-l02xdq87	22	13	cytopathic	cytopathic	JJ
cord-305956-l02xdq87	22	14	liver	liver	NN
cord-305956-l02xdq87	22	15	injury	injury	NN
cord-305956-l02xdq87	22	16	rather	rather	RB
cord-305956-l02xdq87	22	17	than	than	IN
cord-305956-l02xdq87	22	18	inducing	induce	VBG
cord-305956-l02xdq87	22	19	cellular	cellular	JJ
cord-305956-l02xdq87	22	20	stress	stress	NN
cord-305956-l02xdq87	22	21	from	from	IN
cord-305956-l02xdq87	22	22	low	low	JJ
cord-305956-l02xdq87	22	23	oxygen	oxygen	NN
cord-305956-l02xdq87	22	24	supplies	supply	NNS
cord-305956-l02xdq87	22	25	or	or	CC
cord-305956-l02xdq87	22	26	cytokines	cytokine	NNS
cord-305956-l02xdq87	22	27	as	as	IN
cord-305956-l02xdq87	22	28	seen	see	VBN
cord-305956-l02xdq87	22	29	in	in	IN
cord-305956-l02xdq87	22	30	sepsis	sepsis	NN
cord-305956-l02xdq87	22	31	.	.	.
cord-305956-l02xdq87	23	1	1	1	LS
cord-305956-l02xdq87	24	1	Autopsy	autopsy	JJ
cord-305956-l02xdq87	24	2	studies	study	NNS
cord-305956-l02xdq87	24	3	in	in	IN
cord-305956-l02xdq87	24	4	patients	patient	NNS
cord-305956-l02xdq87	24	5	revealed	reveal	VBD
cord-305956-l02xdq87	24	6	that	that	IN
cord-305956-l02xdq87	24	7	SARS	SARS	NNP
cord-305956-l02xdq87	24	8	-	-	HYPH
cord-305956-l02xdq87	24	9	CoV	CoV	NNP
cord-305956-l02xdq87	24	10	was	be	VBD
cord-305956-l02xdq87	24	11	detectable	detectable	JJ
cord-305956-l02xdq87	24	12	in	in	IN
cord-305956-l02xdq87	24	13	41	41	CD
cord-305956-l02xdq87	24	14	%	%	NN
cord-305956-l02xdq87	24	15	of	of	IN
cord-305956-l02xdq87	24	16	the	the	DT
cord-305956-l02xdq87	24	17	liver	liver	NN
cord-305956-l02xdq87	24	18	tissue	tissue	NN
cord-305956-l02xdq87	24	19	,	,	,
cord-305956-l02xdq87	24	20	with	with	IN
cord-305956-l02xdq87	24	21	a	a	DT
cord-305956-l02xdq87	24	22	maximum	maximum	JJ
cord-305956-l02xdq87	24	23	viral	viral	JJ
cord-305956-l02xdq87	24	24	load	load	NN
cord-305956-l02xdq87	24	25	of	of	IN
cord-305956-l02xdq87	24	26	1.6	1.6	CD
cord-305956-l02xdq87	24	27	Â	â	CD
cord-305956-l02xdq87	24	28	10	10	CD
cord-305956-l02xdq87	24	29	6	6	CD
cord-305956-l02xdq87	24	30	copies	copy	NNS
cord-305956-l02xdq87	24	31	/	/	SYM
cord-305956-l02xdq87	24	32	g	g	NN
cord-305956-l02xdq87	24	33	of	of	IN
cord-305956-l02xdq87	24	34	tissue	tissue	NN
cord-305956-l02xdq87	24	35	.	.	.
cord-305956-l02xdq87	25	1	2	2	LS
cord-305956-l02xdq87	26	1	The	the	DT
cord-305956-l02xdq87	26	2	pathological	pathological	JJ
cord-305956-l02xdq87	26	3	findings	finding	NNS
cord-305956-l02xdq87	26	4	of	of	IN
cord-305956-l02xdq87	26	5	liver	liver	NN
cord-305956-l02xdq87	26	6	biopsy	biopsy	NN
cord-305956-l02xdq87	26	7	specimens	specimen	NNS
cord-305956-l02xdq87	26	8	from	from	IN
cord-305956-l02xdq87	26	9	SARS	SARS	NNP
cord-305956-l02xdq87	26	10	patients	patient	NNS
cord-305956-l02xdq87	26	11	showed	show	VBD
cord-305956-l02xdq87	26	12	hepatocellular	hepatocellular	JJ
cord-305956-l02xdq87	26	13	necrosis	necrosis	NN
cord-305956-l02xdq87	26	14	,	,	,
cord-305956-l02xdq87	26	15	mitoses	mitose	NNS
cord-305956-l02xdq87	26	16	,	,	,
cord-305956-l02xdq87	26	17	cellular	cellular	JJ
cord-305956-l02xdq87	26	18	infiltration	infiltration	NN
cord-305956-l02xdq87	26	19	and	and	CC
cord-305956-l02xdq87	26	20	fatty	fatty	JJ
cord-305956-l02xdq87	26	21	degeneration	degeneration	NN
cord-305956-l02xdq87	26	22	.	.	.
cord-305956-l02xdq87	27	1	In	in	IN
cord-305956-l02xdq87	27	2	a	a	DT
cord-305956-l02xdq87	27	3	recent	recent	JJ
cord-305956-l02xdq87	27	4	autopsy	autopsy	JJ
cord-305956-l02xdq87	27	5	analysis	analysis	NN
cord-305956-l02xdq87	27	6	of	of	IN
cord-305956-l02xdq87	27	7	liver	liver	NN
cord-305956-l02xdq87	27	8	tissue	tissue	NN
cord-305956-l02xdq87	27	9	from	from	IN
cord-305956-l02xdq87	27	10	a	a	DT
cord-305956-l02xdq87	27	11	patient	patient	NN
cord-305956-l02xdq87	27	12	with	with	IN
cord-305956-l02xdq87	27	13	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	27	14	,	,	,
cord-305956-l02xdq87	27	15	moderate	moderate	JJ
cord-305956-l02xdq87	27	16	microvesicular	microvesicular	JJ
cord-305956-l02xdq87	27	17	steatosis	steatosis	NN
cord-305956-l02xdq87	27	18	and	and	CC
cord-305956-l02xdq87	27	19	mild	mild	JJ
cord-305956-l02xdq87	27	20	inflammation	inflammation	NN
cord-305956-l02xdq87	27	21	in	in	IN
cord-305956-l02xdq87	27	22	the	the	DT
cord-305956-l02xdq87	27	23	lobular	lobular	NNP
cord-305956-l02xdq87	27	24	and	and	CC
cord-305956-l02xdq87	27	25	portal	portal	JJ
cord-305956-l02xdq87	27	26	area	area	NN
cord-305956-l02xdq87	27	27	was	be	VBD
cord-305956-l02xdq87	27	28	observed	observe	VBN
cord-305956-l02xdq87	27	29	.	.	.
cord-305956-l02xdq87	28	1	However	however	RB
cord-305956-l02xdq87	28	2	,	,	,
cord-305956-l02xdq87	28	3	this	this	DT
cord-305956-l02xdq87	28	4	pattern	pattern	NN
cord-305956-l02xdq87	28	5	of	of	IN
cord-305956-l02xdq87	28	6	histological	histological	JJ
cord-305956-l02xdq87	28	7	injury	injury	NN
cord-305956-l02xdq87	28	8	is	be	VBZ
cord-305956-l02xdq87	28	9	not	not	RB
cord-305956-l02xdq87	28	10	specific	specific	JJ
cord-305956-l02xdq87	28	11	for	for	IN
cord-305956-l02xdq87	28	12	one	one	CD
cord-305956-l02xdq87	28	13	etiology	etiology	NN
cord-305956-l02xdq87	28	14	but	but	CC
cord-305956-l02xdq87	28	15	can	can	MD
cord-305956-l02xdq87	28	16	also	also	RB
cord-305956-l02xdq87	28	17	be	be	VB
cord-305956-l02xdq87	28	18	observed	observe	VBN
cord-305956-l02xdq87	28	19	during	during	IN
cord-305956-l02xdq87	28	20	sepsis	sepsis	NN
cord-305956-l02xdq87	28	21	or	or	CC
cord-305956-l02xdq87	28	22	drug	drug	NN
cord-305956-l02xdq87	28	23	-	-	HYPH
cord-305956-l02xdq87	28	24	induced	induce	VBN
cord-305956-l02xdq87	28	25	liver	liver	NN
cord-305956-l02xdq87	28	26	injury	injury	NN
cord-305956-l02xdq87	28	27	(	(	-LRB-
cord-305956-l02xdq87	28	28	DILI	DILI	NNP
cord-305956-l02xdq87	28	29	)	)	-RRB-
cord-305956-l02xdq87	28	30	.	.	.
cord-305956-l02xdq87	29	1	3	3	CD
cord-305956-l02xdq87	29	2	 	 	_SP
cord-305956-l02xdq87	30	1	Similar	similar	JJ
cord-305956-l02xdq87	30	2	to	to	IN
cord-305956-l02xdq87	30	3	SARS	SARS	NNP
cord-305956-l02xdq87	30	4	-	-	HYPH
cord-305956-l02xdq87	30	5	CoV	CoV	NNP
cord-305956-l02xdq87	30	6	,	,	,
cord-305956-l02xdq87	30	7	SARS	SARS	NNP
cord-305956-l02xdq87	30	8	-	-	HYPH
cord-305956-l02xdq87	30	9	CoV-2	CoV-2	NNP
cord-305956-l02xdq87	30	10	uses	use	VBZ
cord-305956-l02xdq87	30	11	the	the	DT
cord-305956-l02xdq87	30	12	angiotensin-2	angiotensin-2	NNP
cord-305956-l02xdq87	30	13	converting	convert	VBG
cord-305956-l02xdq87	30	14	enzyme	enzyme	NN
cord-305956-l02xdq87	30	15	(	(	-LRB-
cord-305956-l02xdq87	30	16	ACE2	ACE2	NNP
cord-305956-l02xdq87	30	17	)	)	-RRB-
cord-305956-l02xdq87	30	18	receptor	receptor	NN
cord-305956-l02xdq87	30	19	protein	protein	NN
cord-305956-l02xdq87	30	20	to	to	TO
cord-305956-l02xdq87	30	21	attack	attack	VB
cord-305956-l02xdq87	30	22	the	the	DT
cord-305956-l02xdq87	30	23	host	host	NN
cord-305956-l02xdq87	30	24	system	system	NN
cord-305956-l02xdq87	30	25	.	.	.
cord-305956-l02xdq87	31	1	4	4	LS
cord-305956-l02xdq87	32	1	The	the	DT
cord-305956-l02xdq87	32	2	cell	cell	NN
cord-305956-l02xdq87	32	3	entry	entry	NN
cord-305956-l02xdq87	32	4	receptor	receptor	NN
cord-305956-l02xdq87	32	5	,	,	,
cord-305956-l02xdq87	32	6	ACE2	ACE2	NNP
cord-305956-l02xdq87	32	7	,	,	,
cord-305956-l02xdq87	32	8	is	be	VBZ
cord-305956-l02xdq87	32	9	widely	widely	RB
cord-305956-l02xdq87	32	10	expressed	express	VBN
cord-305956-l02xdq87	32	11	across	across	IN
cord-305956-l02xdq87	32	12	the	the	DT
cord-305956-l02xdq87	32	13	human	human	JJ
cord-305956-l02xdq87	32	14	body	body	NN
cord-305956-l02xdq87	32	15	,	,	,
cord-305956-l02xdq87	32	16	including	include	VBG
cord-305956-l02xdq87	32	17	the	the	DT
cord-305956-l02xdq87	32	18	lungs	lung	NNS
cord-305956-l02xdq87	32	19	(	(	-LRB-
cord-305956-l02xdq87	32	20	type	type	NN
cord-305956-l02xdq87	32	21	II	ii	CD
cord-305956-l02xdq87	32	22	alveolar	alveolar	NN
cord-305956-l02xdq87	32	23	cells	cell	NNS
cord-305956-l02xdq87	32	24	)	)	-RRB-
cord-305956-l02xdq87	32	25	,	,	,
cord-305956-l02xdq87	32	26	gastrointestinal	gastrointestinal	JJ
cord-305956-l02xdq87	32	27	tract	tract	NN
cord-305956-l02xdq87	32	28	(	(	-LRB-
cord-305956-l02xdq87	32	29	esophageal	esophageal	JJ
cord-305956-l02xdq87	32	30	epithelial	epithelial	JJ
cord-305956-l02xdq87	32	31	cells	cell	NNS
cord-305956-l02xdq87	32	32	and	and	CC
cord-305956-l02xdq87	32	33	absorptive	absorptive	JJ
cord-305956-l02xdq87	32	34	enterocytes	enterocyte	NNS
cord-305956-l02xdq87	32	35	of	of	IN
cord-305956-l02xdq87	32	36	ileum	ileum	NN
cord-305956-l02xdq87	32	37	and	and	CC
cord-305956-l02xdq87	32	38	colon	colon	NN
cord-305956-l02xdq87	32	39	)	)	-RRB-
cord-305956-l02xdq87	32	40	,	,	,
cord-305956-l02xdq87	32	41	hepatobiliary	hepatobiliary	JJ
cord-305956-l02xdq87	32	42	system	system	NN
cord-305956-l02xdq87	32	43	(	(	-LRB-
cord-305956-l02xdq87	32	44	hepatocytes	hepatocyte	NNS
cord-305956-l02xdq87	32	45	and	and	CC
cord-305956-l02xdq87	32	46	cholangiocytes	cholangiocyte	NNS
cord-305956-l02xdq87	32	47	)	)	-RRB-
cord-305956-l02xdq87	32	48	,	,	,
cord-305956-l02xdq87	32	49	cardiovascular	cardiovascular	JJ
cord-305956-l02xdq87	32	50	system	system	NN
cord-305956-l02xdq87	32	51	(	(	-LRB-
cord-305956-l02xdq87	32	52	myocardial	myocardial	JJ
cord-305956-l02xdq87	32	53	cells	cell	NNS
cord-305956-l02xdq87	32	54	)	)	-RRB-
cord-305956-l02xdq87	32	55	,	,	,
cord-305956-l02xdq87	32	56	the	the	DT
cord-305956-l02xdq87	32	57	renal	renal	JJ
cord-305956-l02xdq87	32	58	system	system	NN
cord-305956-l02xdq87	32	59	(	(	-LRB-
cord-305956-l02xdq87	32	60	proximal	proximal	JJ
cord-305956-l02xdq87	32	61	tubule	tubule	NN
cord-305956-l02xdq87	32	62	cells	cell	NNS
cord-305956-l02xdq87	32	63	and	and	CC
cord-305956-l02xdq87	32	64	urothelial	urothelial	JJ
cord-305956-l02xdq87	32	65	bladder	bladder	NN
cord-305956-l02xdq87	32	66	cells	cell	NNS
cord-305956-l02xdq87	32	67	)	)	-RRB-
cord-305956-l02xdq87	32	68	and	and	CC
cord-305956-l02xdq87	32	69	the	the	DT
cord-305956-l02xdq87	32	70	pancreas	pancrea	NNS
cord-305956-l02xdq87	32	71	.	.	.
cord-305956-l02xdq87	33	1	5	5	LS
cord-305956-l02xdq87	34	1	Recent	recent	JJ
cord-305956-l02xdq87	34	2	studies	study	NNS
cord-305956-l02xdq87	34	3	have	have	VBP
cord-305956-l02xdq87	34	4	observed	observe	VBN
cord-305956-l02xdq87	34	5	that	that	IN
cord-305956-l02xdq87	34	6	ACE2	ACE2	NNP
cord-305956-l02xdq87	34	7	expression	expression	NN
cord-305956-l02xdq87	34	8	in	in	IN
cord-305956-l02xdq87	34	9	the	the	DT
cord-305956-l02xdq87	34	10	cell	cell	NN
cord-305956-l02xdq87	34	11	clusters	cluster	NNS
cord-305956-l02xdq87	34	12	of	of	IN
cord-305956-l02xdq87	34	13	cholangiocytes	cholangiocyte	NNS
cord-305956-l02xdq87	34	14	was	be	VBD
cord-305956-l02xdq87	34	15	significantly	significantly	RB
cord-305956-l02xdq87	34	16	higher	high	JJR
cord-305956-l02xdq87	34	17	than	than	IN
cord-305956-l02xdq87	34	18	that	that	DT
cord-305956-l02xdq87	34	19	in	in	IN
cord-305956-l02xdq87	34	20	the	the	DT
cord-305956-l02xdq87	34	21	hepatocytes	hepatocyte	NNS
cord-305956-l02xdq87	34	22	population	population	NN
cord-305956-l02xdq87	34	23	(	(	-LRB-
cord-305956-l02xdq87	34	24	59.7	59.7	CD
cord-305956-l02xdq87	34	25	%	%	NN
cord-305956-l02xdq87	34	26	vs.	vs.	IN
cord-305956-l02xdq87	34	27	2.6	2.6	CD
cord-305956-l02xdq87	34	28	%	%	NN
cord-305956-l02xdq87	34	29	)	)	-RRB-
cord-305956-l02xdq87	34	30	.	.	.
cord-305956-l02xdq87	35	1	6	6	CD
cord-305956-l02xdq87	36	1	The	the	DT
cord-305956-l02xdq87	36	2	authors	author	NNS
cord-305956-l02xdq87	36	3	conclude	conclude	VBP
cord-305956-l02xdq87	36	4	that	that	IN
cord-305956-l02xdq87	36	5	SARS	SARS	NNP
cord-305956-l02xdq87	36	6	-	-	HYPH
cord-305956-l02xdq87	36	7	CoV-2	CoV-2	NNP
cord-305956-l02xdq87	36	8	may	may	MD
cord-305956-l02xdq87	36	9	directly	directly	RB
cord-305956-l02xdq87	36	10	bind	bind	VB
cord-305956-l02xdq87	36	11	to	to	IN
cord-305956-l02xdq87	36	12	ACE2	ACE2	NNP
cord-305956-l02xdq87	36	13	positive	positive	JJ
cord-305956-l02xdq87	36	14	cholangiocytes	cholangiocyte	NNS
cord-305956-l02xdq87	36	15	,	,	,
cord-305956-l02xdq87	36	16	but	but	CC
cord-305956-l02xdq87	36	17	not	not	RB
cord-305956-l02xdq87	36	18	hepatocytes	hepatocyte	NNS
cord-305956-l02xdq87	36	19	,	,	,
cord-305956-l02xdq87	36	20	to	to	TO
cord-305956-l02xdq87	36	21	exert	exert	VB
cord-305956-l02xdq87	36	22	a	a	DT
cord-305956-l02xdq87	36	23	cytopathic	cytopathic	JJ
cord-305956-l02xdq87	36	24	effect	effect	NN
cord-305956-l02xdq87	36	25	.	.	.
cord-305956-l02xdq87	37	1	Cholangiocytes	cholangiocyte	NNS
cord-305956-l02xdq87	37	2	are	be	VBP
cord-305956-l02xdq87	37	3	involved	involve	VBN
cord-305956-l02xdq87	37	4	in	in	IN
cord-305956-l02xdq87	37	5	many	many	JJ
cord-305956-l02xdq87	37	6	aspects	aspect	NNS
cord-305956-l02xdq87	37	7	of	of	IN
cord-305956-l02xdq87	37	8	liver	liver	NN
cord-305956-l02xdq87	37	9	physiology	physiology	NN
cord-305956-l02xdq87	37	10	,	,	,
cord-305956-l02xdq87	37	11	including	include	VBG
cord-305956-l02xdq87	37	12	regeneration	regeneration	NN
cord-305956-l02xdq87	37	13	and	and	CC
cord-305956-l02xdq87	37	14	adaptive	adaptive	JJ
cord-305956-l02xdq87	37	15	immune	immune	JJ
cord-305956-l02xdq87	37	16	response	response	NN
cord-305956-l02xdq87	37	17	mechanisms	mechanism	NNS
cord-305956-l02xdq87	37	18	,	,	,
cord-305956-l02xdq87	37	19	and	and	CC
cord-305956-l02xdq87	37	20	the	the	DT
cord-305956-l02xdq87	37	21	disruption	disruption	NN
cord-305956-l02xdq87	37	22	of	of	IN
cord-305956-l02xdq87	37	23	cholangiocyte	cholangiocyte	NNP
cord-305956-l02xdq87	37	24	function	function	NN
cord-305956-l02xdq87	37	25	can	can	MD
cord-305956-l02xdq87	37	26	cause	cause	VB
cord-305956-l02xdq87	37	27	hepatobiliary	hepatobiliary	JJ
cord-305956-l02xdq87	37	28	damage	damage	NN
cord-305956-l02xdq87	37	29	.	.	.
cord-305956-l02xdq87	38	1	This	this	DT
cord-305956-l02xdq87	38	2	is	be	VBZ
cord-305956-l02xdq87	38	3	supported	support	VBN
cord-305956-l02xdq87	38	4	by	by	IN
cord-305956-l02xdq87	38	5	cholestatic	cholestatic	JJ
cord-305956-l02xdq87	38	6	markers	marker	NNS
cord-305956-l02xdq87	38	7	,	,	,
cord-305956-l02xdq87	38	8	including	include	VBG
cord-305956-l02xdq87	38	9	gamma	gamma	NN
cord-305956-l02xdq87	38	10	-	-	HYPH
cord-305956-l02xdq87	38	11	glutamyl	glutamyl	NN
cord-305956-l02xdq87	38	12	transferase	transferase	NN
cord-305956-l02xdq87	38	13	(	(	-LRB-
cord-305956-l02xdq87	38	14	GGT	GGT	NNP
cord-305956-l02xdq87	38	15	)	)	-RRB-
cord-305956-l02xdq87	38	16	,	,	,
cord-305956-l02xdq87	38	17	that	that	WDT
cord-305956-l02xdq87	38	18	can	can	MD
cord-305956-l02xdq87	38	19	be	be	VB
cord-305956-l02xdq87	38	20	found	find	VBN
cord-305956-l02xdq87	38	21	in	in	IN
cord-305956-l02xdq87	38	22	some	some	DT
cord-305956-l02xdq87	38	23	,	,	,
cord-305956-l02xdq87	38	24	but	but	CC
cord-305956-l02xdq87	38	25	not	not	RB
cord-305956-l02xdq87	38	26	all	all	DT
cord-305956-l02xdq87	38	27	,	,	,
cord-305956-l02xdq87	38	28	case	case	NN
cord-305956-l02xdq87	38	29	series	series	NN
cord-305956-l02xdq87	38	30	of	of	IN
cord-305956-l02xdq87	38	31	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	38	32	.	.	.
cord-305956-l02xdq87	39	1	[	[	-LRB-
cord-305956-l02xdq87	39	2	7	7	CD
cord-305956-l02xdq87	39	3	]	]	-RRB-
cord-305956-l02xdq87	39	4	[	[	-LRB-
cord-305956-l02xdq87	39	5	8	8	CD
cord-305956-l02xdq87	39	6	]	]	-RRB-
cord-305956-l02xdq87	39	7	[	[	-LRB-
cord-305956-l02xdq87	39	8	9	9	CD
cord-305956-l02xdq87	39	9	]	]	-RRB-
cord-305956-l02xdq87	40	1	Notably	notably	RB
cord-305956-l02xdq87	40	2	,	,	,
cord-305956-l02xdq87	40	3	a	a	DT
cord-305956-l02xdq87	40	4	recent	recent	JJ
cord-305956-l02xdq87	40	5	review	review	NN
cord-305956-l02xdq87	40	6	reported	report	VBD
cord-305956-l02xdq87	40	7	unpublished	unpublished	JJ
cord-305956-l02xdq87	40	8	data	datum	NNS
cord-305956-l02xdq87	40	9	with	with	IN
cord-305956-l02xdq87	40	10	GGT	GGT	NNP
cord-305956-l02xdq87	40	11	elevations	elevation	NNS
cord-305956-l02xdq87	40	12	in	in	IN
cord-305956-l02xdq87	40	13	54	54	CD
cord-305956-l02xdq87	40	14	%	%	NN
cord-305956-l02xdq87	40	15	of	of	IN
cord-305956-l02xdq87	40	16	cases	case	NNS
cord-305956-l02xdq87	40	17	.	.	.
cord-305956-l02xdq87	41	1	8	8	CD
cord-305956-l02xdq87	42	1	In	in	IN
cord-305956-l02xdq87	42	2	a	a	DT
cord-305956-l02xdq87	42	3	human	human	JJ
cord-305956-l02xdq87	42	4	organoid	organoid	NN
cord-305956-l02xdq87	42	5	model	model	NN
cord-305956-l02xdq87	42	6	of	of	IN
cord-305956-l02xdq87	42	7	liver	liver	NN
cord-305956-l02xdq87	42	8	ductal	ductal	JJ
cord-305956-l02xdq87	42	9	organoids	organoid	NNS
cord-305956-l02xdq87	42	10	,	,	,
cord-305956-l02xdq87	42	11	permissiveness	permissiveness	NN
cord-305956-l02xdq87	42	12	to	to	IN
cord-305956-l02xdq87	42	13	SARS	SARS	NNP
cord-305956-l02xdq87	42	14	-	-	HYPH
cord-305956-l02xdq87	42	15	CoV-2	CoV-2	NNP
cord-305956-l02xdq87	42	16	infection	infection	NN
cord-305956-l02xdq87	42	17	was	be	VBD
cord-305956-l02xdq87	42	18	observed	observe	VBN
cord-305956-l02xdq87	42	19	.	.	.
cord-305956-l02xdq87	43	1	Here	here	RB
cord-305956-l02xdq87	43	2	viral	viral	JJ
cord-305956-l02xdq87	43	3	infection	infection	NN
cord-305956-l02xdq87	43	4	impaired	impair	VBD
cord-305956-l02xdq87	43	5	the	the	DT
cord-305956-l02xdq87	43	6	barrier	barrier	NN
cord-305956-l02xdq87	43	7	and	and	CC
cord-305956-l02xdq87	43	8	bile	bile	NN
cord-305956-l02xdq87	43	9	acid	acid	NN
cord-305956-l02xdq87	43	10	transporting	transporting	NN
cord-305956-l02xdq87	43	11	functions	function	NNS
cord-305956-l02xdq87	43	12	of	of	IN
cord-305956-l02xdq87	43	13	cholangiocytes	cholangiocyte	NNS
cord-305956-l02xdq87	43	14	through	through	IN
cord-305956-l02xdq87	43	15	dysregulation	dysregulation	NN
cord-305956-l02xdq87	43	16	of	of	IN
cord-305956-l02xdq87	43	17	genes	gene	NNS
cord-305956-l02xdq87	43	18	involved	involve	VBN
cord-305956-l02xdq87	43	19	in	in	IN
cord-305956-l02xdq87	43	20	tight	tight	JJ
cord-305956-l02xdq87	43	21	junction	junction	NN
cord-305956-l02xdq87	43	22	formation	formation	NN
cord-305956-l02xdq87	43	23	and	and	CC
cord-305956-l02xdq87	43	24	bile	bile	NN
cord-305956-l02xdq87	43	25	acid	acid	NN
cord-305956-l02xdq87	43	26	transportation	transportation	NN
cord-305956-l02xdq87	43	27	,	,	,
cord-305956-l02xdq87	43	28	supporting	support	VBG
cord-305956-l02xdq87	43	29	the	the	DT
cord-305956-l02xdq87	43	30	susceptibility	susceptibility	NN
cord-305956-l02xdq87	43	31	of	of	IN
cord-305956-l02xdq87	43	32	cholangiocytes	cholangiocyte	NNS
cord-305956-l02xdq87	43	33	in	in	IN
cord-305956-l02xdq87	43	34	SARS	SARS	NNP
cord-305956-l02xdq87	43	35	-	-	HYPH
cord-305956-l02xdq87	43	36	CoV-2-related	cov-2-relate	VBN
cord-305956-l02xdq87	43	37	liver	liver	NN
cord-305956-l02xdq87	43	38	injury	injury	NN
cord-305956-l02xdq87	43	39	.	.	.
cord-305956-l02xdq87	44	1	10	10	CD
cord-305956-l02xdq87	44	2	Activation	activation	NN
cord-305956-l02xdq87	44	3	of	of	IN
cord-305956-l02xdq87	44	4	the	the	DT
cord-305956-l02xdq87	44	5	immune	immune	JJ
cord-305956-l02xdq87	44	6	system	system	NN
cord-305956-l02xdq87	44	7	in	in	IN
cord-305956-l02xdq87	44	8	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	44	9	Dysregulation	Dysregulation	NNP
cord-305956-l02xdq87	44	10	of	of	IN
cord-305956-l02xdq87	44	11	the	the	DT
cord-305956-l02xdq87	44	12	innate	innate	JJ
cord-305956-l02xdq87	44	13	immune	immune	JJ
cord-305956-l02xdq87	44	14	response	response	NN
cord-305956-l02xdq87	44	15	can	can	MD
cord-305956-l02xdq87	44	16	be	be	VB
cord-305956-l02xdq87	44	17	one	one	CD
cord-305956-l02xdq87	44	18	aspect	aspect	NN
cord-305956-l02xdq87	44	19	of	of	IN
cord-305956-l02xdq87	44	20	liver	liver	NN
cord-305956-l02xdq87	44	21	injury	injury	NN
cord-305956-l02xdq87	44	22	in	in	IN
cord-305956-l02xdq87	44	23	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	44	24	.	.	.
cord-305956-l02xdq87	45	1	Patients	patient	NNS
cord-305956-l02xdq87	45	2	with	with	IN
cord-305956-l02xdq87	45	3	COVID-19	covid-19	DT
cord-305956-l02xdq87	45	4	exhibit	exhibit	NN
cord-305956-l02xdq87	45	5	marked	marked	JJ
cord-305956-l02xdq87	45	6	activation	activation	NN
cord-305956-l02xdq87	45	7	of	of	IN
cord-305956-l02xdq87	45	8	inflammatory	inflammatory	JJ
cord-305956-l02xdq87	45	9	markers	marker	NNS
cord-305956-l02xdq87	45	10	,	,	,
cord-305956-l02xdq87	45	11	including	include	VBG
cord-305956-l02xdq87	45	12	abnormal	abnormal	JJ
cord-305956-l02xdq87	45	13	levels	level	NNS
cord-305956-l02xdq87	45	14	of	of	IN
cord-305956-l02xdq87	45	15	C	c	NN
cord-305956-l02xdq87	45	16	-	-	HYPH
cord-305956-l02xdq87	45	17	reactive	reactive	JJ
cord-305956-l02xdq87	45	18	protein	protein	NN
cord-305956-l02xdq87	45	19	(	(	-LRB-
cord-305956-l02xdq87	45	20	CRP	CRP	NNP
cord-305956-l02xdq87	45	21	)	)	-RRB-
cord-305956-l02xdq87	45	22	,	,	,
cord-305956-l02xdq87	45	23	lymphocytes	lymphocyte	NNS
cord-305956-l02xdq87	45	24	,	,	,
cord-305956-l02xdq87	45	25	neutrophils	neutrophil	NNS
cord-305956-l02xdq87	45	26	and	and	CC
cord-305956-l02xdq87	45	27	cytokines	cytokine	NNS
cord-305956-l02xdq87	45	28	,	,	,
cord-305956-l02xdq87	45	29	in	in	IN
cord-305956-l02xdq87	45	30	particular	particular	JJ
cord-305956-l02xdq87	45	31	interleukin-6	interleukin-6	NNP
cord-305956-l02xdq87	46	1	(	(	-LRB-
cord-305956-l02xdq87	46	2	IL-6	IL-6	NNP
cord-305956-l02xdq87	46	3	)	)	-RRB-
cord-305956-l02xdq87	46	4	.	.	.
cord-305956-l02xdq87	47	1	8	8	CD
cord-305956-l02xdq87	47	2	,	,	,
cord-305956-l02xdq87	47	3	[	[	-LRB-
cord-305956-l02xdq87	47	4	11	11	CD
cord-305956-l02xdq87	47	5	]	]	-RRB-
cord-305956-l02xdq87	47	6	[	[	-LRB-
cord-305956-l02xdq87	47	7	12	12	CD
cord-305956-l02xdq87	47	8	]	]	-RRB-
cord-305956-l02xdq87	47	9	[	[	-LRB-
cord-305956-l02xdq87	47	10	13	13	CD
cord-305956-l02xdq87	47	11	]	]	-RRB-
cord-305956-l02xdq87	48	1	These	these	DT
cord-305956-l02xdq87	48	2	mechanisms	mechanism	NNS
cord-305956-l02xdq87	48	3	may	may	MD
cord-305956-l02xdq87	48	4	contribute	contribute	VB
cord-305956-l02xdq87	48	5	to	to	IN
cord-305956-l02xdq87	48	6	pulmonary	pulmonary	JJ
cord-305956-l02xdq87	48	7	and	and	CC
cord-305956-l02xdq87	48	8	extrapulmonary	extrapulmonary	JJ
cord-305956-l02xdq87	48	9	injuries	injury	NNS
cord-305956-l02xdq87	48	10	12	12	CD
cord-305956-l02xdq87	48	11	,	,	,
cord-305956-l02xdq87	48	12	14	14	CD
cord-305956-l02xdq87	48	13	and	and	CC
cord-305956-l02xdq87	48	14	the	the	DT
cord-305956-l02xdq87	48	15	control	control	NN
cord-305956-l02xdq87	48	16	of	of	IN
cord-305956-l02xdq87	48	17	cytokine	cytokine	JJ
cord-305956-l02xdq87	48	18	dysregulation	dysregulation	NN
cord-305956-l02xdq87	48	19	at	at	IN
cord-305956-l02xdq87	48	20	an	an	DT
cord-305956-l02xdq87	48	21	early	early	JJ
cord-305956-l02xdq87	48	22	stage	stage	NN
cord-305956-l02xdq87	48	23	could	could	MD
cord-305956-l02xdq87	48	24	be	be	VB
cord-305956-l02xdq87	48	25	beneficial	beneficial	JJ
cord-305956-l02xdq87	48	26	to	to	TO
cord-305956-l02xdq87	48	27	curb	curb	VB
cord-305956-l02xdq87	48	28	the	the	DT
cord-305956-l02xdq87	48	29	disease	disease	NN
cord-305956-l02xdq87	48	30	progression	progression	NN
cord-305956-l02xdq87	48	31	.	.	.
cord-305956-l02xdq87	49	1	15	15	CD
cord-305956-l02xdq87	49	2	Hepatic	hepatic	JJ
cord-305956-l02xdq87	49	3	inflammation	inflammation	NN
cord-305956-l02xdq87	49	4	involving	involve	VBG
cord-305956-l02xdq87	49	5	activation	activation	NN
cord-305956-l02xdq87	49	6	of	of	IN
cord-305956-l02xdq87	49	7	innate	innate	JJ
cord-305956-l02xdq87	49	8	immune	immune	JJ
cord-305956-l02xdq87	49	9	cells	cell	NNS
cord-305956-l02xdq87	49	10	and	and	CC
cord-305956-l02xdq87	49	11	the	the	DT
cord-305956-l02xdq87	49	12	release	release	NN
cord-305956-l02xdq87	49	13	of	of	IN
cord-305956-l02xdq87	49	14	cytokines	cytokine	NNS
cord-305956-l02xdq87	49	15	is	be	VBZ
cord-305956-l02xdq87	49	16	a	a	DT
cord-305956-l02xdq87	49	17	well	well	RB
cord-305956-l02xdq87	49	18	-	-	HYPH
cord-305956-l02xdq87	49	19	established	establish	VBN
cord-305956-l02xdq87	49	20	driver	driver	NN
cord-305956-l02xdq87	49	21	of	of	IN
cord-305956-l02xdq87	49	22	liver	liver	NN
cord-305956-l02xdq87	49	23	injury	injury	NN
cord-305956-l02xdq87	49	24	from	from	IN
cord-305956-l02xdq87	49	25	various	various	JJ
cord-305956-l02xdq87	49	26	causes	cause	NNS
cord-305956-l02xdq87	49	27	.	.	.
cord-305956-l02xdq87	50	1	16	16	CD
cord-305956-l02xdq87	51	1	In	in	IN
cord-305956-l02xdq87	51	2	some	some	DT
cord-305956-l02xdq87	51	3	of	of	IN
cord-305956-l02xdq87	51	4	the	the	DT
cord-305956-l02xdq87	51	5	available	available	JJ
cord-305956-l02xdq87	51	6	case	case	NN
cord-305956-l02xdq87	51	7	series	series	NN
cord-305956-l02xdq87	51	8	of	of	IN
cord-305956-l02xdq87	51	9	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	51	10	,	,	,
cord-305956-l02xdq87	51	11	a	a	DT
cord-305956-l02xdq87	51	12	correlation	correlation	NN
cord-305956-l02xdq87	51	13	between	between	IN
cord-305956-l02xdq87	51	14	lymphopenia	lymphopenia	NNP
cord-305956-l02xdq87	51	15	and	and	CC
cord-305956-l02xdq87	51	16	liver	liver	NN
cord-305956-l02xdq87	51	17	injury	injury	NN
cord-305956-l02xdq87	51	18	was	be	VBD
cord-305956-l02xdq87	51	19	observed	observe	VBN
cord-305956-l02xdq87	51	20	and	and	CC
cord-305956-l02xdq87	51	21	CRP	CRP	NNP
cord-305956-l02xdq87	51	22	!	!	.
cord-305956-l02xdq87	52	1	20	20	CD
cord-305956-l02xdq87	52	2	mg	mg	NNP
cord-305956-l02xdq87	52	3	/	/	SYM
cord-305956-l02xdq87	52	4	L	L	NNP
cord-305956-l02xdq87	52	5	and	and	CC
cord-305956-l02xdq87	52	6	a	a	DT
cord-305956-l02xdq87	52	7	lymphocyte	lymphocyte	NN
cord-305956-l02xdq87	52	8	count	count	NN
cord-305956-l02xdq87	53	1	<	<	XX
cord-305956-l02xdq87	53	2	1.1	1.1	CD
cord-305956-l02xdq87	53	3	Â	â	CD
cord-305956-l02xdq87	53	4	10	10	CD
cord-305956-l02xdq87	53	5	9	9	CD
cord-305956-l02xdq87	53	6	/L	/L	,
cord-305956-l02xdq87	53	7	were	be	VBD
cord-305956-l02xdq87	53	8	independent	independent	JJ
cord-305956-l02xdq87	53	9	risk	risk	NN
cord-305956-l02xdq87	53	10	factors	factor	NNS
cord-305956-l02xdq87	53	11	for	for	IN
cord-305956-l02xdq87	53	12	liver	liver	NN
cord-305956-l02xdq87	53	13	injury	injury	NN
cord-305956-l02xdq87	53	14	.	.	.
cord-305956-l02xdq87	54	1	Notably	notably	RB
cord-305956-l02xdq87	54	2	,	,	,
cord-305956-l02xdq87	54	3	lymphopenia	lymphopenia	NNP
cord-305956-l02xdq87	54	4	in	in	IN
cord-305956-l02xdq87	55	1	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	55	2	studies	study	NNS
cord-305956-l02xdq87	55	3	was	be	VBD
cord-305956-l02xdq87	55	4	reportedly	reportedly	RB
cord-305956-l02xdq87	55	5	observed	observe	VBN
cord-305956-l02xdq87	55	6	in	in	IN
cord-305956-l02xdq87	55	7	63	63	CD
cord-305956-l02xdq87	55	8	%	%	NN
cord-305956-l02xdq87	55	9	to	to	IN
cord-305956-l02xdq87	55	10	70.3	70.3	CD
cord-305956-l02xdq87	55	11	%	%	NN
cord-305956-l02xdq87	55	12	of	of	IN
cord-305956-l02xdq87	55	13	patients	patient	NNS
cord-305956-l02xdq87	55	14	and	and	CC
cord-305956-l02xdq87	55	15	those	those	DT
cord-305956-l02xdq87	55	16	with	with	IN
cord-305956-l02xdq87	55	17	lower	low	JJR
cord-305956-l02xdq87	55	18	lymphocyte	lymphocyte	NN
cord-305956-l02xdq87	55	19	counts	count	VBZ
cord-305956-l02xdq87	55	20	more	more	RBR
cord-305956-l02xdq87	55	21	susceptible	susceptible	JJ
cord-305956-l02xdq87	55	22	to	to	IN
cord-305956-l02xdq87	55	23	fatal	fatal	JJ
cord-305956-l02xdq87	55	24	outcomes	outcome	NNS
cord-305956-l02xdq87	55	25	.	.	.
cord-305956-l02xdq87	56	1	11	11	CD
cord-305956-l02xdq87	56	2	More	More	JJR
cord-305956-l02xdq87	56	3	than	than	IN
cord-305956-l02xdq87	56	4	20	20	CD
cord-305956-l02xdq87	56	5	publications	publication	NNS
cord-305956-l02xdq87	56	6	to	to	IN
cord-305956-l02xdq87	56	7	date	date	NN
cord-305956-l02xdq87	56	8	reported	report	VBD
cord-305956-l02xdq87	56	9	abnormal	abnormal	JJ
cord-305956-l02xdq87	56	10	levels	level	NNS
cord-305956-l02xdq87	56	11	of	of	IN
cord-305956-l02xdq87	56	12	aminotransferases	aminotransferase	NNS
cord-305956-l02xdq87	56	13	in	in	IN
cord-305956-l02xdq87	56	14	patients	patient	NNS
cord-305956-l02xdq87	56	15	with	with	IN
cord-305956-l02xdq87	56	16	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	56	17	.	.	.
cord-305956-l02xdq87	57	1	[	[	-LRB-
cord-305956-l02xdq87	57	2	7	7	CD
cord-305956-l02xdq87	57	3	]	]	-RRB-
cord-305956-l02xdq87	57	4	[	[	-LRB-
cord-305956-l02xdq87	57	5	8	8	CD
cord-305956-l02xdq87	57	6	]	]	-RRB-
cord-305956-l02xdq87	57	7	[	[	-LRB-
cord-305956-l02xdq87	57	8	9	9	CD
cord-305956-l02xdq87	57	9	]	]	-RRB-
cord-305956-l02xdq87	58	1	[	[	-LRB-
cord-305956-l02xdq87	58	2	11	11	CD
cord-305956-l02xdq87	58	3	]	]	-RRB-
cord-305956-l02xdq87	58	4	[	[	-LRB-
cord-305956-l02xdq87	58	5	12	12	CD
cord-305956-l02xdq87	58	6	]	]	-RRB-
cord-305956-l02xdq87	58	7	[	[	-LRB-
cord-305956-l02xdq87	58	8	13	13	CD
cord-305956-l02xdq87	58	9	]	]	-RRB-
cord-305956-l02xdq87	59	1	[	[	-LRB-
cord-305956-l02xdq87	59	2	17	17	CD
cord-305956-l02xdq87	59	3	]	]	-RRB-
cord-305956-l02xdq87	59	4	[	[	-LRB-
cord-305956-l02xdq87	59	5	18	18	CD
cord-305956-l02xdq87	59	6	]	]	-RRB-
cord-305956-l02xdq87	59	7	[	[	-LRB-
cord-305956-l02xdq87	59	8	19	19	CD
cord-305956-l02xdq87	59	9	]	]	-RRB-
cord-305956-l02xdq87	59	10	21	21	CD
cord-305956-l02xdq87	59	11	,	,	,
cord-305956-l02xdq87	59	12	[	[	-LRB-
cord-305956-l02xdq87	59	13	23	23	CD
cord-305956-l02xdq87	59	14	]	]	-RRB-
cord-305956-l02xdq87	60	1	[	[	-LRB-
cord-305956-l02xdq87	60	2	24	24	CD
cord-305956-l02xdq87	60	3	]	]	-RRB-
cord-305956-l02xdq87	60	4	[	[	-LRB-
cord-305956-l02xdq87	60	5	25	25	CD
cord-305956-l02xdq87	60	6	]	]	-RRB-
cord-305956-l02xdq87	60	7	[	[	-LRB-
cord-305956-l02xdq87	60	8	26	26	CD
cord-305956-l02xdq87	60	9	]	]	-RRB-
cord-305956-l02xdq87	60	10	[	[	-LRB-
cord-305956-l02xdq87	60	11	27	27	CD
cord-305956-l02xdq87	60	12	]	]	-RRB-
cord-305956-l02xdq87	60	13	[	[	-LRB-
cord-305956-l02xdq87	60	14	29	29	CD
cord-305956-l02xdq87	60	15	]	]	-RRB-
cord-305956-l02xdq87	61	1	[	[	-LRB-
cord-305956-l02xdq87	61	2	30	30	CD
cord-305956-l02xdq87	61	3	]	]	-RRB-
cord-305956-l02xdq87	61	4	[	[	-LRB-
cord-305956-l02xdq87	61	5	31	31	CD
cord-305956-l02xdq87	61	6	]	]	-RRB-
cord-305956-l02xdq87	62	1	[	[	-LRB-
cord-305956-l02xdq87	62	2	32	32	CD
cord-305956-l02xdq87	62	3	]	]	-RRB-
cord-305956-l02xdq87	62	4	[	[	-LRB-
cord-305956-l02xdq87	62	5	33	33	CD
cord-305956-l02xdq87	62	6	]	]	-RRB-
cord-305956-l02xdq87	62	7	35	35	CD
cord-305956-l02xdq87	62	8	,	,	,
cord-305956-l02xdq87	62	9	36	36	CD
cord-305956-l02xdq87	63	1	A	a	DT
cord-305956-l02xdq87	63	2	recent	recent	JJ
cord-305956-l02xdq87	63	3	systematic	systematic	JJ
cord-305956-l02xdq87	63	4	review	review	NN
cord-305956-l02xdq87	63	5	and	and	CC
cord-305956-l02xdq87	63	6	meta	meta	NNP
cord-305956-l02xdq87	63	7	-	-	HYPH
cord-305956-l02xdq87	63	8	analysis	analysis	NN
cord-305956-l02xdq87	63	9	on	on	IN
cord-305956-l02xdq87	63	10	LFT	LFT	NNP
cord-305956-l02xdq87	63	11	abnormalities	abnormality	NNS
cord-305956-l02xdq87	63	12	provided	provide	VBD
cord-305956-l02xdq87	63	13	a	a	DT
cord-305956-l02xdq87	63	14	pooled	pool	VBN
cord-305956-l02xdq87	63	15	elevation	elevation	NN
cord-305956-l02xdq87	63	16	of	of	IN
cord-305956-l02xdq87	63	17	aspartate	aspartate	NN
cord-305956-l02xdq87	63	18	aminotransferase	aminotransferase	NN
cord-305956-l02xdq87	63	19	(	(	-LRB-
cord-305956-l02xdq87	63	20	AST	AST	NNP
cord-305956-l02xdq87	63	21	)	)	-RRB-
cord-305956-l02xdq87	63	22	in	in	IN
cord-305956-l02xdq87	63	23	33.3	33.3	CD
cord-305956-l02xdq87	63	24	%	%	NN
cord-305956-l02xdq87	63	25	and	and	CC
cord-305956-l02xdq87	63	26	alanine	alanine	NN
cord-305956-l02xdq87	63	27	aminotransferase	aminotransferase	NN
cord-305956-l02xdq87	63	28	(	(	-LRB-
cord-305956-l02xdq87	63	29	ALT	ALT	NNP
cord-305956-l02xdq87	63	30	)	)	-RRB-
cord-305956-l02xdq87	63	31	in	in	IN
cord-305956-l02xdq87	63	32	24.1	24.1	CD
cord-305956-l02xdq87	63	33	%	%	NN
cord-305956-l02xdq87	63	34	of	of	IN
cord-305956-l02xdq87	63	35	cases	case	NNS
cord-305956-l02xdq87	63	36	.	.	.
cord-305956-l02xdq87	64	1	39	39	CD
cord-305956-l02xdq87	64	2	Various	various	JJ
cord-305956-l02xdq87	64	3	investigators	investigator	NNS
cord-305956-l02xdq87	64	4	across	across	IN
cord-305956-l02xdq87	64	5	different	different	JJ
cord-305956-l02xdq87	64	6	studies	study	NNS
cord-305956-l02xdq87	64	7	reported	report	VBD
cord-305956-l02xdq87	64	8	a	a	DT
cord-305956-l02xdq87	64	9	correlation	correlation	NN
cord-305956-l02xdq87	64	10	between	between	IN
cord-305956-l02xdq87	64	11	the	the	DT
cord-305956-l02xdq87	64	12	severity	severity	NN
cord-305956-l02xdq87	64	13	of	of	IN
cord-305956-l02xdq87	64	14	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	64	15	and	and	CC
cord-305956-l02xdq87	64	16	the	the	DT
cord-305956-l02xdq87	64	17	degree	degree	NN
cord-305956-l02xdq87	64	18	of	of	IN
cord-305956-l02xdq87	64	19	liver	liver	NN
cord-305956-l02xdq87	64	20	dysfunction	dysfunction	NN
cord-305956-l02xdq87	64	21	.	.	.
cord-305956-l02xdq87	65	1	8	8	CD
cord-305956-l02xdq87	65	2	,	,	,
cord-305956-l02xdq87	65	3	11	11	CD
cord-305956-l02xdq87	65	4	,	,	,
cord-305956-l02xdq87	65	5	25	25	CD
cord-305956-l02xdq87	65	6	In	in	IN
cord-305956-l02xdq87	65	7	one	one	CD
cord-305956-l02xdq87	65	8	retrospective	retrospective	JJ
cord-305956-l02xdq87	65	9	study	study	NN
cord-305956-l02xdq87	65	10	,	,	,
cord-305956-l02xdq87	65	11	one	one	CD
cord-305956-l02xdq87	65	12	patient	patient	NN
cord-305956-l02xdq87	65	13	experienced	experience	VBD
cord-305956-l02xdq87	65	14	severe	severe	JJ
cord-305956-l02xdq87	65	15	hepatitis	hepatitis	NN
cord-305956-l02xdq87	65	16	with	with	IN
cord-305956-l02xdq87	65	17	ALT	ALT	NNP
cord-305956-l02xdq87	65	18	of	of	IN
cord-305956-l02xdq87	65	19	7	7	CD
cord-305956-l02xdq87	66	1	On	on	IN
cord-305956-l02xdq87	66	2	the	the	DT
cord-305956-l02xdq87	66	3	other	other	JJ
cord-305956-l02xdq87	66	4	hand	hand	NN
cord-305956-l02xdq87	66	5	,	,	,
cord-305956-l02xdq87	66	6	mild	mild	JJ
cord-305956-l02xdq87	66	7	and	and	CC
cord-305956-l02xdq87	66	8	moderate	moderate	JJ
cord-305956-l02xdq87	66	9	cases	case	NNS
cord-305956-l02xdq87	66	10	experienced	experience	VBD
cord-305956-l02xdq87	66	11	only	only	RB
cord-305956-l02xdq87	66	12	discrete	discrete	JJ
cord-305956-l02xdq87	66	13	abnormal	abnormal	JJ
cord-305956-l02xdq87	66	14	LFT	LFT	NNP
cord-305956-l02xdq87	66	15	values	value	NNS
cord-305956-l02xdq87	66	16	.	.	.
cord-305956-l02xdq87	67	1	These	these	DT
cord-305956-l02xdq87	67	2	reports	report	NNS
cord-305956-l02xdq87	67	3	support	support	VBP
cord-305956-l02xdq87	67	4	the	the	DT
cord-305956-l02xdq87	67	5	concept	concept	NN
cord-305956-l02xdq87	67	6	that	that	IN
cord-305956-l02xdq87	67	7	the	the	DT
cord-305956-l02xdq87	67	8	disease	disease	NN
cord-305956-l02xdq87	67	9	severity	severity	NN
cord-305956-l02xdq87	67	10	and	and	CC
cord-305956-l02xdq87	67	11	an	an	DT
cord-305956-l02xdq87	67	12	older	old	JJR
cord-305956-l02xdq87	67	13	age	age	NN
cord-305956-l02xdq87	67	14	predispose	predispose	VBP
cord-305956-l02xdq87	67	15	to	to	IN
cord-305956-l02xdq87	67	16	more	more	RBR
cord-305956-l02xdq87	67	17	severe	severe	JJ
cord-305956-l02xdq87	67	18	liver	liver	NN
cord-305956-l02xdq87	67	19	injury	injury	NN
cord-305956-l02xdq87	67	20	from	from	IN
cord-305956-l02xdq87	67	21	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	67	22	.	.	.
cord-305956-l02xdq87	68	1	Based	base	VBN
cord-305956-l02xdq87	68	2	on	on	IN
cord-305956-l02xdq87	68	3	these	these	DT
cord-305956-l02xdq87	68	4	case	case	NN
cord-305956-l02xdq87	68	5	series	series	NN
cord-305956-l02xdq87	68	6	,	,	,
cord-305956-l02xdq87	68	7	patients	patient	NNS
cord-305956-l02xdq87	68	8	with	with	IN
cord-305956-l02xdq87	68	9	severe	severe	JJ
cord-305956-l02xdq87	68	10	COVID-19	covid-19	JJ
cord-305956-l02xdq87	68	11	and	and	CC
cord-305956-l02xdq87	68	12	pre	pre	JJ
cord-305956-l02xdq87	68	13	-	-	JJ
cord-305956-l02xdq87	68	14	existing	existing	JJ
cord-305956-l02xdq87	68	15	liver	liver	NN
cord-305956-l02xdq87	68	16	conditions	condition	NNS
cord-305956-l02xdq87	68	17	8but	8but	CD
cord-305956-l02xdq87	68	18	also	also	RB
cord-305956-l02xdq87	68	19	elderly	elderly	JJ
cord-305956-l02xdq87	68	20	patients	patient	NNS
cord-305956-l02xdq87	68	21	11	11	CD
cord-305956-l02xdq87	68	22	-should	-should	MD
cord-305956-l02xdq87	68	23	undergo	undergo	VB
cord-305956-l02xdq87	68	24	surveillance	surveillance	NN
cord-305956-l02xdq87	68	25	and	and	CC
cord-305956-l02xdq87	68	26	individually	individually	RB
cord-305956-l02xdq87	68	27	tailored	tailor	VBN
cord-305956-l02xdq87	68	28	therapeutic	therapeutic	JJ
cord-305956-l02xdq87	68	29	approaches	approach	NNS
cord-305956-l02xdq87	68	30	for	for	IN
cord-305956-l02xdq87	68	31	potential	potential	JJ
cord-305956-l02xdq87	68	32	liver	liver	NN
cord-305956-l02xdq87	68	33	injury	injury	NN
cord-305956-l02xdq87	68	34	.	.	.
cord-305956-l02xdq87	69	1	A	a	DT
cord-305956-l02xdq87	69	2	recently	recently	RB
cord-305956-l02xdq87	69	3	published	publish	VBN
cord-305956-l02xdq87	69	4	article	article	NN
cord-305956-l02xdq87	69	5	by	by	IN
cord-305956-l02xdq87	69	6	Bangash	Bangash	NNP
cord-305956-l02xdq87	69	7	et	et	NNP
cord-305956-l02xdq87	69	8	al	al	NNP
cord-305956-l02xdq87	69	9	.	.	.
cord-305956-l02xdq87	70	1	argues	argue	VBZ
cord-305956-l02xdq87	70	2	after	after	IN
cord-305956-l02xdq87	70	3	careful	careful	JJ
cord-305956-l02xdq87	70	4	review	review	NN
cord-305956-l02xdq87	70	5	of	of	IN
cord-305956-l02xdq87	70	6	seven	seven	CD
cord-305956-l02xdq87	70	7	relevant	relevant	JJ
cord-305956-l02xdq87	70	8	studies	study	NNS
cord-305956-l02xdq87	70	9	that	that	WDT
cord-305956-l02xdq87	70	10	elevated	elevate	VBD
cord-305956-l02xdq87	70	11	ALT	alt	NN
cord-305956-l02xdq87	70	12	and	and	CC
cord-305956-l02xdq87	70	13	AST	AST	NNP
cord-305956-l02xdq87	70	14	may	may	MD
cord-305956-l02xdq87	70	15	not	not	RB
cord-305956-l02xdq87	70	16	necessarily	necessarily	RB
cord-305956-l02xdq87	70	17	be	be	VB
cord-305956-l02xdq87	70	18	of	of	IN
cord-305956-l02xdq87	70	19	hepatic	hepatic	JJ
cord-305956-l02xdq87	70	20	origin	origin	NN
cord-305956-l02xdq87	70	21	alone	alone	RB
cord-305956-l02xdq87	70	22	.	.	.
cord-305956-l02xdq87	71	1	The	the	DT
cord-305956-l02xdq87	71	2	authors	author	NNS
cord-305956-l02xdq87	71	3	have	have	VBP
cord-305956-l02xdq87	71	4	given	give	VBN
cord-305956-l02xdq87	71	5	a	a	DT
cord-305956-l02xdq87	71	6	timely	timely	JJ
cord-305956-l02xdq87	71	7	reminder	reminder	NN
cord-305956-l02xdq87	71	8	that	that	IN
cord-305956-l02xdq87	71	9	it	-PRON-	PRP
cord-305956-l02xdq87	71	10	is	be	VBZ
cord-305956-l02xdq87	71	11	common	common	JJ
cord-305956-l02xdq87	71	12	for	for	IN
cord-305956-l02xdq87	71	13	other	other	JJ
cord-305956-l02xdq87	71	14	respiratory	respiratory	JJ
cord-305956-l02xdq87	71	15	viruses	virus	NNS
cord-305956-l02xdq87	71	16	to	to	TO
cord-305956-l02xdq87	71	17	create	create	VB
cord-305956-l02xdq87	71	18	similar	similar	JJ
cord-305956-l02xdq87	71	19	LFT	LFT	NNP
cord-305956-l02xdq87	71	20	elevations	elevation	NNS
cord-305956-l02xdq87	71	21	28	28	CD
cord-305956-l02xdq87	71	22	and	and	CC
cord-305956-l02xdq87	71	23	thus	thus	RB
cord-305956-l02xdq87	71	24	more	more	RBR
cord-305956-l02xdq87	71	25	prospective	prospective	JJ
cord-305956-l02xdq87	71	26	data	datum	NNS
cord-305956-l02xdq87	71	27	related	relate	VBN
cord-305956-l02xdq87	71	28	to	to	IN
cord-305956-l02xdq87	71	29	the	the	DT
cord-305956-l02xdq87	71	30	clinical	clinical	JJ
cord-305956-l02xdq87	71	31	relevance	relevance	NN
cord-305956-l02xdq87	71	32	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	71	33	and	and	CC
cord-305956-l02xdq87	71	34	liver	liver	NN
cord-305956-l02xdq87	71	35	injury	injury	NN
cord-305956-l02xdq87	71	36	is	be	VBZ
cord-305956-l02xdq87	71	37	required	require	VBN
cord-305956-l02xdq87	71	38	.	.	.
cord-305956-l02xdq87	72	1	The	the	DT
cord-305956-l02xdq87	72	2	previous	previous	JJ
cord-305956-l02xdq87	72	3	pathogenic	pathogenic	JJ
cord-305956-l02xdq87	72	4	coronaviruses	coronaviruse	NNS
cord-305956-l02xdq87	72	5	,	,	,
cord-305956-l02xdq87	72	6	such	such	JJ
cord-305956-l02xdq87	72	7	as	as	IN
cord-305956-l02xdq87	72	8	SARS	SARS	NNP
cord-305956-l02xdq87	72	9	-	-	HYPH
cord-305956-l02xdq87	72	10	CoV	CoV	NNP
cord-305956-l02xdq87	72	11	and	and	CC
cord-305956-l02xdq87	72	12	the	the	DT
cord-305956-l02xdq87	72	13	Middle	Middle	NNP
cord-305956-l02xdq87	72	14	East	East	NNP
cord-305956-l02xdq87	72	15	respiratory	respiratory	JJ
cord-305956-l02xdq87	72	16	syndrome	syndrome	NN
cord-305956-l02xdq87	72	17	coronavirus	coronavirus	NN
cord-305956-l02xdq87	72	18	(	(	-LRB-
cord-305956-l02xdq87	72	19	MERS	MERS	NNP
cord-305956-l02xdq87	72	20	-	-	HYPH
cord-305956-l02xdq87	72	21	CoV	CoV	NNP
cord-305956-l02xdq87	72	22	)	)	-RRB-
cord-305956-l02xdq87	72	23	,	,	,
cord-305956-l02xdq87	72	24	were	be	VBD
cord-305956-l02xdq87	72	25	also	also	RB
cord-305956-l02xdq87	72	26	reported	report	VBN
cord-305956-l02xdq87	72	27	to	to	TO
cord-305956-l02xdq87	72	28	manifest	manifest	VB
cord-305956-l02xdq87	72	29	with	with	IN
cord-305956-l02xdq87	72	30	elevated	elevated	JJ
cord-305956-l02xdq87	72	31	levels	level	NNS
cord-305956-l02xdq87	72	32	of	of	IN
cord-305956-l02xdq87	72	33	ALT	ALT	NNP
cord-305956-l02xdq87	72	34	and	and	CC
cord-305956-l02xdq87	72	35	AST	AST	NNP
cord-305956-l02xdq87	72	36	.	.	.
cord-305956-l02xdq87	73	1	39	39	CD
cord-305956-l02xdq87	73	2	More	More	JJR
cord-305956-l02xdq87	73	3	generally	generally	RB
cord-305956-l02xdq87	73	4	,	,	,
cord-305956-l02xdq87	73	5	non	non	JJ
cord-305956-l02xdq87	73	6	-	-	JJ
cord-305956-l02xdq87	73	7	hepatotropic	hepatotropic	JJ
cord-305956-l02xdq87	73	8	viral	viral	JJ
cord-305956-l02xdq87	73	9	infections	infection	NNS
cord-305956-l02xdq87	73	10	may	may	MD
cord-305956-l02xdq87	73	11	affect	affect	VB
cord-305956-l02xdq87	73	12	the	the	DT
cord-305956-l02xdq87	73	13	liver	liver	NN
cord-305956-l02xdq87	73	14	and	and	CC
cord-305956-l02xdq87	73	15	induce	induce	VB
cord-305956-l02xdq87	73	16	hepatitis	hepatitis	NN
cord-305956-l02xdq87	73	17	or	or	CC
cord-305956-l02xdq87	73	18	fulminant	fulminant	JJ
cord-305956-l02xdq87	73	19	acute	acute	JJ
cord-305956-l02xdq87	73	20	liver	liver	NN
cord-305956-l02xdq87	73	21	failure	failure	NN
cord-305956-l02xdq87	73	22	.	.	.
cord-305956-l02xdq87	74	1	However	however	RB
cord-305956-l02xdq87	74	2	,	,	,
cord-305956-l02xdq87	74	3	in	in	IN
cord-305956-l02xdq87	74	4	the	the	DT
cord-305956-l02xdq87	74	5	majority	majority	NN
cord-305956-l02xdq87	74	6	of	of	IN
cord-305956-l02xdq87	74	7	cases	case	NNS
cord-305956-l02xdq87	74	8	,	,	,
cord-305956-l02xdq87	74	9	recovery	recovery	NN
cord-305956-l02xdq87	74	10	from	from	IN
cord-305956-l02xdq87	74	11	viral	viral	JJ
cord-305956-l02xdq87	74	12	illness	illness	NN
cord-305956-l02xdq87	74	13	is	be	VBZ
cord-305956-l02xdq87	74	14	often	often	RB
cord-305956-l02xdq87	74	15	sufficient	sufficient	JJ
cord-305956-l02xdq87	74	16	to	to	TO
cord-305956-l02xdq87	74	17	resolve	resolve	VB
cord-305956-l02xdq87	74	18	liver	liver	NN
cord-305956-l02xdq87	74	19	injury	injury	NN
cord-305956-l02xdq87	74	20	.	.	.
cord-305956-l02xdq87	75	1	40	40	CD
cord-305956-l02xdq87	76	1	Like	like	IN
cord-305956-l02xdq87	76	2	in	in	IN
cord-305956-l02xdq87	76	3	SARS	SARS	NNP
cord-305956-l02xdq87	76	4	-	-	HYPH
cord-305956-l02xdq87	76	5	CoV	CoV	NNP
cord-305956-l02xdq87	76	6	and	and	CC
cord-305956-l02xdq87	76	7	MERS	MERS	NNP
cord-305956-l02xdq87	76	8	-	-	HYPH
cord-305956-l02xdq87	76	9	CoV	cov	NN
cord-305956-l02xdq87	76	10	infections	infection	NNS
cord-305956-l02xdq87	76	11	,	,	,
cord-305956-l02xdq87	76	12	abnormal	abnormal	JJ
cord-305956-l02xdq87	76	13	levels	level	NNS
cord-305956-l02xdq87	76	14	of	of	IN
cord-305956-l02xdq87	76	15	albumin	albumin	NN
cord-305956-l02xdq87	76	16	and	and	CC
cord-305956-l02xdq87	76	17	lactate	lactate	NN
cord-305956-l02xdq87	76	18	dehydrogenase	dehydrogenase	NN
cord-305956-l02xdq87	76	19	(	(	-LRB-
cord-305956-l02xdq87	76	20	LDH	LDH	NNP
cord-305956-l02xdq87	76	21	)	)	-RRB-
cord-305956-l02xdq87	76	22	were	be	VBD
cord-305956-l02xdq87	76	23	also	also	RB
cord-305956-l02xdq87	76	24	reported	report	VBN
cord-305956-l02xdq87	76	25	in	in	IN
cord-305956-l02xdq87	76	26	SARS	SARS	NNP
cord-305956-l02xdq87	76	27	-	-	HYPH
cord-305956-l02xdq87	76	28	CoV-2	CoV-2	NNP
cord-305956-l02xdq87	76	29	infection	infection	NN
cord-305956-l02xdq87	76	30	,	,	,
cord-305956-l02xdq87	76	31	with	with	IN
cord-305956-l02xdq87	76	32	the	the	DT
cord-305956-l02xdq87	76	33	maximum	maximum	NN
cord-305956-l02xdq87	76	34	of	of	IN
cord-305956-l02xdq87	76	35	98	98	CD
cord-305956-l02xdq87	76	36	%	%	NN
cord-305956-l02xdq87	76	37	and	and	CC
cord-305956-l02xdq87	76	38	76	76	CD
cord-305956-l02xdq87	76	39	%	%	NN
cord-305956-l02xdq87	76	40	of	of	IN
cord-305956-l02xdq87	76	41	the	the	DT
cord-305956-l02xdq87	76	42	patients	patient	NNS
cord-305956-l02xdq87	76	43	affected	affect	VBN
cord-305956-l02xdq87	76	44	as	as	IN
cord-305956-l02xdq87	76	45	reported	report	VBN
cord-305956-l02xdq87	76	46	in	in	IN
cord-305956-l02xdq87	76	47	the	the	DT
cord-305956-l02xdq87	76	48	study	study	NN
cord-305956-l02xdq87	76	49	by	by	IN
cord-305956-l02xdq87	76	50	Chen	Chen	NNP
cord-305956-l02xdq87	76	51	et	et	NNP
cord-305956-l02xdq87	76	52	al	al	NNP
cord-305956-l02xdq87	76	53	.	.	.
cord-305956-l02xdq87	77	1	17	17	CD
cord-305956-l02xdq87	78	1	It	-PRON-	PRP
cord-305956-l02xdq87	78	2	is	be	VBZ
cord-305956-l02xdq87	78	3	important	important	JJ
cord-305956-l02xdq87	78	4	to	to	TO
cord-305956-l02xdq87	78	5	remember	remember	VB
cord-305956-l02xdq87	78	6	that	that	IN
cord-305956-l02xdq87	78	7	LDH	LDH	NNP
cord-305956-l02xdq87	78	8	and	and	CC
cord-305956-l02xdq87	78	9	AST	AST	NNP
cord-305956-l02xdq87	78	10	elevation	elevation	NN
cord-305956-l02xdq87	78	11	could	could	MD
cord-305956-l02xdq87	78	12	be	be	VB
cord-305956-l02xdq87	78	13	from	from	IN
cord-305956-l02xdq87	78	14	muscle	muscle	NN
cord-305956-l02xdq87	78	15	damage	damage	NN
cord-305956-l02xdq87	78	16	and	and	CC
cord-305956-l02xdq87	78	17	not	not	RB
cord-305956-l02xdq87	78	18	necessarily	necessarily	RB
cord-305956-l02xdq87	78	19	reflect	reflect	VBP
cord-305956-l02xdq87	78	20	liver	liver	NN
cord-305956-l02xdq87	78	21	injury	injury	NN
cord-305956-l02xdq87	78	22	.	.	.
cord-305956-l02xdq87	79	1	The	the	DT
cord-305956-l02xdq87	79	2	current	current	JJ
cord-305956-l02xdq87	79	3	armory	armory	NN
cord-305956-l02xdq87	79	4	of	of	IN
cord-305956-l02xdq87	79	5	therapeutic	therapeutic	JJ
cord-305956-l02xdq87	79	6	agents	agent	NNS
cord-305956-l02xdq87	79	7	explored	explore	VBN
cord-305956-l02xdq87	79	8	against	against	IN
cord-305956-l02xdq87	79	9	SARS	SARS	NNP
cord-305956-l02xdq87	79	10	-	-	HYPH
cord-305956-l02xdq87	79	11	CoV-2	CoV-2	NNP
cord-305956-l02xdq87	79	12	includes	include	VBZ
cord-305956-l02xdq87	79	13	several	several	JJ
cord-305956-l02xdq87	79	14	antiviral	antiviral	JJ
cord-305956-l02xdq87	79	15	agents	agent	NNS
cord-305956-l02xdq87	79	16	,	,	,
cord-305956-l02xdq87	79	17	supportive	supportive	JJ
cord-305956-l02xdq87	79	18	therapy	therapy	NN
cord-305956-l02xdq87	79	19	and	and	CC
cord-305956-l02xdq87	79	20	trials	trial	NNS
cord-305956-l02xdq87	79	21	of	of	IN
cord-305956-l02xdq87	79	22	alternative	alternative	JJ
cord-305956-l02xdq87	79	23	medicines	medicine	NNS
cord-305956-l02xdq87	79	24	in	in	IN
cord-305956-l02xdq87	79	25	many	many	JJ
cord-305956-l02xdq87	79	26	regions	region	NNS
cord-305956-l02xdq87	79	27	of	of	IN
cord-305956-l02xdq87	79	28	the	the	DT
cord-305956-l02xdq87	79	29	world	world	NN
cord-305956-l02xdq87	79	30	.	.	.
cord-305956-l02xdq87	80	1	Given	give	VBN
cord-305956-l02xdq87	80	2	the	the	DT
cord-305956-l02xdq87	80	3	fact	fact	NN
cord-305956-l02xdq87	80	4	that	that	IN
cord-305956-l02xdq87	80	5	the	the	DT
cord-305956-l02xdq87	80	6	liver	liver	NN
cord-305956-l02xdq87	80	7	is	be	VBZ
cord-305956-l02xdq87	80	8	involved	involve	VBN
cord-305956-l02xdq87	80	9	in	in	IN
cord-305956-l02xdq87	80	10	the	the	DT
cord-305956-l02xdq87	80	11	metabolism	metabolism	NN
cord-305956-l02xdq87	80	12	of	of	IN
cord-305956-l02xdq87	80	13	many	many	JJ
cord-305956-l02xdq87	80	14	drugs	drug	NNS
cord-305956-l02xdq87	80	15	,	,	,
cord-305956-l02xdq87	80	16	including	include	VBG
cord-305956-l02xdq87	80	17	nucleoside	nucleoside	JJ
cord-305956-l02xdq87	80	18	analogs	analog	NNS
cord-305956-l02xdq87	80	19	and	and	CC
cord-305956-l02xdq87	80	20	protease	protease	NN
cord-305956-l02xdq87	80	21	inhibitors	inhibitor	NNS
cord-305956-l02xdq87	80	22	that	that	WDT
cord-305956-l02xdq87	80	23	are	be	VBP
cord-305956-l02xdq87	80	24	currently	currently	RB
cord-305956-l02xdq87	80	25	used	use	VBN
cord-305956-l02xdq87	80	26	to	to	TO
cord-305956-l02xdq87	80	27	treat	treat	VB
cord-305956-l02xdq87	80	28	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	80	29	,	,	,
cord-305956-l02xdq87	80	30	hepatotoxicity	hepatotoxicity	NN
cord-305956-l02xdq87	80	31	from	from	IN
cord-305956-l02xdq87	80	32	these	these	DT
cord-305956-l02xdq87	80	33	drugs	drug	NNS
cord-305956-l02xdq87	80	34	can	can	MD
cord-305956-l02xdq87	80	35	arise	arise	VB
cord-305956-l02xdq87	80	36	.	.	.
cord-305956-l02xdq87	81	1	A	a	DT
cord-305956-l02xdq87	81	2	recent	recent	JJ
cord-305956-l02xdq87	81	3	randomized	randomize	VBN
cord-305956-l02xdq87	81	4	controlled	control	VBN
cord-305956-l02xdq87	81	5	trial	trial	NN
cord-305956-l02xdq87	81	6	of	of	IN
cord-305956-l02xdq87	81	7	lopinavir	lopinavir	NNS
cord-305956-l02xdq87	81	8	and	and	CC
cord-305956-l02xdq87	81	9	ritonavir	ritonavir	NNP
cord-305956-l02xdq87	81	10	in	in	IN
cord-305956-l02xdq87	81	11	severe	severe	JJ
cord-305956-l02xdq87	81	12	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	81	13	reported	report	VBD
cord-305956-l02xdq87	81	14	that	that	IN
cord-305956-l02xdq87	81	15	elevated	elevated	JJ
cord-305956-l02xdq87	81	16	levels	level	NNS
cord-305956-l02xdq87	81	17	of	of	IN
cord-305956-l02xdq87	81	18	AST	ast	NN
cord-305956-l02xdq87	81	19	,	,	,
cord-305956-l02xdq87	81	20	ALT	alt	NN
cord-305956-l02xdq87	81	21	and	and	CC
cord-305956-l02xdq87	81	22	total	total	JJ
cord-305956-l02xdq87	81	23	bilirubin	bilirubin	NN
cord-305956-l02xdq87	81	24	occurred	occur	VBD
cord-305956-l02xdq87	81	25	as	as	IN
cord-305956-l02xdq87	81	26	adverse	adverse	JJ
cord-305956-l02xdq87	81	27	effects	effect	NNS
cord-305956-l02xdq87	81	28	in	in	IN
cord-305956-l02xdq87	81	29	a	a	DT
cord-305956-l02xdq87	81	30	few	few	JJ
cord-305956-l02xdq87	81	31	patients	patient	NNS
cord-305956-l02xdq87	81	32	.	.	.
cord-305956-l02xdq87	82	1	41	41	CD
cord-305956-l02xdq87	83	1	Another	another	DT
cord-305956-l02xdq87	83	2	case	case	NN
cord-305956-l02xdq87	83	3	series	series	NN
cord-305956-l02xdq87	83	4	from	from	IN
cord-305956-l02xdq87	83	5	Wuhan	Wuhan	NNP
cord-305956-l02xdq87	83	6	reported	report	VBD
cord-305956-l02xdq87	83	7	that	that	IN
cord-305956-l02xdq87	83	8	55.4	55.4	CD
cord-305956-l02xdq87	83	9	%	%	NN
cord-305956-l02xdq87	83	10	of	of	IN
cord-305956-l02xdq87	83	11	patients	patient	NNS
cord-305956-l02xdq87	83	12	experienced	experience	VBD
cord-305956-l02xdq87	83	13	liver	liver	NN
cord-305956-l02xdq87	83	14	injuries	injury	NNS
cord-305956-l02xdq87	83	15	after	after	IN
cord-305956-l02xdq87	83	16	treatment	treatment	NN
cord-305956-l02xdq87	83	17	with	with	IN
cord-305956-l02xdq87	83	18	lopinavir	lopinavir	NNS
cord-305956-l02xdq87	83	19	and	and	CC
cord-305956-l02xdq87	83	20	ritonavir	ritonavir	NNP
cord-305956-l02xdq87	83	21	.	.	.
cord-305956-l02xdq87	84	1	26	26	CD
cord-305956-l02xdq87	85	1	Fan	Fan	NNP
cord-305956-l02xdq87	85	2	et	et	NNP
cord-305956-l02xdq87	85	3	al	al	NNP
cord-305956-l02xdq87	85	4	.	.	.
cord-305956-l02xdq87	86	1	published	publish	VBD
cord-305956-l02xdq87	86	2	a	a	DT
cord-305956-l02xdq87	86	3	retrospective	retrospective	JJ
cord-305956-l02xdq87	86	4	study	study	NN
cord-305956-l02xdq87	86	5	on	on	IN
cord-305956-l02xdq87	86	6	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	86	7	and	and	CC
cord-305956-l02xdq87	86	8	observed	observe	VBD
cord-305956-l02xdq87	86	9	that	that	IN
cord-305956-l02xdq87	86	10	the	the	DT
cord-305956-l02xdq87	86	11	utilization	utilization	NN
cord-305956-l02xdq87	86	12	rate	rate	NN
cord-305956-l02xdq87	86	13	of	of	IN
cord-305956-l02xdq87	86	14	this	this	DT
cord-305956-l02xdq87	86	15	drug	drug	NN
cord-305956-l02xdq87	86	16	combination	combination	NN
cord-305956-l02xdq87	86	17	was	be	VBD
cord-305956-l02xdq87	86	18	significantly	significantly	RB
cord-305956-l02xdq87	86	19	higher	high	JJR
cord-305956-l02xdq87	86	20	in	in	IN
cord-305956-l02xdq87	86	21	patients	patient	NNS
cord-305956-l02xdq87	86	22	with	with	IN
cord-305956-l02xdq87	86	23	abnormal	abnormal	JJ
cord-305956-l02xdq87	86	24	LFTs	lft	NNS
cord-305956-l02xdq87	86	25	compared	compare	VBN
cord-305956-l02xdq87	86	26	with	with	IN
cord-305956-l02xdq87	86	27	patients	patient	NNS
cord-305956-l02xdq87	86	28	without	without	IN
cord-305956-l02xdq87	86	29	LFT	LFT	NNP
cord-305956-l02xdq87	86	30	elevations	elevation	NNS
cord-305956-l02xdq87	86	31	(	(	-LRB-
cord-305956-l02xdq87	86	32	56.1	56.1	CD
cord-305956-l02xdq87	86	33	%	%	NN
cord-305956-l02xdq87	86	34	vs.	vs.	IN
cord-305956-l02xdq87	86	35	25	25	CD
cord-305956-l02xdq87	86	36	%	%	NN
cord-305956-l02xdq87	86	37	,	,	,
cord-305956-l02xdq87	86	38	p	p	NN
cord-305956-l02xdq87	86	39	¼	¼	CD
cord-305956-l02xdq87	86	40	0.009	0.009	CD
cord-305956-l02xdq87	86	41	)	)	-RRB-
cord-305956-l02xdq87	86	42	.	.	.
cord-305956-l02xdq87	87	1	In	in	IN
cord-305956-l02xdq87	87	2	this	this	DT
cord-305956-l02xdq87	87	3	study	study	NN
cord-305956-l02xdq87	87	4	,	,	,
cord-305956-l02xdq87	87	5	47.3	47.3	CD
cord-305956-l02xdq87	87	6	%	%	NN
cord-305956-l02xdq87	87	7	of	of	IN
cord-305956-l02xdq87	87	8	the	the	DT
cord-305956-l02xdq87	87	9	discharged	discharge	VBN
cord-305956-l02xdq87	87	10	patients	patient	NNS
cord-305956-l02xdq87	87	11	showed	show	VBD
cord-305956-l02xdq87	87	12	elevated	elevated	JJ
cord-305956-l02xdq87	87	13	LFTs	lft	NNS
cord-305956-l02xdq87	87	14	at	at	IN
cord-305956-l02xdq87	87	15	baseline	baseline	NN
cord-305956-l02xdq87	87	16	,	,	,
cord-305956-l02xdq87	87	17	and	and	CC
cord-305956-l02xdq87	87	18	23.7	23.7	CD
cord-305956-l02xdq87	87	19	%	%	NN
cord-305956-l02xdq87	87	20	developed	develop	VBD
cord-305956-l02xdq87	87	21	abnormalities	abnormality	NNS
cord-305956-l02xdq87	87	22	during	during	IN
cord-305956-l02xdq87	87	23	hospitalization	hospitalization	NN
cord-305956-l02xdq87	87	24	,	,	,
cord-305956-l02xdq87	87	25	suggesting	suggest	VBG
cord-305956-l02xdq87	87	26	emerging	emerge	VBG
cord-305956-l02xdq87	87	27	liver	liver	NN
cord-305956-l02xdq87	87	28	injury	injury	NN
cord-305956-l02xdq87	87	29	from	from	IN
cord-305956-l02xdq87	87	30	drugs	drug	NNS
cord-305956-l02xdq87	87	31	or	or	CC
cord-305956-l02xdq87	87	32	during	during	IN
cord-305956-l02xdq87	87	33	the	the	DT
cord-305956-l02xdq87	87	34	course	course	NN
cord-305956-l02xdq87	87	35	of	of	IN
cord-305956-l02xdq87	87	36	the	the	DT
cord-305956-l02xdq87	87	37	infection	infection	NN
cord-305956-l02xdq87	87	38	.	.	.
cord-305956-l02xdq87	88	1	Importantly	importantly	RB
cord-305956-l02xdq87	88	2	,	,	,
cord-305956-l02xdq87	88	3	LFT	LFT	NNP
cord-305956-l02xdq87	88	4	elevation	elevation	NN
cord-305956-l02xdq87	88	5	during	during	IN
cord-305956-l02xdq87	88	6	the	the	DT
cord-305956-l02xdq87	88	7	hospital	hospital	NN
cord-305956-l02xdq87	88	8	stay	stay	NN
cord-305956-l02xdq87	88	9	was	be	VBD
cord-305956-l02xdq87	88	10	associated	associate	VBN
cord-305956-l02xdq87	88	11	with	with	IN
cord-305956-l02xdq87	88	12	prolonged	prolonged	JJ
cord-305956-l02xdq87	88	13	length	length	NN
cord-305956-l02xdq87	88	14	of	of	IN
cord-305956-l02xdq87	88	15	hospitalization	hospitalization	NN
cord-305956-l02xdq87	88	16	.	.	.
cord-305956-l02xdq87	89	1	7	7	CD
cord-305956-l02xdq87	89	2	Chloroquine	Chloroquine	NNP
cord-305956-l02xdq87	89	3	,	,	,
cord-305956-l02xdq87	89	4	an	an	DT
cord-305956-l02xdq87	89	5	old	old	JJ
cord-305956-l02xdq87	89	6	drug	drug	NN
cord-305956-l02xdq87	89	7	with	with	IN
cord-305956-l02xdq87	89	8	a	a	DT
cord-305956-l02xdq87	89	9	potential	potential	NN
cord-305956-l02xdq87	89	10	of	of	IN
cord-305956-l02xdq87	89	11	repositioning	reposition	VBG
cord-305956-l02xdq87	89	12	for	for	IN
cord-305956-l02xdq87	89	13	new	new	JJ
cord-305956-l02xdq87	89	14	treatment	treatment	NN
cord-305956-l02xdq87	89	15	indications	indication	NNS
cord-305956-l02xdq87	89	16	,	,	,
cord-305956-l02xdq87	89	17	has	have	VBZ
cord-305956-l02xdq87	89	18	recently	recently	RB
cord-305956-l02xdq87	89	19	been	be	VBN
cord-305956-l02xdq87	89	20	tried	try	VBN
cord-305956-l02xdq87	89	21	in	in	IN
cord-305956-l02xdq87	89	22	patients	patient	NNS
cord-305956-l02xdq87	89	23	infected	infect	VBN
cord-305956-l02xdq87	89	24	with	with	IN
cord-305956-l02xdq87	89	25	SARS	SARS	NNP
cord-305956-l02xdq87	89	26	-	-	HYPH
cord-305956-l02xdq87	89	27	CoV-2	CoV-2	NNP
cord-305956-l02xdq87	89	28	.	.	.
cord-305956-l02xdq87	90	1	After	after	IN
cord-305956-l02xdq87	90	2	a	a	DT
cord-305956-l02xdq87	90	3	profound	profound	JJ
cord-305956-l02xdq87	90	4	success	success	NN
cord-305956-l02xdq87	90	5	in	in	IN
cord-305956-l02xdq87	90	6	inhibiting	inhibit	VBG
cord-305956-l02xdq87	90	7	viral	viral	JJ
cord-305956-l02xdq87	90	8	replication	replication	NN
cord-305956-l02xdq87	90	9	in	in	IN
cord-305956-l02xdq87	90	10	vitro	vitro	FW
cord-305956-l02xdq87	90	11	,	,	,
cord-305956-l02xdq87	90	12	concurrent	concurrent	JJ
cord-305956-l02xdq87	90	13	clinical	clinical	JJ
cord-305956-l02xdq87	90	14	trials	trial	NNS
cord-305956-l02xdq87	90	15	(	(	-LRB-
cord-305956-l02xdq87	90	16	>	>	NFP
cord-305956-l02xdq87	90	17	20	20	CD
cord-305956-l02xdq87	90	18	)	)	-RRB-
cord-305956-l02xdq87	90	19	on	on	IN
cord-305956-l02xdq87	90	20	chloroquine	chloroquine	NN
cord-305956-l02xdq87	90	21	conducted	conduct	VBN
cord-305956-l02xdq87	90	22	at	at	IN
cord-305956-l02xdq87	90	23	10	10	CD
cord-305956-l02xdq87	90	24	hospitals	hospital	NNS
cord-305956-l02xdq87	90	25	across	across	IN
cord-305956-l02xdq87	90	26	China	China	NNP
cord-305956-l02xdq87	90	27	have	have	VBP
cord-305956-l02xdq87	90	28	demonstrated	demonstrate	VBN
cord-305956-l02xdq87	90	29	superior	superior	JJ
cord-305956-l02xdq87	90	30	efficacy	efficacy	NN
cord-305956-l02xdq87	90	31	in	in	IN
cord-305956-l02xdq87	90	32	viral	viral	JJ
cord-305956-l02xdq87	90	33	control	control	NN
cord-305956-l02xdq87	90	34	.	.	.
cord-305956-l02xdq87	91	1	42	42	CD
cord-305956-l02xdq87	92	1	The	the	DT
cord-305956-l02xdq87	92	2	pharmacodynamic	pharmacodynamic	JJ
cord-305956-l02xdq87	92	3	activity	activity	NN
cord-305956-l02xdq87	92	4	of	of	IN
cord-305956-l02xdq87	92	5	this	this	DT
cord-305956-l02xdq87	92	6	drug	drug	NN
cord-305956-l02xdq87	92	7	in	in	IN
cord-305956-l02xdq87	92	8	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	92	9	may	may	MD
cord-305956-l02xdq87	92	10	involve	involve	VB
cord-305956-l02xdq87	92	11	the	the	DT
cord-305956-l02xdq87	92	12	arresting	arresting	NN
cord-305956-l02xdq87	92	13	of	of	IN
cord-305956-l02xdq87	92	14	cytokine	cytokine	NN
cord-305956-l02xdq87	92	15	storms	storm	NNS
cord-305956-l02xdq87	92	16	or	or	CC
cord-305956-l02xdq87	92	17	the	the	DT
cord-305956-l02xdq87	92	18	activation	activation	NN
cord-305956-l02xdq87	92	19	of	of	IN
cord-305956-l02xdq87	92	20	CD8þ	CD8þ	NNP
cord-305956-l02xdq87	92	21	cells	cell	NNS
cord-305956-l02xdq87	92	22	or	or	CC
cord-305956-l02xdq87	92	23	by	by	IN
cord-305956-l02xdq87	92	24	preventing	prevent	VBG
cord-305956-l02xdq87	92	25	endocytosismediated	endocytosismediate	VBN
cord-305956-l02xdq87	92	26	uptake	uptake	NN
cord-305956-l02xdq87	92	27	of	of	IN
cord-305956-l02xdq87	92	28	the	the	DT
cord-305956-l02xdq87	92	29	virus	virus	NN
cord-305956-l02xdq87	92	30	.	.	.
cord-305956-l02xdq87	93	1	43	43	CD
cord-305956-l02xdq87	94	1	Importantly	importantly	RB
cord-305956-l02xdq87	94	2	,	,	,
cord-305956-l02xdq87	94	3	hepatotoxicity	hepatotoxicity	NN
cord-305956-l02xdq87	94	4	related	relate	VBN
cord-305956-l02xdq87	94	5	to	to	IN
cord-305956-l02xdq87	94	6	chloroquine	chloroquine	NN
cord-305956-l02xdq87	94	7	or	or	CC
cord-305956-l02xdq87	94	8	hydroxychloroquine	hydroxychloroquine	NN
cord-305956-l02xdq87	94	9	has	have	VBZ
cord-305956-l02xdq87	94	10	rarely	rarely	RB
cord-305956-l02xdq87	94	11	been	be	VBN
cord-305956-l02xdq87	94	12	reported	report	VBN
cord-305956-l02xdq87	94	13	.	.	.
cord-305956-l02xdq87	95	1	In	in	IN
cord-305956-l02xdq87	95	2	severe	severe	JJ
cord-305956-l02xdq87	95	3	cases	case	NNS
cord-305956-l02xdq87	95	4	of	of	IN
cord-305956-l02xdq87	95	5	COVID-19	covid-19	DT
cord-305956-l02xdq87	95	6	with	with	IN
cord-305956-l02xdq87	95	7	cytokine	cytokine	NN
cord-305956-l02xdq87	95	8	release	release	NN
cord-305956-l02xdq87	95	9	,	,	,
cord-305956-l02xdq87	95	10	tocilizumab	tocilizumab	NNP
cord-305956-l02xdq87	95	11	,	,	,
cord-305956-l02xdq87	95	12	an	an	DT
cord-305956-l02xdq87	95	13	IL-6	IL-6	NNP
cord-305956-l02xdq87	95	14	antagonist	antagonist	NN
cord-305956-l02xdq87	95	15	,	,	,
cord-305956-l02xdq87	95	16	which	which	WDT
cord-305956-l02xdq87	95	17	is	be	VBZ
cord-305956-l02xdq87	95	18	humanized	humanize	VBN
cord-305956-l02xdq87	95	19	IgG1	igg1	CD
cord-305956-l02xdq87	95	20	monoclonal	monoclonal	JJ
cord-305956-l02xdq87	95	21	antibody	antibody	NN
cord-305956-l02xdq87	95	22	to	to	IN
cord-305956-l02xdq87	95	23	the	the	DT
cord-305956-l02xdq87	95	24	IL-6	IL-6	NNP
cord-305956-l02xdq87	95	25	receptor	receptor	NN
cord-305956-l02xdq87	95	26	,	,	,
cord-305956-l02xdq87	95	27	has	have	VBZ
cord-305956-l02xdq87	95	28	been	be	VBN
cord-305956-l02xdq87	95	29	used	use	VBN
cord-305956-l02xdq87	95	30	as	as	IN
cord-305956-l02xdq87	95	31	a	a	DT
cord-305956-l02xdq87	95	32	potential	potential	JJ
cord-305956-l02xdq87	95	33	therapy	therapy	NN
cord-305956-l02xdq87	95	34	for	for	IN
cord-305956-l02xdq87	95	35	SARS	SARS	NNP
cord-305956-l02xdq87	95	36	-	-	HYPH
cord-305956-l02xdq87	95	37	CoV-2	CoV-2	NNP
cord-305956-l02xdq87	95	38	.	.	.
cord-305956-l02xdq87	96	1	In	in	IN
cord-305956-l02xdq87	96	2	previous	previous	JJ
cord-305956-l02xdq87	96	3	clinical	clinical	JJ
cord-305956-l02xdq87	96	4	trials	trial	NNS
cord-305956-l02xdq87	96	5	for	for	IN
cord-305956-l02xdq87	96	6	other	other	JJ
cord-305956-l02xdq87	96	7	indications	indication	NNS
cord-305956-l02xdq87	96	8	tocilizumab	tocilizumab	NN
cord-305956-l02xdq87	96	9	was	be	VBD
cord-305956-l02xdq87	96	10	reported	report	VBN
cord-305956-l02xdq87	96	11	to	to	TO
cord-305956-l02xdq87	96	12	cause	cause	VB
cord-305956-l02xdq87	96	13	mild	mild	JJ
cord-305956-l02xdq87	96	14	elevations	elevation	NNS
cord-305956-l02xdq87	96	15	of	of	IN
cord-305956-l02xdq87	96	16	LFTs	lft	NNS
cord-305956-l02xdq87	96	17	which	which	WDT
cord-305956-l02xdq87	96	18	were	be	VBD
cord-305956-l02xdq87	96	19	usually	usually	RB
cord-305956-l02xdq87	96	20	transient	transient	JJ
cord-305956-l02xdq87	96	21	and	and	CC
cord-305956-l02xdq87	96	22	commonly	commonly	RB
cord-305956-l02xdq87	96	23	resolved	resolve	VBN
cord-305956-l02xdq87	96	24	within	within	IN
cord-305956-l02xdq87	96	25	2	2	CD
cord-305956-l02xdq87	96	26	-	-	SYM
cord-305956-l02xdq87	96	27	6	6	CD
cord-305956-l02xdq87	96	28	weeks	week	NNS
cord-305956-l02xdq87	96	29	from	from	IN
cord-305956-l02xdq87	96	30	exposure	exposure	NN
cord-305956-l02xdq87	96	31	.	.	.
cord-305956-l02xdq87	97	1	37	37	CD
cord-305956-l02xdq87	97	2	Remdesivir	Remdesivir	NNP
cord-305956-l02xdq87	97	3	is	be	VBZ
cord-305956-l02xdq87	97	4	an	an	DT
cord-305956-l02xdq87	97	5	experimental	experimental	JJ
cord-305956-l02xdq87	97	6	antiviral	antiviral	JJ
cord-305956-l02xdq87	97	7	nucleotide	nucleotide	NN
cord-305956-l02xdq87	97	8	analog	analog	NN
cord-305956-l02xdq87	97	9	with	with	IN
cord-305956-l02xdq87	97	10	broad	broad	JJ
cord-305956-l02xdq87	97	11	activity	activity	NN
cord-305956-l02xdq87	97	12	against	against	IN
cord-305956-l02xdq87	97	13	coronaviruses	coronaviruse	NNS
cord-305956-l02xdq87	97	14	44	44	CD
cord-305956-l02xdq87	97	15	that	that	WDT
cord-305956-l02xdq87	97	16	is	be	VBZ
cord-305956-l02xdq87	97	17	currently	currently	RB
cord-305956-l02xdq87	97	18	being	be	VBG
cord-305956-l02xdq87	97	19	trialed	triale	VBN
cord-305956-l02xdq87	97	20	for	for	IN
cord-305956-l02xdq87	97	21	SARS	SARS	NNP
cord-305956-l02xdq87	97	22	-	-	HYPH
cord-305956-l02xdq87	97	23	Cov-2	Cov-2	NNP
cord-305956-l02xdq87	97	24	infection	infection	NN
cord-305956-l02xdq87	97	25	.	.	.
cord-305956-l02xdq87	98	1	Safety	safety	NN
cord-305956-l02xdq87	98	2	data	datum	NNS
cord-305956-l02xdq87	98	3	from	from	IN
cord-305956-l02xdq87	98	4	ongoing	ongoing	JJ
cord-305956-l02xdq87	98	5	studies	study	NNS
cord-305956-l02xdq87	98	6	will	will	MD
cord-305956-l02xdq87	98	7	guide	guide	VB
cord-305956-l02xdq87	98	8	on	on	IN
cord-305956-l02xdq87	98	9	its	-PRON-	PRP$
cord-305956-l02xdq87	98	10	use	use	NN
cord-305956-l02xdq87	98	11	in	in	IN
cord-305956-l02xdq87	98	12	patients	patient	NNS
cord-305956-l02xdq87	98	13	,	,	,
cord-305956-l02xdq87	98	14	but	but	CC
cord-305956-l02xdq87	98	15	so	so	RB
cord-305956-l02xdq87	98	16	far	far	RB
cord-305956-l02xdq87	98	17	no	no	DT
cord-305956-l02xdq87	98	18	reports	report	NNS
cord-305956-l02xdq87	98	19	of	of	IN
cord-305956-l02xdq87	98	20	liver	liver	NN
cord-305956-l02xdq87	98	21	toxicity	toxicity	NN
cord-305956-l02xdq87	98	22	have	have	VBP
cord-305956-l02xdq87	98	23	emerged	emerge	VBN
cord-305956-l02xdq87	98	24	.	.	.
cord-305956-l02xdq87	99	1	Patients	patient	NNS
cord-305956-l02xdq87	99	2	with	with	IN
cord-305956-l02xdq87	99	3	pre	pre	JJ
cord-305956-l02xdq87	99	4	-	-	JJ
cord-305956-l02xdq87	99	5	existing	existing	JJ
cord-305956-l02xdq87	99	6	liver	liver	NN
cord-305956-l02xdq87	99	7	disease	disease	NN
cord-305956-l02xdq87	99	8	Scare	Scare	NNP
cord-305956-l02xdq87	99	9	data	datum	NNS
cord-305956-l02xdq87	99	10	has	have	VBZ
cord-305956-l02xdq87	99	11	been	be	VBN
cord-305956-l02xdq87	99	12	published	publish	VBN
cord-305956-l02xdq87	99	13	for	for	IN
cord-305956-l02xdq87	99	14	COVID-19	covid-19	JJ
cord-305956-l02xdq87	99	15	infection	infection	NN
cord-305956-l02xdq87	99	16	in	in	IN
cord-305956-l02xdq87	99	17	patients	patient	NNS
cord-305956-l02xdq87	99	18	with	with	IN
cord-305956-l02xdq87	99	19	pre	pre	JJ
cord-305956-l02xdq87	99	20	-	-	JJ
cord-305956-l02xdq87	99	21	existing	existing	JJ
cord-305956-l02xdq87	99	22	liver	liver	NN
cord-305956-l02xdq87	99	23	disease	disease	NN
cord-305956-l02xdq87	99	24	.	.	.
cord-305956-l02xdq87	100	1	Experience	experience	NN
cord-305956-l02xdq87	100	2	from	from	IN
cord-305956-l02xdq87	100	3	previous	previous	JJ
cord-305956-l02xdq87	100	4	episodes	episode	NNS
cord-305956-l02xdq87	100	5	of	of	IN
cord-305956-l02xdq87	100	6	coronavirus	coronavirus	NN
cord-305956-l02xdq87	100	7	infection	infection	NN
cord-305956-l02xdq87	100	8	can	can	MD
cord-305956-l02xdq87	100	9	guide	guide	VB
cord-305956-l02xdq87	100	10	on	on	IN
cord-305956-l02xdq87	100	11	the	the	DT
cord-305956-l02xdq87	100	12	extent	extent	NN
cord-305956-l02xdq87	100	13	of	of	IN
cord-305956-l02xdq87	100	14	hepatic	hepatic	JJ
cord-305956-l02xdq87	100	15	involvement	involvement	NN
cord-305956-l02xdq87	100	16	and	and	CC
cord-305956-l02xdq87	100	17	on	on	IN
cord-305956-l02xdq87	100	18	the	the	DT
cord-305956-l02xdq87	100	19	management	management	NN
cord-305956-l02xdq87	100	20	of	of	IN
cord-305956-l02xdq87	100	21	patients	patient	NNS
cord-305956-l02xdq87	100	22	with	with	IN
cord-305956-l02xdq87	100	23	pre	pre	JJ
cord-305956-l02xdq87	100	24	-	-	JJ
cord-305956-l02xdq87	100	25	existing	existing	JJ
cord-305956-l02xdq87	100	26	liver	liver	NN
cord-305956-l02xdq87	100	27	disease	disease	NN
cord-305956-l02xdq87	100	28	.	.	.
cord-305956-l02xdq87	101	1	In	in	IN
cord-305956-l02xdq87	101	2	SARS	SARS	NNP
cord-305956-l02xdq87	101	3	,	,	,
cord-305956-l02xdq87	101	4	the	the	DT
cord-305956-l02xdq87	101	5	highest	high	JJS
cord-305956-l02xdq87	101	6	mortality	mortality	NN
cord-305956-l02xdq87	101	7	rates	rate	NNS
cord-305956-l02xdq87	101	8	were	be	VBD
cord-305956-l02xdq87	101	9	observed	observe	VBN
cord-305956-l02xdq87	101	10	in	in	IN
cord-305956-l02xdq87	101	11	the	the	DT
cord-305956-l02xdq87	101	12	elderly	elderly	JJ
cord-305956-l02xdq87	101	13	and	and	CC
cord-305956-l02xdq87	101	14	adults	adult	NNS
cord-305956-l02xdq87	101	15	with	with	IN
cord-305956-l02xdq87	101	16	underlying	underlie	VBG
cord-305956-l02xdq87	101	17	liver	liver	NN
cord-305956-l02xdq87	101	18	disease	disease	NN
cord-305956-l02xdq87	101	19	.	.	.
cord-305956-l02xdq87	102	1	45	45	CD
cord-305956-l02xdq87	103	1	Therefore	therefore	RB
cord-305956-l02xdq87	103	2	,	,	,
cord-305956-l02xdq87	103	3	it	-PRON-	PRP
cord-305956-l02xdq87	103	4	has	have	VBZ
cord-305956-l02xdq87	103	5	to	to	TO
cord-305956-l02xdq87	103	6	be	be	VB
cord-305956-l02xdq87	103	7	expected	expect	VBN
cord-305956-l02xdq87	103	8	that	that	IN
cord-305956-l02xdq87	103	9	the	the	DT
cord-305956-l02xdq87	103	10	patients	patient	NNS
cord-305956-l02xdq87	103	11	with	with	IN
cord-305956-l02xdq87	103	12	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	103	13	are	be	VBP
cord-305956-l02xdq87	103	14	also	also	RB
cord-305956-l02xdq87	103	15	more	more	RBR
cord-305956-l02xdq87	103	16	vulnerable	vulnerable	JJ
cord-305956-l02xdq87	103	17	to	to	IN
cord-305956-l02xdq87	103	18	hepatic	hepatic	JJ
cord-305956-l02xdq87	103	19	injury	injury	NN
cord-305956-l02xdq87	103	20	.	.	.
cord-305956-l02xdq87	104	1	9	9	CD
cord-305956-l02xdq87	105	1	In	in	IN
cord-305956-l02xdq87	105	2	a	a	DT
cord-305956-l02xdq87	105	3	case	case	NN
cord-305956-l02xdq87	105	4	series	series	NN
cord-305956-l02xdq87	105	5	from	from	IN
cord-305956-l02xdq87	105	6	the	the	DT
cord-305956-l02xdq87	105	7	Zhejiang	Zhejiang	NNP
cord-305956-l02xdq87	105	8	province	province	NN
cord-305956-l02xdq87	105	9	,	,	,
cord-305956-l02xdq87	105	10	a	a	DT
cord-305956-l02xdq87	105	11	prevalence	prevalence	NN
cord-305956-l02xdq87	105	12	of	of	IN
cord-305956-l02xdq87	105	13	11	11	CD
cord-305956-l02xdq87	105	14	%	%	NN
cord-305956-l02xdq87	105	15	of	of	IN
cord-305956-l02xdq87	105	16	underlying	underlie	VBG
cord-305956-l02xdq87	105	17	liver	liver	NN
cord-305956-l02xdq87	105	18	disease	disease	NN
cord-305956-l02xdq87	105	19	was	be	VBD
cord-305956-l02xdq87	105	20	reported	report	VBN
cord-305956-l02xdq87	105	21	.	.	.
cord-305956-l02xdq87	106	1	About	about	RB
cord-305956-l02xdq87	106	2	half	half	NN
cord-305956-l02xdq87	106	3	of	of	IN
cord-305956-l02xdq87	106	4	them	-PRON-	PRP
cord-305956-l02xdq87	106	5	experienced	experience	VBD
cord-305956-l02xdq87	106	6	symptoms	symptom	NNS
cord-305956-l02xdq87	106	7	for	for	IN
cord-305956-l02xdq87	106	8	more	more	JJR
cord-305956-l02xdq87	106	9	than	than	IN
cord-305956-l02xdq87	106	10	10	10	CD
cord-305956-l02xdq87	106	11	days	day	NNS
cord-305956-l02xdq87	106	12	after	after	IN
cord-305956-l02xdq87	106	13	the	the	DT
cord-305956-l02xdq87	106	14	illness	illness	NN
cord-305956-l02xdq87	106	15	onset	onset	NN
cord-305956-l02xdq87	106	16	.	.	.
cord-305956-l02xdq87	107	1	21	21	CD
cord-305956-l02xdq87	108	1	In	in	IN
cord-305956-l02xdq87	108	2	another	another	DT
cord-305956-l02xdq87	108	3	study	study	NN
cord-305956-l02xdq87	108	4	from	from	IN
cord-305956-l02xdq87	108	5	Wuhan	Wuhan	NNP
cord-305956-l02xdq87	108	6	,	,	,
cord-305956-l02xdq87	108	7	9	9	CD
cord-305956-l02xdq87	108	8	%	%	NN
cord-305956-l02xdq87	108	9	of	of	IN
cord-305956-l02xdq87	108	10	patients	patient	NNS
cord-305956-l02xdq87	108	11	had	have	VBD
cord-305956-l02xdq87	108	12	the	the	DT
cord-305956-l02xdq87	108	13	underlying	underlying	JJ
cord-305956-l02xdq87	108	14	liver	liver	NN
cord-305956-l02xdq87	108	15	disease	disease	NN
cord-305956-l02xdq87	108	16	of	of	IN
cord-305956-l02xdq87	108	17	cirrhosis	cirrhosis	NN
cord-305956-l02xdq87	108	18	or	or	CC
cord-305956-l02xdq87	108	19	hepatitis	hepatitis	NN
cord-305956-l02xdq87	108	20	.	.	.
cord-305956-l02xdq87	109	1	23	23	CD
cord-305956-l02xdq87	110	1	Li	Li	NNP
cord-305956-l02xdq87	110	2	et	et	NNP
cord-305956-l02xdq87	110	3	al	al	NNP
cord-305956-l02xdq87	110	4	.	.	NNP
cord-305956-l02xdq87	110	5	,	,	,
cord-305956-l02xdq87	110	6	who	who	WP
cord-305956-l02xdq87	110	7	investigated	investigate	VBD
cord-305956-l02xdq87	110	8	risk	risk	NN
cord-305956-l02xdq87	110	9	factors	factor	NNS
cord-305956-l02xdq87	110	10	involved	involve	VBN
cord-305956-l02xdq87	110	11	with	with	IN
cord-305956-l02xdq87	110	12	hepatic	hepatic	JJ
cord-305956-l02xdq87	110	13	injury	injury	NN
cord-305956-l02xdq87	110	14	,	,	,
cord-305956-l02xdq87	110	15	stated	state	VBD
cord-305956-l02xdq87	110	16	that	that	IN
cord-305956-l02xdq87	110	17	two	two	CD
cord-305956-l02xdq87	110	18	patients	patient	NNS
cord-305956-l02xdq87	110	19	had	have	VBD
cord-305956-l02xdq87	110	20	presented	present	VBN
cord-305956-l02xdq87	110	21	with	with	IN
cord-305956-l02xdq87	110	22	alcoholic	alcoholic	JJ
cord-305956-l02xdq87	110	23	liver	liver	NN
cord-305956-l02xdq87	110	24	disease	disease	NN
cord-305956-l02xdq87	110	25	at	at	IN
cord-305956-l02xdq87	110	26	baseline	baseline	NN
cord-305956-l02xdq87	110	27	.	.	.
cord-305956-l02xdq87	111	1	One	one	CD
cord-305956-l02xdq87	111	2	of	of	IN
cord-305956-l02xdq87	111	3	them	-PRON-	PRP
cord-305956-l02xdq87	111	4	had	have	VBD
cord-305956-l02xdq87	111	5	a	a	DT
cord-305956-l02xdq87	111	6	moderate	moderate	JJ
cord-305956-l02xdq87	111	7	elevation	elevation	NN
cord-305956-l02xdq87	111	8	of	of	IN
cord-305956-l02xdq87	111	9	ALT	alt	NN
cord-305956-l02xdq87	111	10	(	(	-LRB-
cord-305956-l02xdq87	111	11	120	120	CD
cord-305956-l02xdq87	111	12	U	u	NN
cord-305956-l02xdq87	111	13	/	/	SYM
cord-305956-l02xdq87	111	14	L	L	NNP
cord-305956-l02xdq87	111	15	)	)	-RRB-
cord-305956-l02xdq87	111	16	within	within	IN
cord-305956-l02xdq87	111	17	a	a	DT
cord-305956-l02xdq87	111	18	week	week	NN
cord-305956-l02xdq87	111	19	of	of	IN
cord-305956-l02xdq87	111	20	hospitalization	hospitalization	NN
cord-305956-l02xdq87	111	21	,	,	,
cord-305956-l02xdq87	111	22	while	while	IN
cord-305956-l02xdq87	111	23	the	the	DT
cord-305956-l02xdq87	111	24	other	other	JJ
cord-305956-l02xdq87	111	25	showed	show	VBD
cord-305956-l02xdq87	111	26	no	no	DT
cord-305956-l02xdq87	111	27	such	such	JJ
cord-305956-l02xdq87	111	28	abnormalities	abnormality	NNS
cord-305956-l02xdq87	111	29	.	.	.
cord-305956-l02xdq87	112	1	11	11	CD
cord-305956-l02xdq87	113	1	In	in	IN
cord-305956-l02xdq87	113	2	the	the	DT
cord-305956-l02xdq87	113	3	initial	initial	JJ
cord-305956-l02xdq87	113	4	cohort	cohort	NN
cord-305956-l02xdq87	113	5	described	describe	VBN
cord-305956-l02xdq87	113	6	from	from	IN
cord-305956-l02xdq87	113	7	China	China	NNP
cord-305956-l02xdq87	113	8	,	,	,
cord-305956-l02xdq87	113	9	2.7	2.7	CD
cord-305956-l02xdq87	113	10	%	%	NN
cord-305956-l02xdq87	113	11	exhibited	exhibit	VBD
cord-305956-l02xdq87	113	12	hepatitis	hepatitis	NN
cord-305956-l02xdq87	113	13	B	B	NNP
cord-305956-l02xdq87	113	14	virus	virus	NN
cord-305956-l02xdq87	113	15	infection	infection	NN
cord-305956-l02xdq87	113	16	with	with	IN
cord-305956-l02xdq87	113	17	no	no	DT
cord-305956-l02xdq87	113	18	mention	mention	NN
cord-305956-l02xdq87	113	19	of	of	IN
cord-305956-l02xdq87	113	20	worsening	worsen	VBG
cord-305956-l02xdq87	113	21	outcomes	outcome	NNS
cord-305956-l02xdq87	113	22	.	.	.
cord-305956-l02xdq87	114	1	26	26	CD
cord-305956-l02xdq87	115	1	Therefore	therefore	RB
cord-305956-l02xdq87	115	2	,	,	,
cord-305956-l02xdq87	115	3	the	the	DT
cord-305956-l02xdq87	115	4	association	association	NN
cord-305956-l02xdq87	115	5	of	of	IN
cord-305956-l02xdq87	115	6	the	the	DT
cord-305956-l02xdq87	115	7	pre	pre	JJ
cord-305956-l02xdq87	115	8	-	-	JJ
cord-305956-l02xdq87	115	9	existing	existing	JJ
cord-305956-l02xdq87	115	10	liver	liver	NN
cord-305956-l02xdq87	115	11	conditions	condition	NNS
cord-305956-l02xdq87	115	12	with	with	IN
cord-305956-l02xdq87	115	13	disease	disease	NN
cord-305956-l02xdq87	115	14	prognosis	prognosis	NN
cord-305956-l02xdq87	115	15	and	and	CC
cord-305956-l02xdq87	115	16	outcomes	outcome	NNS
cord-305956-l02xdq87	115	17	in	in	IN
cord-305956-l02xdq87	115	18	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	115	19	will	will	MD
cord-305956-l02xdq87	115	20	have	have	VB
cord-305956-l02xdq87	115	21	to	to	TO
cord-305956-l02xdq87	115	22	be	be	VB
cord-305956-l02xdq87	115	23	evaluated	evaluate	VBN
cord-305956-l02xdq87	115	24	by	by	IN
cord-305956-l02xdq87	115	25	comprehensive	comprehensive	JJ
cord-305956-l02xdq87	115	26	data	datum	NNS
cord-305956-l02xdq87	115	27	registries	registry	NNS
cord-305956-l02xdq87	115	28	which	which	WDT
cord-305956-l02xdq87	115	29	recently	recently	RB
cord-305956-l02xdq87	115	30	started	start	VBD
cord-305956-l02xdq87	115	31	enrolling	enrol	VBG
cord-305956-l02xdq87	115	32	patients	patient	NNS
cord-305956-l02xdq87	115	33	(	(	-LRB-
cord-305956-l02xdq87	115	34	e.g.	e.g.	RB
cord-305956-l02xdq87	115	35	COVID	COVID	NNP
cord-305956-l02xdq87	115	36	-	-	HYPH
cord-305956-l02xdq87	115	37	Hep	Hep	NNP
cord-305956-l02xdq87	115	38	Registry	Registry	NNP
cord-305956-l02xdq87	115	39	and	and	CC
cord-305956-l02xdq87	115	40	SECURE	secure	JJ
cord-305956-l02xdq87	115	41	-	-	HYPH
cord-305956-l02xdq87	115	42	Cirrhosis	Cirrhosis	NNP
cord-305956-l02xdq87	115	43	Registry	Registry	NNP
cord-305956-l02xdq87	115	44	)	)	-RRB-
cord-305956-l02xdq87	115	45	.	.	.
cord-305956-l02xdq87	116	1	Management	management	NN
cord-305956-l02xdq87	116	2	of	of	IN
cord-305956-l02xdq87	116	3	post	post	JJ
cord-305956-l02xdq87	116	4	liver	liver	NN
cord-305956-l02xdq87	116	5	transplant	transplant	NN
cord-305956-l02xdq87	116	6	recipients	recipient	NNS
cord-305956-l02xdq87	116	7	during	during	IN
cord-305956-l02xdq87	116	8	the	the	DT
cord-305956-l02xdq87	116	9	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	116	10	pandemic	pandemic	NN
cord-305956-l02xdq87	116	11	presents	present	VBZ
cord-305956-l02xdq87	116	12	a	a	DT
cord-305956-l02xdq87	116	13	special	special	JJ
cord-305956-l02xdq87	116	14	challenge	challenge	NN
cord-305956-l02xdq87	116	15	for	for	IN
cord-305956-l02xdq87	116	16	clinicians	clinician	NNS
cord-305956-l02xdq87	116	17	because	because	IN
cord-305956-l02xdq87	116	18	of	of	IN
cord-305956-l02xdq87	116	19	the	the	DT
cord-305956-l02xdq87	116	20	limited	limited	JJ
cord-305956-l02xdq87	116	21	data	datum	NNS
cord-305956-l02xdq87	116	22	available	available	JJ
cord-305956-l02xdq87	116	23	and	and	CC
cord-305956-l02xdq87	116	24	the	the	DT
cord-305956-l02xdq87	116	25	crucial	crucial	JJ
cord-305956-l02xdq87	116	26	need	need	NN
cord-305956-l02xdq87	116	27	to	to	TO
cord-305956-l02xdq87	116	28	continue	continue	VB
cord-305956-l02xdq87	116	29	immunosuppressive	immunosuppressive	JJ
cord-305956-l02xdq87	116	30	drugs	drug	NNS
cord-305956-l02xdq87	116	31	in	in	IN
cord-305956-l02xdq87	116	32	these	these	DT
cord-305956-l02xdq87	116	33	patients	patient	NNS
cord-305956-l02xdq87	116	34	,	,	,
cord-305956-l02xdq87	116	35	which	which	WDT
cord-305956-l02xdq87	116	36	puts	put	VBZ
cord-305956-l02xdq87	116	37	them	-PRON-	PRP
cord-305956-l02xdq87	116	38	at	at	IN
cord-305956-l02xdq87	116	39	risk	risk	NN
cord-305956-l02xdq87	116	40	for	for	IN
cord-305956-l02xdq87	116	41	more	more	JJR
cord-305956-l02xdq87	116	42	severe	severe	JJ
cord-305956-l02xdq87	116	43	courses	course	NNS
cord-305956-l02xdq87	116	44	of	of	IN
cord-305956-l02xdq87	116	45	COVID-19	covid-19	JJ
cord-305956-l02xdq87	116	46	infection	infection	NN
cord-305956-l02xdq87	116	47	and	and	CC
cord-305956-l02xdq87	116	48	possible	possible	JJ
cord-305956-l02xdq87	116	49	prolonged	prolong	VBN
cord-305956-l02xdq87	116	50	viral	viral	JJ
cord-305956-l02xdq87	116	51	shedding	shedding	NN
cord-305956-l02xdq87	116	52	.	.	.
cord-305956-l02xdq87	117	1	Case	case	NN
cord-305956-l02xdq87	117	2	reports	report	NNS
cord-305956-l02xdq87	117	3	from	from	IN
cord-305956-l02xdq87	117	4	China	China	NNP
cord-305956-l02xdq87	117	5	did	do	VBD
cord-305956-l02xdq87	117	6	not	not	RB
cord-305956-l02xdq87	117	7	reveal	reveal	VB
cord-305956-l02xdq87	117	8	an	an	DT
cord-305956-l02xdq87	117	9	increased	increase	VBN
cord-305956-l02xdq87	117	10	mortality	mortality	NN
cord-305956-l02xdq87	117	11	in	in	IN
cord-305956-l02xdq87	117	12	organ	organ	NN
cord-305956-l02xdq87	117	13	transplant	transplant	NN
cord-305956-l02xdq87	117	14	recipients	recipient	NNS
cord-305956-l02xdq87	117	15	.	.	.
cord-305956-l02xdq87	118	1	Qin	Qin	NNP
cord-305956-l02xdq87	118	2	et	et	NNP
cord-305956-l02xdq87	118	3	al	al	NNP
cord-305956-l02xdq87	118	4	.	.	NNP
cord-305956-l02xdq87	118	5	reported	report	VBD
cord-305956-l02xdq87	118	6	the	the	DT
cord-305956-l02xdq87	118	7	first	first	JJ
cord-305956-l02xdq87	118	8	case	case	NN
cord-305956-l02xdq87	118	9	of	of	IN
cord-305956-l02xdq87	118	10	SARS	SARS	NNP
cord-305956-l02xdq87	118	11	-	-	HYPH
cord-305956-l02xdq87	118	12	CoV-2	CoV-2	NNP
cord-305956-l02xdq87	118	13	infection	infection	NN
cord-305956-l02xdq87	118	14	in	in	IN
cord-305956-l02xdq87	118	15	a	a	DT
cord-305956-l02xdq87	118	16	patient	patient	NN
cord-305956-l02xdq87	118	17	with	with	IN
cord-305956-l02xdq87	118	18	hepatocellular	hepatocellular	JJ
cord-305956-l02xdq87	118	19	carcinoma	carcinoma	NN
cord-305956-l02xdq87	118	20	who	who	WP
cord-305956-l02xdq87	118	21	underwent	undergo	VBD
cord-305956-l02xdq87	118	22	liver	liver	NN
cord-305956-l02xdq87	118	23	transplantation	transplantation	NN
cord-305956-l02xdq87	118	24	.	.	.
cord-305956-l02xdq87	119	1	29	29	CD
cord-305956-l02xdq87	120	1	Lowering	lower	VBG
cord-305956-l02xdq87	120	2	immunosuppression	immunosuppression	NN
cord-305956-l02xdq87	120	3	to	to	IN
cord-305956-l02xdq87	120	4	the	the	DT
cord-305956-l02xdq87	120	5	most	most	RBS
cord-305956-l02xdq87	120	6	acceptable	acceptable	JJ
cord-305956-l02xdq87	120	7	level	level	NN
cord-305956-l02xdq87	120	8	appears	appear	VBZ
cord-305956-l02xdq87	120	9	reasonable	reasonable	JJ
cord-305956-l02xdq87	120	10	in	in	IN
cord-305956-l02xdq87	120	11	infected	infected	JJ
cord-305956-l02xdq87	120	12	liver	liver	NN
cord-305956-l02xdq87	120	13	transplant	transplant	NN
cord-305956-l02xdq87	120	14	patients	patient	NNS
cord-305956-l02xdq87	120	15	,	,	,
cord-305956-l02xdq87	120	16	in	in	IN
cord-305956-l02xdq87	120	17	particular	particular	JJ
cord-305956-l02xdq87	120	18	,	,	,
cord-305956-l02xdq87	120	19	in	in	IN
cord-305956-l02xdq87	120	20	the	the	DT
cord-305956-l02xdq87	120	21	setting	setting	NN
cord-305956-l02xdq87	120	22	of	of	IN
cord-305956-l02xdq87	120	23	lymphopenia	lymphopenia	NN
cord-305956-l02xdq87	120	24	or	or	CC
cord-305956-l02xdq87	120	25	clinical	clinical	JJ
cord-305956-l02xdq87	120	26	worsening	worsening	NN
cord-305956-l02xdq87	120	27	of	of	IN
cord-305956-l02xdq87	120	28	infection	infection	NN
cord-305956-l02xdq87	120	29	.	.	.
cord-305956-l02xdq87	121	1	46	46	CD
cord-305956-l02xdq87	122	1	In	in	IN
cord-305956-l02xdq87	122	2	addition	addition	NN
cord-305956-l02xdq87	122	3	clinicians	clinician	NNS
cord-305956-l02xdq87	122	4	have	have	VBP
cord-305956-l02xdq87	122	5	to	to	TO
cord-305956-l02xdq87	122	6	be	be	VB
cord-305956-l02xdq87	122	7	aware	aware	JJ
cord-305956-l02xdq87	122	8	of	of	IN
cord-305956-l02xdq87	122	9	drug	drug	NN
cord-305956-l02xdq87	122	10	-	-	HYPH
cord-305956-l02xdq87	122	11	drug	drug	NN
cord-305956-l02xdq87	122	12	interactions	interaction	NNS
cord-305956-l02xdq87	122	13	in	in	IN
cord-305956-l02xdq87	122	14	the	the	DT
cord-305956-l02xdq87	122	15	transplant	transplant	NN
cord-305956-l02xdq87	122	16	setting	setting	NN
cord-305956-l02xdq87	122	17	.	.	.
cord-305956-l02xdq87	123	1	In	in	IN
cord-305956-l02xdq87	123	2	particular	particular	JJ
cord-305956-l02xdq87	123	3	immunosuppressive	immunosuppressive	JJ
cord-305956-l02xdq87	123	4	drugs	drug	NNS
cord-305956-l02xdq87	123	5	and	and	CC
cord-305956-l02xdq87	123	6	ritonavir	ritonavir	NNS
cord-305956-l02xdq87	123	7	-	-	HYPH
cord-305956-l02xdq87	123	8	boosted	boost	VBN
cord-305956-l02xdq87	123	9	antiviral	antiviral	JJ
cord-305956-l02xdq87	123	10	therapies	therapy	NNS
cord-305956-l02xdq87	123	11	exhibit	exhibit	VBP
cord-305956-l02xdq87	123	12	relevant	relevant	JJ
cord-305956-l02xdq87	123	13	interactions	interaction	NNS
cord-305956-l02xdq87	123	14	through	through	IN
cord-305956-l02xdq87	123	15	CYP34A	CYP34A	NNP
cord-305956-l02xdq87	123	16	which	which	WDT
cord-305956-l02xdq87	123	17	lead	lead	VBP
cord-305956-l02xdq87	123	18	to	to	IN
cord-305956-l02xdq87	123	19	increased	increase	VBN
cord-305956-l02xdq87	123	20	levels	level	NNS
cord-305956-l02xdq87	123	21	of	of	IN
cord-305956-l02xdq87	123	22	calcineurin	calcineurin	NNP
cord-305956-l02xdq87	123	23	and	and	CC
cord-305956-l02xdq87	123	24	mTOR	mTOR	NNP
cord-305956-l02xdq87	123	25	inhibitors	inhibitor	NNS
cord-305956-l02xdq87	123	26	.	.	.
cord-305956-l02xdq87	124	1	Accordingly	accordingly	RB
cord-305956-l02xdq87	124	2	,	,	,
cord-305956-l02xdq87	124	3	chloroquine	chloroquine	NN
cord-305956-l02xdq87	124	4	-	-	HYPH
cord-305956-l02xdq87	124	5	based	base	VBN
cord-305956-l02xdq87	124	6	regimes	regime	NNS
cord-305956-l02xdq87	124	7	or	or	CC
cord-305956-l02xdq87	124	8	remdesivir	remdesivir	JJ
cord-305956-l02xdq87	124	9	(	(	-LRB-
cord-305956-l02xdq87	124	10	compassionate	compassionate	JJ
cord-305956-l02xdq87	124	11	use	use	NN
cord-305956-l02xdq87	124	12	program	program	NN
cord-305956-l02xdq87	124	13	only	only	RB
cord-305956-l02xdq87	124	14	)	)	-RRB-
cord-305956-l02xdq87	124	15	appear	appear	VBP
cord-305956-l02xdq87	124	16	to	to	TO
cord-305956-l02xdq87	124	17	be	be	VB
cord-305956-l02xdq87	124	18	safe	safe	JJ
cord-305956-l02xdq87	124	19	,	,	,
cord-305956-l02xdq87	124	20	while	while	IN
cord-305956-l02xdq87	124	21	boosted	boost	VBN
cord-305956-l02xdq87	124	22	protease	protease	NN
cord-305956-l02xdq87	124	23	inhibitors	inhibitor	NNS
cord-305956-l02xdq87	124	24	should	should	MD
cord-305956-l02xdq87	124	25	be	be	VB
cord-305956-l02xdq87	124	26	avoided	avoid	VBN
cord-305956-l02xdq87	124	27	(	(	-LRB-
cord-305956-l02xdq87	124	28	see	see	VB
cord-305956-l02xdq87	124	29	Table	table	NN
cord-305956-l02xdq87	124	30	2	2	CD
cord-305956-l02xdq87	124	31	)	)	-RRB-
cord-305956-l02xdq87	124	32	.	.	.
cord-305956-l02xdq87	125	1	Additionally	additionally	RB
cord-305956-l02xdq87	125	2	,	,	,
cord-305956-l02xdq87	125	3	preventive	preventive	JJ
cord-305956-l02xdq87	125	4	strategies	strategy	NNS
cord-305956-l02xdq87	125	5	in	in	IN
cord-305956-l02xdq87	125	6	those	those	DT
cord-305956-l02xdq87	125	7	vulnerable	vulnerable	JJ
cord-305956-l02xdq87	125	8	patients	patient	NNS
cord-305956-l02xdq87	125	9	include	include	VBP
cord-305956-l02xdq87	125	10	early	early	JJ
cord-305956-l02xdq87	125	11	and	and	CC
cord-305956-l02xdq87	125	12	prolonged	prolonged	JJ
cord-305956-l02xdq87	125	13	screening	screening	NN
cord-305956-l02xdq87	125	14	with	with	IN
cord-305956-l02xdq87	125	15	polymerase	polymerase	NN
cord-305956-l02xdq87	125	16	chain	chain	NN
cord-305956-l02xdq87	125	17	reaction	reaction	NN
cord-305956-l02xdq87	125	18	-	-	HYPH
cord-305956-l02xdq87	125	19	based	base	VBN
cord-305956-l02xdq87	125	20	testing	testing	NN
cord-305956-l02xdq87	125	21	for	for	IN
cord-305956-l02xdq87	125	22	patients	patient	NNS
cord-305956-l02xdq87	125	23	with	with	IN
cord-305956-l02xdq87	125	24	early	early	JJ
cord-305956-l02xdq87	125	25	symptoms	symptom	NNS
cord-305956-l02xdq87	125	26	,	,	,
cord-305956-l02xdq87	125	27	a	a	DT
cord-305956-l02xdq87	125	28	contact	contact	NN
cord-305956-l02xdq87	125	29	history	history	NN
cord-305956-l02xdq87	125	30	or	or	CC
cord-305956-l02xdq87	125	31	infection	infection	NN
cord-305956-l02xdq87	125	32	.	.	.
cord-305956-l02xdq87	126	1	Personal	personal	JJ
cord-305956-l02xdq87	126	2	 	 	_SP
cord-305956-l02xdq87	126	3	Liver	Liver	NNP
cord-305956-l02xdq87	126	4	function	function	NN
cord-305956-l02xdq87	126	5	abnormalities	abnormality	NNS
cord-305956-l02xdq87	126	6	-predominantly	-predominantly	RB
cord-305956-l02xdq87	127	1	AST	AST	NNP
cord-305956-l02xdq87	127	2	elevation	elevation	NN
cord-305956-l02xdq87	127	3	-in	-in	.
cord-305956-l02xdq87	128	1	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	128	2	appear	appear	VBP
cord-305956-l02xdq87	128	3	to	to	TO
cord-305956-l02xdq87	128	4	be	be	VB
cord-305956-l02xdq87	128	5	frequent	frequent	JJ
cord-305956-l02xdq87	128	6	but	but	CC
cord-305956-l02xdq87	128	7	not	not	RB
cord-305956-l02xdq87	128	8	severe	severe	JJ
cord-305956-l02xdq87	128	9	in	in	IN
cord-305956-l02xdq87	128	10	most	most	JJS
cord-305956-l02xdq87	128	11	cases	case	NNS
cord-305956-l02xdq87	128	12	.	.	.
cord-305956-l02xdq87	129	1	Direct	direct	JJ
cord-305956-l02xdq87	129	2	viral	viral	JJ
cord-305956-l02xdq87	129	3	hepatotoxicity	hepatotoxicity	NN
cord-305956-l02xdq87	129	4	,	,	,
cord-305956-l02xdq87	129	5	DILI	DILI	NNP
cord-305956-l02xdq87	129	6	,	,	,
cord-305956-l02xdq87	129	7	'	'	''
cord-305956-l02xdq87	129	8	bystander	bystander	NN
cord-305956-l02xdq87	129	9	effects	effect	NNS
cord-305956-l02xdq87	129	10	'	'	''
cord-305956-l02xdq87	129	11	during	during	IN
cord-305956-l02xdq87	129	12	a	a	DT
cord-305956-l02xdq87	129	13	systemic	systemic	JJ
cord-305956-l02xdq87	129	14	viral	viral	JJ
cord-305956-l02xdq87	129	15	infection	infection	NN
cord-305956-l02xdq87	129	16	and	and	CC
cord-305956-l02xdq87	129	17	potentially	potentially	RB
cord-305956-l02xdq87	129	18	sepsis	sepsis	NN
cord-305956-l02xdq87	129	19	,	,	,
cord-305956-l02xdq87	129	20	or	or	CC
cord-305956-l02xdq87	129	21	exacerbation	exacerbation	NN
cord-305956-l02xdq87	129	22	of	of	IN
cord-305956-l02xdq87	129	23	an	an	DT
cord-305956-l02xdq87	129	24	underlying	underlie	VBG
cord-305956-l02xdq87	129	25	liver	liver	NN
cord-305956-l02xdq87	129	26	disease	disease	NN
cord-305956-l02xdq87	129	27	have	have	VBP
cord-305956-l02xdq87	129	28	to	to	TO
cord-305956-l02xdq87	129	29	be	be	VB
cord-305956-l02xdq87	129	30	considered	consider	VBN
cord-305956-l02xdq87	129	31	.	.	.
cord-305956-l02xdq87	130	1	Ex	Ex	NNP
cord-305956-l02xdq87	130	2	vivo	vivo	NNP
cord-305956-l02xdq87	130	3	studies	study	NNS
cord-305956-l02xdq87	130	4	offer	offer	VBP
cord-305956-l02xdq87	130	5	that	that	IN
cord-305956-l02xdq87	130	6	SARS	SARS	NNP
cord-305956-l02xdq87	130	7	-	-	HYPH
cord-305956-l02xdq87	130	8	CoV-2	CoV-2	NNP
cord-305956-l02xdq87	130	9	can	can	MD
cord-305956-l02xdq87	130	10	selectively	selectively	RB
cord-305956-l02xdq87	130	11	target	target	VB
cord-305956-l02xdq87	130	12	the	the	DT
cord-305956-l02xdq87	130	13	liver	liver	NN
cord-305956-l02xdq87	130	14	,	,	,
cord-305956-l02xdq87	130	15	in	in	IN
cord-305956-l02xdq87	130	16	particular	particular	JJ
cord-305956-l02xdq87	130	17	cholangiocytes	cholangiocyte	NNS
cord-305956-l02xdq87	130	18	through	through	IN
cord-305956-l02xdq87	130	19	ACE2	ACE2	NNP
cord-305956-l02xdq87	130	20	,	,	,
cord-305956-l02xdq87	130	21	and	and	CC
cord-305956-l02xdq87	130	22	thus	thus	RB
cord-305956-l02xdq87	130	23	hepatobiliary	hepatobiliary	NNP
cord-305956-l02xdq87	130	24	injury	injury	NNP
cord-305956-l02xdq87	130	25	appears	appear	VBZ
cord-305956-l02xdq87	130	26	plausible	plausible	JJ
cord-305956-l02xdq87	130	27	.	.	.
cord-305956-l02xdq87	131	1	Irrespective	irrespective	RB
cord-305956-l02xdq87	131	2	of	of	IN
cord-305956-l02xdq87	131	3	the	the	DT
cord-305956-l02xdq87	131	4	mechanisms	mechanism	NNS
cord-305956-l02xdq87	131	5	involved	involve	VBN
cord-305956-l02xdq87	131	6	in	in	IN
cord-305956-l02xdq87	131	7	the	the	DT
cord-305956-l02xdq87	131	8	hepatic	hepatic	JJ
cord-305956-l02xdq87	131	9	injury	injury	NN
cord-305956-l02xdq87	131	10	of	of	IN
cord-305956-l02xdq87	131	11	patients	patient	NNS
cord-305956-l02xdq87	131	12	with	with	IN
cord-305956-l02xdq87	131	13	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	131	14	,	,	,
cord-305956-l02xdq87	131	15	activation	activation	NN
cord-305956-l02xdq87	131	16	of	of	IN
cord-305956-l02xdq87	131	17	the	the	DT
cord-305956-l02xdq87	131	18	immune	immune	NN
cord-305956-l02xdq87	131	19	-	-	HYPH
cord-305956-l02xdq87	131	20	mediated	mediate	VBN
cord-305956-l02xdq87	131	21	pathway	pathway	NN
cord-305956-l02xdq87	131	22	seems	seem	VBZ
cord-305956-l02xdq87	131	23	to	to	TO
cord-305956-l02xdq87	131	24	be	be	VB
cord-305956-l02xdq87	131	25	critical	critical	JJ
cord-305956-l02xdq87	131	26	.	.	.
cord-305956-l02xdq87	132	1	Special	special	JJ
cord-305956-l02xdq87	132	2	high	high	JJ
cord-305956-l02xdq87	132	3	risk	risk	NN
cord-305956-l02xdq87	132	4	populations	population	NNS
cord-305956-l02xdq87	132	5	require	require	VBP
cord-305956-l02xdq87	132	6	close	close	JJ
cord-305956-l02xdq87	132	7	monitoring	monitoring	NN
cord-305956-l02xdq87	132	8	.	.	.
cord-305956-l02xdq87	133	1	These	these	DT
cord-305956-l02xdq87	133	2	include	include	VBP
cord-305956-l02xdq87	133	3	the	the	DT
cord-305956-l02xdq87	133	4	elderly	elderly	JJ
cord-305956-l02xdq87	133	5	population	population	NN
cord-305956-l02xdq87	133	6	,	,	,
cord-305956-l02xdq87	133	7	patients	patient	NNS
cord-305956-l02xdq87	133	8	with	with	IN
cord-305956-l02xdq87	133	9	endstage	endstage	NN
cord-305956-l02xdq87	133	10	liver	liver	NN
cord-305956-l02xdq87	133	11	disease	disease	NN
cord-305956-l02xdq87	133	12	and	and	CC
cord-305956-l02xdq87	133	13	liver	liver	NN
cord-305956-l02xdq87	133	14	transplant	transplant	NN
cord-305956-l02xdq87	133	15	recipients	recipient	NNS
cord-305956-l02xdq87	133	16	.	.	.
cord-305956-l02xdq87	134	1	Symptomatic	symptomatic	JJ
cord-305956-l02xdq87	134	2	treatment	treatment	NN
cord-305956-l02xdq87	134	3	with	with	IN
cord-305956-l02xdq87	134	4	acetaminophen	acetaminophen	NN
cord-305956-l02xdq87	134	5	and	and	CC
cord-305956-l02xdq87	134	6	avoidance	avoidance	NN
cord-305956-l02xdq87	134	7	of	of	IN
cord-305956-l02xdq87	134	8	non	non	JJ
cord-305956-l02xdq87	134	9	-	-	JJ
cord-305956-l02xdq87	134	10	steroidal	steroidal	JJ
cord-305956-l02xdq87	134	11	anti	anti	JJ
cord-305956-l02xdq87	134	12	-	-	JJ
cord-305956-l02xdq87	134	13	inflammatory	inflammatory	JJ
cord-305956-l02xdq87	134	14	drugs	drug	NNS
cord-305956-l02xdq87	134	15	in	in	IN
cord-305956-l02xdq87	134	16	cirrhosis	cirrhosis	NN
cord-305956-l02xdq87	134	17	is	be	VBZ
cord-305956-l02xdq87	134	18	recommended	recommend	VBN
cord-305956-l02xdq87	134	19	.	.	.
cord-305956-l02xdq87	135	1	Cautious	cautious	JJ
cord-305956-l02xdq87	135	2	use	use	NN
cord-305956-l02xdq87	135	3	of	of	IN
cord-305956-l02xdq87	135	4	antiviral	antiviral	JJ
cord-305956-l02xdq87	135	5	agents	agent	NNS
cord-305956-l02xdq87	135	6	in	in	IN
cord-305956-l02xdq87	135	7	patients	patient	NNS
cord-305956-l02xdq87	135	8	with	with	IN
cord-305956-l02xdq87	135	9	decompensated	decompensated	JJ
cord-305956-l02xdq87	135	10	liver	liver	NN
cord-305956-l02xdq87	135	11	disease	disease	NN
cord-305956-l02xdq87	135	12	and	and	CC
cord-305956-l02xdq87	135	13	drug	drug	NN
cord-305956-l02xdq87	135	14	-	-	HYPH
cord-305956-l02xdq87	135	15	drug	drug	NN
cord-305956-l02xdq87	135	16	interactions	interaction	NNS
cord-305956-l02xdq87	135	17	in	in	IN
cord-305956-l02xdq87	135	18	post	post	JJ
cord-305956-l02xdq87	135	19	liver	liver	NN
cord-305956-l02xdq87	135	20	transplant	transplant	NN
cord-305956-l02xdq87	135	21	patients	patient	NNS
cord-305956-l02xdq87	135	22	has	have	VBZ
cord-305956-l02xdq87	135	23	to	to	TO
cord-305956-l02xdq87	135	24	be	be	VB
cord-305956-l02xdq87	135	25	considered	consider	VBN
cord-305956-l02xdq87	135	26	.	.	.
cord-305956-l02xdq87	136	1	As	as	IN
cord-305956-l02xdq87	136	2	emphasized	emphasize	VBN
cord-305956-l02xdq87	136	3	by	by	IN
cord-305956-l02xdq87	136	4	a	a	DT
cord-305956-l02xdq87	136	5	recent	recent	JJ
cord-305956-l02xdq87	136	6	position	position	NN
cord-305956-l02xdq87	136	7	paper	paper	NN
cord-305956-l02xdq87	136	8	of	of	IN
cord-305956-l02xdq87	136	9	the	the	DT
cord-305956-l02xdq87	136	10	European	European	NNP
cord-305956-l02xdq87	136	11	Study	Study	NNP
cord-305956-l02xdq87	136	12	of	of	IN
cord-305956-l02xdq87	136	13	Liver	Liver	NNP
cord-305956-l02xdq87	136	14	Disease	Disease	NNP
cord-305956-l02xdq87	136	15	,	,	,
cord-305956-l02xdq87	136	16	elective	elective	JJ
cord-305956-l02xdq87	136	17	procedures	procedure	NNS
cord-305956-l02xdq87	136	18	and	and	CC
cord-305956-l02xdq87	136	19	routine	routine	JJ
cord-305956-l02xdq87	136	20	tests	test	NNS
cord-305956-l02xdq87	136	21	should	should	MD
cord-305956-l02xdq87	136	22	be	be	VB
cord-305956-l02xdq87	136	23	postponed	postpone	VBN
cord-305956-l02xdq87	136	24	according	accord	VBG
cord-305956-l02xdq87	136	25	to	to	IN
cord-305956-l02xdq87	136	26	the	the	DT
cord-305956-l02xdq87	136	27	risk	risk	NN
cord-305956-l02xdq87	136	28	-	-	HYPH
cord-305956-l02xdq87	136	29	benefit	benefit	NN
cord-305956-l02xdq87	136	30	at	at	IN
cord-305956-l02xdq87	136	31	the	the	DT
cord-305956-l02xdq87	136	32	given	give	VBN
cord-305956-l02xdq87	136	33	time	time	NN
cord-305956-l02xdq87	136	34	.	.	.
cord-305956-l02xdq87	137	1	On	on	IN
cord-305956-l02xdq87	137	2	the	the	DT
cord-305956-l02xdq87	137	3	other	other	JJ
cord-305956-l02xdq87	137	4	hand	hand	NN
cord-305956-l02xdq87	137	5	,	,	,
cord-305956-l02xdq87	137	6	emergency	emergency	NN
cord-305956-l02xdq87	137	7	medical	medical	JJ
cord-305956-l02xdq87	137	8	care	care	NN
cord-305956-l02xdq87	137	9	needs	need	VBZ
cord-305956-l02xdq87	137	10	to	to	TO
cord-305956-l02xdq87	137	11	be	be	VB
cord-305956-l02xdq87	137	12	done	do	VBN
cord-305956-l02xdq87	137	13	with	with	IN
cord-305956-l02xdq87	137	14	appropriate	appropriate	JJ
cord-305956-l02xdq87	137	15	measures	measure	NNS
cord-305956-l02xdq87	137	16	to	to	TO
cord-305956-l02xdq87	137	17	prevent	prevent	VB
cord-305956-l02xdq87	137	18	infection	infection	NN
cord-305956-l02xdq87	137	19	.	.	.
cord-305956-l02xdq87	138	1	46	46	CD
cord-305956-l02xdq87	138	2	Declaration	Declaration	NNP
cord-305956-l02xdq87	138	3	of	of	IN
cord-305956-l02xdq87	138	4	conflicting	conflict	VBG
cord-305956-l02xdq87	138	5	interests	interest	NNS
cord-305956-l02xdq87	138	6	SA	SA	NNP
cord-305956-l02xdq87	138	7	has	have	VBZ
cord-305956-l02xdq87	138	8	nothing	nothing	NN
cord-305956-l02xdq87	138	9	to	to	TO
cord-305956-l02xdq87	138	10	declare	declare	VB
cord-305956-l02xdq87	138	11	.	.	.
cord-305956-l02xdq87	139	1	JMS	JMS	NNP
cord-305956-l02xdq87	139	2	has	have	VBZ
cord-305956-l02xdq87	139	3	acted	act	VBN
cord-305956-l02xdq87	139	4	independently	independently	RB
cord-305956-l02xdq87	139	5	of	of	IN
cord-305956-l02xdq87	139	6	this	this	DT
cord-305956-l02xdq87	139	7	study	study	NN
cord-305956-l02xdq87	139	8	as	as	IN
cord-305956-l02xdq87	139	9	a	a	DT
cord-305956-l02xdq87	139	10	consultant	consultant	NN
cord-305956-l02xdq87	139	11	to	to	IN
cord-305956-l02xdq87	139	12	Boehringer	Boehringer	NNP
cord-305956-l02xdq87	139	13	Ingelheim	Ingelheim	NNP
cord-305956-l02xdq87	139	14	,	,	,
cord-305956-l02xdq87	139	15	Galmed	Galmed	NNP
cord-305956-l02xdq87	139	16	,	,	,
cord-305956-l02xdq87	139	17	Genfit	Genfit	NNP
cord-305956-l02xdq87	139	18	,	,	,
cord-305956-l02xdq87	139	19	Gilead	Gilead	NNP
cord-305956-l02xdq87	139	20	Sciences	Sciences	NNPS
cord-305956-l02xdq87	139	21	,	,	,
cord-305956-l02xdq87	139	22	Intercept	Intercept	NNP
cord-305956-l02xdq87	139	23	Pharmaceuticals	Pharmaceuticals	NNP
cord-305956-l02xdq87	139	24	,	,	,
cord-305956-l02xdq87	139	25	Novartis	Novartis	NNP
cord-305956-l02xdq87	139	26	,	,	,
cord-305956-l02xdq87	139	27	Roche	Roche	NNP
cord-305956-l02xdq87	139	28	,	,	,
cord-305956-l02xdq87	139	29	Siemens	Siemens	NNP
cord-305956-l02xdq87	139	30	Healthineers	Healthineers	NNP
cord-305956-l02xdq87	139	31	,	,	,
cord-305956-l02xdq87	139	32	and	and	CC
cord-305956-l02xdq87	139	33	has	have	VBZ
cord-305956-l02xdq87	139	34	received	receive	VBN
cord-305956-l02xdq87	139	35	research	research	NN
cord-305956-l02xdq87	139	36	funding	funding	NN
cord-305956-l02xdq87	139	37	from	from	IN
cord-305956-l02xdq87	139	38	Gilead	Gilead	NNP
cord-305956-l02xdq87	139	39	Sciences	Sciences	NNPS
cord-305956-l02xdq87	139	40	.	.	.
cord-305956-l02xdq87	140	1	Clinical	clinical	JJ
cord-305956-l02xdq87	140	2	characteristics	characteristic	NNS
cord-305956-l02xdq87	140	3	and	and	CC
cord-305956-l02xdq87	140	4	mechanism	mechanism	NN
cord-305956-l02xdq87	140	5	of	of	IN
cord-305956-l02xdq87	140	6	liver	liver	NN
cord-305956-l02xdq87	140	7	damage	damage	NN
cord-305956-l02xdq87	140	8	in	in	IN
cord-305956-l02xdq87	140	9	patients	patient	NNS
cord-305956-l02xdq87	140	10	with	with	IN
cord-305956-l02xdq87	140	11	severe	severe	JJ
cord-305956-l02xdq87	140	12	acute	acute	JJ
cord-305956-l02xdq87	140	13	respiratory	respiratory	JJ
cord-305956-l02xdq87	140	14	syndrome	syndrome	NN
cord-305956-l02xdq87	140	15	Fatal	fatal	JJ
cord-305956-l02xdq87	140	16	severe	severe	JJ
cord-305956-l02xdq87	140	17	acute	acute	JJ
cord-305956-l02xdq87	140	18	respiratory	respiratory	JJ
cord-305956-l02xdq87	140	19	syndrome	syndrome	NN
cord-305956-l02xdq87	140	20	is	be	VBZ
cord-305956-l02xdq87	140	21	associated	associate	VBN
cord-305956-l02xdq87	140	22	with	with	IN
cord-305956-l02xdq87	140	23	multiorgan	multiorgan	NN
cord-305956-l02xdq87	140	24	involvement	involvement	NN
cord-305956-l02xdq87	140	25	by	by	IN
cord-305956-l02xdq87	140	26	coronavirus	coronavirus	NN
cord-305956-l02xdq87	140	27	Pathological	pathological	JJ
cord-305956-l02xdq87	140	28	findings	finding	NNS
cord-305956-l02xdq87	140	29	of	of	IN
cord-305956-l02xdq87	140	30	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	140	31	associated	associate	VBN
cord-305956-l02xdq87	140	32	with	with	IN
cord-305956-l02xdq87	140	33	acute	acute	JJ
cord-305956-l02xdq87	140	34	respiratory	respiratory	JJ
cord-305956-l02xdq87	140	35	distress	distress	NN
cord-305956-l02xdq87	140	36	syndrome	syndrome	NN
cord-305956-l02xdq87	140	37	SARS	SARS	NNP
cord-305956-l02xdq87	140	38	-	-	HYPH
cord-305956-l02xdq87	140	39	CoV-2	CoV-2	NNP
cord-305956-l02xdq87	140	40	cell	cell	NN
cord-305956-l02xdq87	140	41	entry	entry	NN
cord-305956-l02xdq87	140	42	depends	depend	VBZ
cord-305956-l02xdq87	140	43	on	on	IN
cord-305956-l02xdq87	140	44	ACE2	ACE2	NNP
cord-305956-l02xdq87	140	45	and	and	CC
cord-305956-l02xdq87	140	46	TMPRSS2	TMPRSS2	NNP
cord-305956-l02xdq87	140	47	and	and	CC
cord-305956-l02xdq87	140	48	is	be	VBZ
cord-305956-l02xdq87	140	49	blocked	block	VBN
cord-305956-l02xdq87	140	50	by	by	IN
cord-305956-l02xdq87	140	51	a	a	DT
cord-305956-l02xdq87	140	52	clinically	clinically	RB
cord-305956-l02xdq87	140	53	proven	prove	VBN
cord-305956-l02xdq87	140	54	protease	protease	NN
cord-305956-l02xdq87	140	55	inhibitor	inhibitor	NN
cord-305956-l02xdq87	140	56	Highly	highly	RB
cord-305956-l02xdq87	140	57	ACE2	ACE2	NNP
cord-305956-l02xdq87	140	58	expression	expression	NN
cord-305956-l02xdq87	140	59	in	in	IN
cord-305956-l02xdq87	140	60	pancreas	pancrea	NNS
cord-305956-l02xdq87	140	61	may	may	MD
cord-305956-l02xdq87	140	62	cause	cause	VB
cord-305956-l02xdq87	140	63	pancreas	pancreas	NN
cord-305956-l02xdq87	140	64	damage	damage	NN
cord-305956-l02xdq87	140	65	after	after	IN
cord-305956-l02xdq87	140	66	SARS	SARS	NNP
cord-305956-l02xdq87	140	67	-	-	HYPH
cord-305956-l02xdq87	140	68	CoV-2	CoV-2	NNP
cord-305956-l02xdq87	140	69	infection	infection	NN
cord-305956-l02xdq87	140	70	Specific	specific	JJ
cord-305956-l02xdq87	140	71	ACE2	ACE2	NNP
cord-305956-l02xdq87	140	72	expression	expression	NN
cord-305956-l02xdq87	140	73	in	in	IN
cord-305956-l02xdq87	140	74	cholangiocytes	cholangiocyte	NNS
cord-305956-l02xdq87	140	75	may	may	MD
cord-305956-l02xdq87	140	76	cause	cause	VB
cord-305956-l02xdq87	140	77	liver	liver	NN
cord-305956-l02xdq87	140	78	damage	damage	NN
cord-305956-l02xdq87	140	79	after	after	IN
cord-305956-l02xdq87	140	80	2019-nCoV	2019-ncov	CD
cord-305956-l02xdq87	140	81	infection	infection	NN
cord-305956-l02xdq87	140	82	Clinical	Clinical	NNP
cord-305956-l02xdq87	140	83	Features	Features	NNPS
cord-305956-l02xdq87	140	84	of	of	IN
cord-305956-l02xdq87	140	85	COVID-19	covid-19	JJ
cord-305956-l02xdq87	140	86	related	related	JJ
cord-305956-l02xdq87	140	87	liver	liver	NN
cord-305956-l02xdq87	140	88	damage	damage	NN
cord-305956-l02xdq87	140	89	Liver	liver	NN
cord-305956-l02xdq87	140	90	injury	injury	NN
cord-305956-l02xdq87	140	91	in	in	IN
cord-305956-l02xdq87	140	92	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	140	93	:	:	:
cord-305956-l02xdq87	140	94	Management	management	NN
cord-305956-l02xdq87	140	95	and	and	CC
cord-305956-l02xdq87	140	96	challenges	challenge	VBZ
cord-305956-l02xdq87	140	97	Liver	liver	NN
cord-305956-l02xdq87	140	98	injury	injury	NN
cord-305956-l02xdq87	140	99	during	during	IN
cord-305956-l02xdq87	140	100	highly	highly	RB
cord-305956-l02xdq87	140	101	pathogenic	pathogenic	JJ
cord-305956-l02xdq87	140	102	human	human	JJ
cord-305956-l02xdq87	140	103	coronavirus	coronavirus	NN
cord-305956-l02xdq87	140	104	infections	infection	NNS
cord-305956-l02xdq87	140	105	.	.	.
cord-305956-l02xdq87	141	1	Liver	liver	NN
cord-305956-l02xdq87	141	2	Int	Int	NNP
cord-305956-l02xdq87	141	3	.	.	.
cord-305956-l02xdq87	141	4	Epub	Epub	NNP
cord-305956-l02xdq87	141	5	ahead	ahead	RB
cord-305956-l02xdq87	141	6	of	of	IN
cord-305956-l02xdq87	141	7	print	print	NN
cord-305956-l02xdq87	141	8	14	14	CD
cord-305956-l02xdq87	141	9	Recapitulation	Recapitulation	NNP
cord-305956-l02xdq87	141	10	of	of	IN
cord-305956-l02xdq87	141	11	SARS	SARS	NNP
cord-305956-l02xdq87	141	12	-	-	HYPH
cord-305956-l02xdq87	141	13	CoV-2	CoV-2	NNP
cord-305956-l02xdq87	141	14	infection	infection	NN
cord-305956-l02xdq87	141	15	and	and	CC
cord-305956-l02xdq87	141	16	cholangiocyte	cholangiocyte	NNP
cord-305956-l02xdq87	141	17	damage	damage	NN
cord-305956-l02xdq87	141	18	with	with	IN
cord-305956-l02xdq87	141	19	human	human	JJ
cord-305956-l02xdq87	141	20	liver	liver	NN
cord-305956-l02xdq87	141	21	organoids	organoids	NNP
cord-305956-l02xdq87	141	22	Risk	Risk	NNP
cord-305956-l02xdq87	141	23	factors	factor	NNS
cord-305956-l02xdq87	141	24	related	relate	VBN
cord-305956-l02xdq87	141	25	to	to	IN
cord-305956-l02xdq87	141	26	hepatic	hepatic	JJ
cord-305956-l02xdq87	141	27	injury	injury	NN
cord-305956-l02xdq87	141	28	in	in	IN
cord-305956-l02xdq87	141	29	patients	patient	NNS
cord-305956-l02xdq87	141	30	with	with	IN
cord-305956-l02xdq87	141	31	corona	corona	NN
cord-305956-l02xdq87	141	32	virus	virus	NN
cord-305956-l02xdq87	141	33	disease	disease	NN
cord-305956-l02xdq87	141	34	2019	2019	CD
cord-305956-l02xdq87	141	35	Clinical	clinical	JJ
cord-305956-l02xdq87	141	36	features	feature	NNS
cord-305956-l02xdq87	141	37	of	of	IN
cord-305956-l02xdq87	141	38	patients	patient	NNS
cord-305956-l02xdq87	141	39	infected	infect	VBN
cord-305956-l02xdq87	141	40	with	with	IN
cord-305956-l02xdq87	141	41	2019	2019	CD
cord-305956-l02xdq87	141	42	novel	novel	JJ
cord-305956-l02xdq87	141	43	coronavirus	coronavirus	NN
cord-305956-l02xdq87	141	44	in	in	IN
cord-305956-l02xdq87	141	45	Wuhan	Wuhan	NNP
cord-305956-l02xdq87	141	46	,	,	,
cord-305956-l02xdq87	142	1	China	China	NNP
cord-305956-l02xdq87	142	2	A	a	DT
cord-305956-l02xdq87	142	3	55-day	55-day	CD
cord-305956-l02xdq87	142	4	-	-	HYPH
cord-305956-l02xdq87	142	5	old	old	JJ
cord-305956-l02xdq87	142	6	female	female	JJ
cord-305956-l02xdq87	142	7	infant	infant	NN
cord-305956-l02xdq87	142	8	infected	infect	VBN
cord-305956-l02xdq87	142	9	with	with	IN
cord-305956-l02xdq87	142	10	COVID	COVID	NNP
cord-305956-l02xdq87	142	11	19	19	CD
cord-305956-l02xdq87	142	12	:	:	:
cord-305956-l02xdq87	143	1	Presenting	present	VBG
cord-305956-l02xdq87	143	2	with	with	IN
cord-305956-l02xdq87	143	3	pneumonia	pneumonia	NN
cord-305956-l02xdq87	143	4	,	,	,
cord-305956-l02xdq87	143	5	liver	liver	NN
cord-305956-l02xdq87	143	6	injury	injury	NN
cord-305956-l02xdq87	143	7	,	,	,
cord-305956-l02xdq87	143	8	and	and	CC
cord-305956-l02xdq87	143	9	heart	heart	NN
cord-305956-l02xdq87	143	10	damage	damage	NN
cord-305956-l02xdq87	144	1	COVID-19	covid-19	JJ
cord-305956-l02xdq87	144	2	infection	infection	NN
cord-305956-l02xdq87	144	3	:	:	:
cord-305956-l02xdq87	144	4	The	the	DT
cord-305956-l02xdq87	144	5	perspectives	perspective	NNS
cord-305956-l02xdq87	144	6	on	on	IN
cord-305956-l02xdq87	144	7	immune	immune	JJ
cord-305956-l02xdq87	144	8	responses	response	NNS
cord-305956-l02xdq87	144	9	COVID-19	covid-19	VBP
cord-305956-l02xdq87	144	10	:	:	:
cord-305956-l02xdq87	144	11	consider	consider	VB
cord-305956-l02xdq87	144	12	cytokine	cytokine	JJ
cord-305956-l02xdq87	144	13	storm	storm	NN
cord-305956-l02xdq87	144	14	syndromes	syndrome	NNS
cord-305956-l02xdq87	144	15	and	and	CC
cord-305956-l02xdq87	144	16	immunosuppression	immunosuppression	NN
cord-305956-l02xdq87	144	17	Innate	innate	JJ
cord-305956-l02xdq87	144	18	immune	immune	JJ
cord-305956-l02xdq87	144	19	cell	cell	NN
cord-305956-l02xdq87	144	20	trafficking	trafficking	NN
cord-305956-l02xdq87	144	21	and	and	CC
cord-305956-l02xdq87	144	22	function	function	NN
cord-305956-l02xdq87	144	23	during	during	IN
cord-305956-l02xdq87	144	24	sterile	sterile	JJ
cord-305956-l02xdq87	144	25	inflammation	inflammation	NN
cord-305956-l02xdq87	144	26	of	of	IN
cord-305956-l02xdq87	144	27	the	the	DT
cord-305956-l02xdq87	144	28	liver	liver	NN
cord-305956-l02xdq87	144	29	Epidemiological	epidemiological	JJ
cord-305956-l02xdq87	144	30	and	and	CC
cord-305956-l02xdq87	144	31	clinical	clinical	JJ
cord-305956-l02xdq87	144	32	characteristics	characteristic	NNS
cord-305956-l02xdq87	144	33	of	of	IN
cord-305956-l02xdq87	144	34	99	99	CD
cord-305956-l02xdq87	144	35	cases	case	NNS
cord-305956-l02xdq87	144	36	of	of	IN
cord-305956-l02xdq87	144	37	2019	2019	CD
cord-305956-l02xdq87	144	38	novel	novel	JJ
cord-305956-l02xdq87	144	39	coronavirus	coronavirus	NN
cord-305956-l02xdq87	144	40	pneumonia	pneumonia	NN
cord-305956-l02xdq87	144	41	in	in	IN
cord-305956-l02xdq87	144	42	Wuhan	Wuhan	NNP
cord-305956-l02xdq87	144	43	,	,	,
cord-305956-l02xdq87	144	44	China	China	NNP
cord-305956-l02xdq87	144	45	:	:	:
cord-305956-l02xdq87	145	1	A	a	DT
cord-305956-l02xdq87	145	2	descriptive	descriptive	JJ
cord-305956-l02xdq87	145	3	study	study	NN
cord-305956-l02xdq87	146	1	Clinical	clinical	JJ
cord-305956-l02xdq87	146	2	course	course	NN
cord-305956-l02xdq87	146	3	and	and	CC
cord-305956-l02xdq87	146	4	outcomes	outcome	NNS
cord-305956-l02xdq87	146	5	of	of	IN
cord-305956-l02xdq87	146	6	critically	critically	RB
cord-305956-l02xdq87	146	7	ill	ill	JJ
cord-305956-l02xdq87	146	8	patients	patient	NNS
cord-305956-l02xdq87	146	9	with	with	IN
cord-305956-l02xdq87	146	10	SARS	SARS	NNP
cord-305956-l02xdq87	146	11	-	-	HYPH
cord-305956-l02xdq87	146	12	CoV-2	CoV-2	NNP
cord-305956-l02xdq87	146	13	pneumonia	pneumonia	NN
cord-305956-l02xdq87	146	14	in	in	IN
cord-305956-l02xdq87	146	15	Wuhan	Wuhan	NNP
cord-305956-l02xdq87	146	16	,	,	,
cord-305956-l02xdq87	146	17	China	China	NNP
cord-305956-l02xdq87	146	18	:	:	:
cord-305956-l02xdq87	147	1	A	a	DT
cord-305956-l02xdq87	147	2	single	single	RB
cord-305956-l02xdq87	147	3	-	-	HYPH
cord-305956-l02xdq87	147	4	centered	centered	JJ
cord-305956-l02xdq87	147	5	,	,	,
cord-305956-l02xdq87	147	6	retrospective	retrospective	JJ
cord-305956-l02xdq87	147	7	,	,	,
cord-305956-l02xdq87	147	8	observational	observational	JJ
cord-305956-l02xdq87	147	9	study	study	NN
cord-305956-l02xdq87	147	10	Clinical	clinical	JJ
cord-305956-l02xdq87	147	11	characteristics	characteristic	NNS
cord-305956-l02xdq87	147	12	of	of	IN
cord-305956-l02xdq87	147	13	82	82	CD
cord-305956-l02xdq87	147	14	death	death	NN
cord-305956-l02xdq87	147	15	cases	case	NNS
cord-305956-l02xdq87	147	16	with	with	IN
cord-305956-l02xdq87	147	17	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	147	18	Epidemiological	epidemiological	JJ
cord-305956-l02xdq87	147	19	and	and	CC
cord-305956-l02xdq87	147	20	clinical	clinical	JJ
cord-305956-l02xdq87	147	21	features	feature	NNS
cord-305956-l02xdq87	147	22	of	of	IN
cord-305956-l02xdq87	147	23	the	the	DT
cord-305956-l02xdq87	147	24	2019	2019	CD
cord-305956-l02xdq87	147	25	novel	novel	JJ
cord-305956-l02xdq87	147	26	coronavirus	coronavirus	NN
cord-305956-l02xdq87	147	27	outbreak	outbreak	NN
cord-305956-l02xdq87	147	28	in	in	IN
cord-305956-l02xdq87	147	29	China	China	NNP
cord-305956-l02xdq87	147	30	Clinical	clinical	JJ
cord-305956-l02xdq87	147	31	findings	finding	NNS
cord-305956-l02xdq87	147	32	in	in	IN
cord-305956-l02xdq87	147	33	a	a	DT
cord-305956-l02xdq87	147	34	group	group	NN
cord-305956-l02xdq87	147	35	of	of	IN
cord-305956-l02xdq87	147	36	patients	patient	NNS
cord-305956-l02xdq87	147	37	infected	infect	VBN
cord-305956-l02xdq87	147	38	with	with	IN
cord-305956-l02xdq87	147	39	the	the	DT
cord-305956-l02xdq87	147	40	2019	2019	CD
cord-305956-l02xdq87	147	41	novel	novel	NN
cord-305956-l02xdq87	147	42	coronavirus	coronavirus	NN
cord-305956-l02xdq87	147	43	(	(	-LRB-
cord-305956-l02xdq87	147	44	SARS	SARS	NNP
cord-305956-l02xdq87	147	45	-	-	HYPH
cord-305956-l02xdq87	147	46	Cov-2	Cov-2	NNP
cord-305956-l02xdq87	147	47	)	)	-RRB-
cord-305956-l02xdq87	147	48	outside	outside	IN
cord-305956-l02xdq87	147	49	of	of	IN
cord-305956-l02xdq87	147	50	Wuhan	Wuhan	NNP
cord-305956-l02xdq87	147	51	,	,	,
cord-305956-l02xdq87	147	52	China	China	NNP
cord-305956-l02xdq87	147	53	:	:	:
cord-305956-l02xdq87	148	1	Retrospective	retrospective	JJ
cord-305956-l02xdq87	148	2	case	case	NN
cord-305956-l02xdq87	148	3	series	series	NN
cord-305956-l02xdq87	148	4	Clinical	clinical	JJ
cord-305956-l02xdq87	148	5	characteristics	characteristic	NNS
cord-305956-l02xdq87	148	6	of	of	IN
cord-305956-l02xdq87	148	7	138	138	CD
cord-305956-l02xdq87	148	8	hospitalized	hospitalize	VBN
cord-305956-l02xdq87	148	9	patients	patient	NNS
cord-305956-l02xdq87	148	10	with	with	IN
cord-305956-l02xdq87	148	11	2019	2019	CD
cord-305956-l02xdq87	148	12	novel	novel	JJ
cord-305956-l02xdq87	148	13	coronavirusinfected	coronavirusinfecte	VBN
cord-305956-l02xdq87	148	14	pneumonia	pneumonia	NN
cord-305956-l02xdq87	148	15	in	in	IN
cord-305956-l02xdq87	148	16	Wuhan	Wuhan	NNP
cord-305956-l02xdq87	148	17	,	,	,
cord-305956-l02xdq87	149	1	China	China	NNP
cord-305956-l02xdq87	149	2	Radiological	radiological	JJ
cord-305956-l02xdq87	149	3	findings	finding	NNS
cord-305956-l02xdq87	149	4	from	from	IN
cord-305956-l02xdq87	149	5	81	81	CD
cord-305956-l02xdq87	149	6	patients	patient	NNS
cord-305956-l02xdq87	149	7	with	with	IN
cord-305956-l02xdq87	149	8	COVID-19	covid-19	JJ
cord-305956-l02xdq87	149	9	pneumonia	pneumonia	NN
cord-305956-l02xdq87	149	10	in	in	IN
cord-305956-l02xdq87	149	11	Wuhan	Wuhan	NNP
cord-305956-l02xdq87	149	12	,	,	,
cord-305956-l02xdq87	149	13	China	China	NNP
cord-305956-l02xdq87	149	14	:	:	:
cord-305956-l02xdq87	150	1	A	a	DT
cord-305956-l02xdq87	150	2	descriptive	descriptive	JJ
cord-305956-l02xdq87	150	3	study	study	NN
cord-305956-l02xdq87	150	4	Clinical	clinical	JJ
cord-305956-l02xdq87	150	5	characteristics	characteristic	NNS
cord-305956-l02xdq87	150	6	of	of	IN
cord-305956-l02xdq87	150	7	36	36	CD
cord-305956-l02xdq87	150	8	non	non	NNS
cord-305956-l02xdq87	150	9	-	-	NNS
cord-305956-l02xdq87	150	10	survivors	survivor	NNS
cord-305956-l02xdq87	150	11	with	with	IN
cord-305956-l02xdq87	150	12	COVID-19	covid-19	CD
cord-305956-l02xdq87	150	13	in	in	IN
cord-305956-l02xdq87	150	14	Wuhan	Wuhan	NNP
cord-305956-l02xdq87	150	15	Clinical	clinical	JJ
cord-305956-l02xdq87	150	16	characteristics	characteristic	NNS
cord-305956-l02xdq87	150	17	of	of	IN
cord-305956-l02xdq87	150	18	coronavirus	coronavirus	NN
cord-305956-l02xdq87	150	19	disease	disease	NN
cord-305956-l02xdq87	150	20	2019	2019	CD
cord-305956-l02xdq87	150	21	in	in	IN
cord-305956-l02xdq87	150	22	China	China	NNP
cord-305956-l02xdq87	150	23	COVID-19	covid-19	VBP
cord-305956-l02xdq87	150	24	in	in	IN
cord-305956-l02xdq87	150	25	a	a	DT
cord-305956-l02xdq87	150	26	designated	designate	VBN
cord-305956-l02xdq87	150	27	infectious	infectious	JJ
cord-305956-l02xdq87	150	28	diseases	disease	NNS
cord-305956-l02xdq87	150	29	hospital	hospital	NN
cord-305956-l02xdq87	150	30	outside	outside	IN
cord-305956-l02xdq87	150	31	Hubei	Hubei	NNP
cord-305956-l02xdq87	150	32	Province	Province	NNP
cord-305956-l02xdq87	150	33	Clinical	Clinical	NNP
cord-305956-l02xdq87	150	34	features	feature	NNS
cord-305956-l02xdq87	150	35	and	and	CC
cord-305956-l02xdq87	150	36	laboratory	laboratory	NN
cord-305956-l02xdq87	150	37	inspection	inspection	NN
cord-305956-l02xdq87	150	38	of	of	IN
cord-305956-l02xdq87	150	39	novel	novel	JJ
cord-305956-l02xdq87	150	40	coronavirus	coronavirus	NN
cord-305956-l02xdq87	150	41	pneumonia	pneumonia	NN
cord-305956-l02xdq87	150	42	(	(	-LRB-
cord-305956-l02xdq87	150	43	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	150	44	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	150	45	and	and	CC
cord-305956-l02xdq87	150	46	the	the	DT
cord-305956-l02xdq87	150	47	liver	liver	NN
cord-305956-l02xdq87	150	48	:	:	:
cord-305956-l02xdq87	150	49	Little	little	JJ
cord-305956-l02xdq87	150	50	cause	cause	NN
cord-305956-l02xdq87	150	51	for	for	IN
cord-305956-l02xdq87	150	52	concern	concern	NN
cord-305956-l02xdq87	150	53	Perioperative	Perioperative	NNP
cord-305956-l02xdq87	150	54	presentation	presentation	NN
cord-305956-l02xdq87	150	55	of	of	IN
cord-305956-l02xdq87	150	56	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	150	57	disease	disease	NN
cord-305956-l02xdq87	150	58	in	in	IN
cord-305956-l02xdq87	150	59	a	a	DT
cord-305956-l02xdq87	150	60	liver	liver	NN
cord-305956-l02xdq87	150	61	transplant	transplant	NN
cord-305956-l02xdq87	150	62	recipient	recipient	NN
cord-305956-l02xdq87	150	63	.	.	.
cord-305956-l02xdq87	151	1	Hepatology	Hepatology	NNP
cord-305956-l02xdq87	151	2	2020	2020	CD
cord-305956-l02xdq87	151	3	.	.	.
cord-305956-l02xdq87	152	1	Epub	Epub	NNP
cord-305956-l02xdq87	152	2	ahead	ahead	RB
cord-305956-l02xdq87	152	3	of	of	IN
cord-305956-l02xdq87	152	4	print	print	NN
cord-305956-l02xdq87	152	5	27	27	CD
cord-305956-l02xdq87	152	6	Clinical	clinical	JJ
cord-305956-l02xdq87	152	7	characteristics	characteristic	NNS
cord-305956-l02xdq87	152	8	of	of	IN
cord-305956-l02xdq87	152	9	non	non	JJ
cord-305956-l02xdq87	152	10	-	-	JJ
cord-305956-l02xdq87	152	11	ICU	ICU	NNP
cord-305956-l02xdq87	152	12	hospitalized	hospitalize	VBD
cord-305956-l02xdq87	152	13	patients	patient	NNS
cord-305956-l02xdq87	152	14	with	with	IN
cord-305956-l02xdq87	152	15	coronavirus	coronavirus	NN
cord-305956-l02xdq87	152	16	disease	disease	NN
cord-305956-l02xdq87	152	17	2019	2019	CD
cord-305956-l02xdq87	152	18	and	and	CC
cord-305956-l02xdq87	152	19	liver	liver	NN
cord-305956-l02xdq87	152	20	injury	injury	NN
cord-305956-l02xdq87	152	21	.	.	.
cord-305956-l02xdq87	153	1	A	a	DT
cord-305956-l02xdq87	153	2	retrospective	retrospective	JJ
cord-305956-l02xdq87	153	3	study	study	NN
cord-305956-l02xdq87	153	4	Liver	liver	NN
cord-305956-l02xdq87	153	5	impairment	impairment	NN
cord-305956-l02xdq87	153	6	in	in	IN
cord-305956-l02xdq87	153	7	COVID-19	covid-19	JJ
cord-305956-l02xdq87	153	8	patients	patient	NNS
cord-305956-l02xdq87	153	9	:	:	:
cord-305956-l02xdq87	153	10	A	a	DT
cord-305956-l02xdq87	153	11	retrospective	retrospective	JJ
cord-305956-l02xdq87	153	12	analysis	analysis	NN
cord-305956-l02xdq87	153	13	of	of	IN
cord-305956-l02xdq87	153	14	115	115	CD
cord-305956-l02xdq87	153	15	cases	case	NNS
cord-305956-l02xdq87	153	16	from	from	IN
cord-305956-l02xdq87	153	17	a	a	DT
cord-305956-l02xdq87	153	18	single	single	JJ
cord-305956-l02xdq87	153	19	center	center	NN
cord-305956-l02xdq87	153	20	in	in	IN
cord-305956-l02xdq87	153	21	Wuhan	Wuhan	NNP
cord-305956-l02xdq87	153	22	city	city	NN
cord-305956-l02xdq87	153	23	,	,	,
cord-305956-l02xdq87	153	24	China	China	NNP
cord-305956-l02xdq87	153	25	.	.	.
cord-305956-l02xdq87	154	1	Liver	liver	NN
cord-305956-l02xdq87	154	2	Int	Int	NNP
cord-305956-l02xdq87	154	3	2020	2020	CD
cord-305956-l02xdq87	154	4	.	.	.
cord-305956-l02xdq87	155	1	Epub	Epub	NNP
cord-305956-l02xdq87	155	2	ahead	ahead	RB
cord-305956-l02xdq87	155	3	of	of	IN
cord-305956-l02xdq87	155	4	print	print	NN
cord-305956-l02xdq87	155	5	2	2	CD
cord-305956-l02xdq87	156	1	The	the	DT
cord-305956-l02xdq87	156	2	clinical	clinical	JJ
cord-305956-l02xdq87	156	3	characteristics	characteristic	NNS
cord-305956-l02xdq87	156	4	of	of	IN
cord-305956-l02xdq87	156	5	pneumonia	pneumonia	NN
cord-305956-l02xdq87	156	6	patients	patient	NNS
cord-305956-l02xdq87	156	7	coinfected	coinfecte	VBD
cord-305956-l02xdq87	156	8	with	with	IN
cord-305956-l02xdq87	156	9	2019	2019	CD
cord-305956-l02xdq87	156	10	novel	novel	JJ
cord-305956-l02xdq87	156	11	coronavirus	coronavirus	NN
cord-305956-l02xdq87	156	12	and	and	CC
cord-305956-l02xdq87	156	13	influenza	influenza	NN
cord-305956-l02xdq87	156	14	virus	virus	NN
cord-305956-l02xdq87	156	15	in	in	IN
cord-305956-l02xdq87	156	16	Wuhan	Wuhan	NNP
cord-305956-l02xdq87	156	17	A	A	NNP
cord-305956-l02xdq87	156	18	comparative	comparative	JJ
cord-305956-l02xdq87	156	19	study	study	NN
cord-305956-l02xdq87	156	20	on	on	IN
cord-305956-l02xdq87	156	21	the	the	DT
cord-305956-l02xdq87	156	22	clinical	clinical	JJ
cord-305956-l02xdq87	156	23	features	feature	NNS
cord-305956-l02xdq87	156	24	of	of	IN
cord-305956-l02xdq87	156	25	COVID-19	covid-19	JJ
cord-305956-l02xdq87	156	26	pneumonia	pneumonia	NN
cord-305956-l02xdq87	156	27	to	to	IN
cord-305956-l02xdq87	156	28	other	other	JJ
cord-305956-l02xdq87	156	29	pneumonias	pneumonia	NNS
cord-305956-l02xdq87	156	30	COVID-19	covid-19	VBP
cord-305956-l02xdq87	156	31	and	and	CC
cord-305956-l02xdq87	156	32	liver	liver	NN
cord-305956-l02xdq87	156	33	dysfunction	dysfunction	NN
cord-305956-l02xdq87	156	34	:	:	:
cord-305956-l02xdq87	156	35	Current	current	JJ
cord-305956-l02xdq87	156	36	insights	insight	NNS
cord-305956-l02xdq87	156	37	and	and	CC
cord-305956-l02xdq87	156	38	emergent	emergent	JJ
cord-305956-l02xdq87	156	39	therapeutic	therapeutic	JJ
cord-305956-l02xdq87	156	40	strategies	strategy	NNS
cord-305956-l02xdq87	156	41	Clinical	clinical	JJ
cord-305956-l02xdq87	156	42	characteristics	characteristic	NNS
cord-305956-l02xdq87	156	43	and	and	CC
cord-305956-l02xdq87	156	44	intrauterine	intrauterine	JJ
cord-305956-l02xdq87	156	45	vertical	vertical	JJ
cord-305956-l02xdq87	156	46	transmission	transmission	NN
cord-305956-l02xdq87	156	47	potential	potential	NN
cord-305956-l02xdq87	156	48	of	of	IN
cord-305956-l02xdq87	156	49	COVID-19	covid-19	JJ
cord-305956-l02xdq87	156	50	infection	infection	NN
cord-305956-l02xdq87	156	51	in	in	IN
cord-305956-l02xdq87	156	52	nine	nine	CD
cord-305956-l02xdq87	156	53	pregnant	pregnant	JJ
cord-305956-l02xdq87	156	54	women	woman	NNS
cord-305956-l02xdq87	156	55	:	:	:
cord-305956-l02xdq87	156	56	A	a	DT
cord-305956-l02xdq87	156	57	retrospective	retrospective	JJ
cord-305956-l02xdq87	156	58	review	review	NN
cord-305956-l02xdq87	156	59	of	of	IN
cord-305956-l02xdq87	156	60	medical	medical	JJ
cord-305956-l02xdq87	156	61	records	record	NNS
cord-305956-l02xdq87	156	62	Time	Time	NNP
cord-305956-l02xdq87	156	63	course	course	NN
cord-305956-l02xdq87	156	64	of	of	IN
cord-305956-l02xdq87	156	65	lung	lung	NN
cord-305956-l02xdq87	156	66	changes	change	NNS
cord-305956-l02xdq87	156	67	on	on	IN
cord-305956-l02xdq87	156	68	chest	chest	NN
cord-305956-l02xdq87	156	69	CT	CT	NNP
cord-305956-l02xdq87	156	70	during	during	IN
cord-305956-l02xdq87	156	71	recovery	recovery	NN
cord-305956-l02xdq87	156	72	from	from	IN
cord-305956-l02xdq87	156	73	2019	2019	CD
cord-305956-l02xdq87	156	74	novel	novel	JJ
cord-305956-l02xdq87	156	75	coronavirus	coronavirus	NN
cord-305956-l02xdq87	156	76	(	(	-LRB-
cord-305956-l02xdq87	156	77	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	156	78	)	)	-RRB-
cord-305956-l02xdq87	156	79	pneumonia	pneumonia	NN
cord-305956-l02xdq87	156	80	.	.	.
cord-305956-l02xdq87	157	1	Radiology	Radiology	NNP
cord-305956-l02xdq87	157	2	Epub	Epub	NNP
cord-305956-l02xdq87	157	3	ahead	ahead	RB
cord-305956-l02xdq87	157	4	of	of	IN
cord-305956-l02xdq87	157	5	print	print	NN
cord-305956-l02xdq87	157	6	Bethesda	Bethesda	NNP
cord-305956-l02xdq87	157	7	(	(	-LRB-
cord-305956-l02xdq87	157	8	MD	MD	NNP
cord-305956-l02xdq87	157	9	)	)	-RRB-
cord-305956-l02xdq87	157	10	:	:	:
cord-305956-l02xdq87	157	11	National	National	NNP
cord-305956-l02xdq87	157	12	Institute	Institute	NNP
cord-305956-l02xdq87	157	13	of	of	IN
cord-305956-l02xdq87	157	14	Diabetes	Diabetes	NNP
cord-305956-l02xdq87	157	15	and	and	CC
cord-305956-l02xdq87	157	16	Digestive	digestive	JJ
cord-305956-l02xdq87	157	17	and	and	CC
cord-305956-l02xdq87	157	18	Kidney	kidney	NN
cord-305956-l02xdq87	157	19	Diseases	disease	NNS
cord-305956-l02xdq87	158	1	Clinical	clinical	JJ
cord-305956-l02xdq87	158	2	,	,	,
cord-305956-l02xdq87	158	3	laboratory	laboratory	NN
cord-305956-l02xdq87	158	4	and	and	CC
cord-305956-l02xdq87	158	5	imaging	imaging	NN
cord-305956-l02xdq87	158	6	features	feature	NNS
cord-305956-l02xdq87	158	7	of	of	IN
cord-305956-l02xdq87	158	8	COVID-19	covid-19	NN
cord-305956-l02xdq87	158	9	:	:	:
cord-305956-l02xdq87	158	10	A	a	DT
cord-305956-l02xdq87	158	11	systematic	systematic	JJ
cord-305956-l02xdq87	158	12	review	review	NN
cord-305956-l02xdq87	158	13	and	and	CC
cord-305956-l02xdq87	158	14	metaanalysis	metaanalysis	NN
cord-305956-l02xdq87	158	15	Clinical	clinical	JJ
cord-305956-l02xdq87	158	16	manifestations	manifestation	NNS
cord-305956-l02xdq87	158	17	,	,	,
cord-305956-l02xdq87	158	18	laboratory	laboratory	NN
cord-305956-l02xdq87	158	19	findings	finding	NNS
cord-305956-l02xdq87	158	20	,	,	,
cord-305956-l02xdq87	158	21	and	and	CC
cord-305956-l02xdq87	158	22	treatment	treatment	NN
cord-305956-l02xdq87	158	23	outcomes	outcome	NNS
cord-305956-l02xdq87	158	24	of	of	IN
cord-305956-l02xdq87	158	25	SARS	SARS	NNP
cord-305956-l02xdq87	158	26	patients	patient	NNS
cord-305956-l02xdq87	158	27	Systemic	systemic	JJ
cord-305956-l02xdq87	158	28	viral	viral	JJ
cord-305956-l02xdq87	158	29	infections	infection	NNS
cord-305956-l02xdq87	158	30	and	and	CC
cord-305956-l02xdq87	158	31	collateral	collateral	JJ
cord-305956-l02xdq87	158	32	damage	damage	NN
cord-305956-l02xdq87	158	33	in	in	IN
cord-305956-l02xdq87	158	34	the	the	DT
cord-305956-l02xdq87	158	35	liver	liver	NN
cord-305956-l02xdq87	159	1	A	a	DT
cord-305956-l02xdq87	159	2	trial	trial	NN
cord-305956-l02xdq87	159	3	of	of	IN
cord-305956-l02xdq87	159	4	lopinavir	lopinavir	NNS
cord-305956-l02xdq87	159	5	-	-	HYPH
cord-305956-l02xdq87	159	6	ritonavir	ritonavir	NNS
cord-305956-l02xdq87	159	7	in	in	IN
cord-305956-l02xdq87	159	8	adults	adult	NNS
cord-305956-l02xdq87	159	9	hospitalized	hospitalize	VBN
cord-305956-l02xdq87	159	10	with	with	IN
cord-305956-l02xdq87	159	11	severe	severe	JJ
cord-305956-l02xdq87	159	12	Covid-19	covid-19	NN
cord-305956-l02xdq87	159	13	Breakthrough	Breakthrough	NNP
cord-305956-l02xdq87	160	1	:	:	:
cord-305956-l02xdq87	160	2	Chloroquine	chloroquine	NN
cord-305956-l02xdq87	160	3	phosphate	phosphate	NN
cord-305956-l02xdq87	160	4	has	have	VBZ
cord-305956-l02xdq87	160	5	shown	show	VBN
cord-305956-l02xdq87	160	6	apparent	apparent	JJ
cord-305956-l02xdq87	160	7	efficacy	efficacy	NN
cord-305956-l02xdq87	160	8	in	in	IN
cord-305956-l02xdq87	160	9	treatment	treatment	NN
cord-305956-l02xdq87	160	10	of	of	IN
cord-305956-l02xdq87	160	11	COVID-19	covid-19	JJ
cord-305956-l02xdq87	160	12	associated	associated	JJ
cord-305956-l02xdq87	160	13	pneumonia	pneumonia	NN
cord-305956-l02xdq87	160	14	in	in	IN
cord-305956-l02xdq87	160	15	clinical	clinical	JJ
cord-305956-l02xdq87	160	16	studies	study	NNS
cord-305956-l02xdq87	160	17	Insights	insight	NNS
cord-305956-l02xdq87	160	18	from	from	IN
cord-305956-l02xdq87	160	19	nanomedicine	nanomedicine	NN
cord-305956-l02xdq87	160	20	into	into	IN
cord-305956-l02xdq87	160	21	chloroquine	chloroquine	JJ
cord-305956-l02xdq87	160	22	efficacy	efficacy	NN
cord-305956-l02xdq87	160	23	against	against	IN
cord-305956-l02xdq87	160	24	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	160	25	Prophylactic	prophylactic	JJ
cord-305956-l02xdq87	160	26	and	and	CC
cord-305956-l02xdq87	160	27	therapeutic	therapeutic	JJ
cord-305956-l02xdq87	160	28	remdesivir	remdesivir	NNS
cord-305956-l02xdq87	160	29	(	(	-LRB-
cord-305956-l02xdq87	160	30	GS-5734	GS-5734	NNP
cord-305956-l02xdq87	160	31	)	)	-RRB-
cord-305956-l02xdq87	160	32	treatment	treatment	NN
cord-305956-l02xdq87	160	33	in	in	IN
cord-305956-l02xdq87	160	34	the	the	DT
cord-305956-l02xdq87	160	35	rhesus	rhesus	NNP
cord-305956-l02xdq87	160	36	macaque	macaque	NN
cord-305956-l02xdq87	160	37	model	model	NN
cord-305956-l02xdq87	160	38	of	of	IN
cord-305956-l02xdq87	160	39	MERS	MERS	NNP
cord-305956-l02xdq87	160	40	-	-	HYPH
cord-305956-l02xdq87	160	41	CoV	CoV	NNP
cord-305956-l02xdq87	160	42	infection	infection	NN
cord-305956-l02xdq87	160	43	Clinical	clinical	JJ
cord-305956-l02xdq87	160	44	progression	progression	NN
cord-305956-l02xdq87	160	45	and	and	CC
cord-305956-l02xdq87	160	46	viral	viral	JJ
cord-305956-l02xdq87	160	47	load	load	NN
cord-305956-l02xdq87	160	48	in	in	IN
cord-305956-l02xdq87	160	49	a	a	DT
cord-305956-l02xdq87	160	50	community	community	NN
cord-305956-l02xdq87	160	51	outbreak	outbreak	NN
cord-305956-l02xdq87	160	52	of	of	IN
cord-305956-l02xdq87	160	53	coronavirusassociated	coronavirusassociate	VBN
cord-305956-l02xdq87	160	54	SARS	SARS	NNP
cord-305956-l02xdq87	160	55	pneumonia	pneumonia	NN
cord-305956-l02xdq87	160	56	:	:	:
cord-305956-l02xdq87	161	1	A	a	DT
cord-305956-l02xdq87	161	2	prospective	prospective	JJ
cord-305956-l02xdq87	161	3	study	study	NN
cord-305956-l02xdq87	161	4	Care	care	NN
cord-305956-l02xdq87	161	5	of	of	IN
cord-305956-l02xdq87	161	6	patients	patient	NNS
cord-305956-l02xdq87	161	7	with	with	IN
cord-305956-l02xdq87	161	8	liver	liver	NN
cord-305956-l02xdq87	161	9	disease	disease	NN
cord-305956-l02xdq87	161	10	during	during	IN
cord-305956-l02xdq87	161	11	the	the	DT
cord-305956-l02xdq87	161	12	COVID-19	COVID-19	NNP
cord-305956-l02xdq87	161	13	pandemic	pandemic	NN
cord-305956-l02xdq87	162	1	:	:	:
cord-305956-l02xdq87	162	2	EASL	EASL	NNP
cord-305956-l02xdq87	162	3	-	-	HYPH
cord-305956-l02xdq87	162	4	ESCMID	ESCMID	NNP
cord-305956-l02xdq87	162	5	position	position	NN
cord-305956-l02xdq87	162	6	paper	paper	NN
cord-305956-l02xdq87	163	1	The	the	DT
cord-305956-l02xdq87	163	2	authors	author	NNS
cord-305956-l02xdq87	163	3	received	receive	VBD
cord-305956-l02xdq87	163	4	no	no	DT
cord-305956-l02xdq87	163	5	financial	financial	JJ
cord-305956-l02xdq87	163	6	support	support	NN
cord-305956-l02xdq87	163	7	for	for	IN
cord-305956-l02xdq87	163	8	the	the	DT
cord-305956-l02xdq87	163	9	research	research	NN
cord-305956-l02xdq87	163	10	,	,	,
cord-305956-l02xdq87	163	11	authorship	authorship	NN
cord-305956-l02xdq87	163	12	,	,	,
cord-305956-l02xdq87	163	13	and/or	and/or	CC
cord-305956-l02xdq87	163	14	publication	publication	NN
cord-305956-l02xdq87	163	15	of	of	IN
cord-305956-l02xdq87	163	16	this	this	DT
cord-305956-l02xdq87	163	17	article	article	NN
cord-305956-l02xdq87	163	18	.	.	.
cord-305956-l02xdq87	164	1	J€	J€	NNP
cord-305956-l02xdq87	164	2	orn	orn	NN
cord-305956-l02xdq87	164	3	M	M	NNP
cord-305956-l02xdq87	164	4	Schattenberg	Schattenberg	NNP
cord-305956-l02xdq87	164	5	https://orcid.org/0000-0002-4224-4703	https://orcid.org/0000-0002-4224-4703	NNP